uid	similarity	catnum	ti_uid	gene	indication_mesh_id	indication_mesh_term	hcat	acat	ccat	hcatnum	acatnum	ccatnum	succ_p_1	succ_1_2	succ_2_3	succ_3_a	orphan	year_launch	arow	assoc_mesh_id	assoc_mesh_term	assoc_source	assoc_info	original_trait	original_link	assoc_year	pic_qtl_pval	pic_h4	af_gnomad_nfe	l2g_share	l2g_rank	tia	cat	assoc_share	assoc_rank	source_name	gwas_source	min_assoc_year	abs_beta	abs_or	highest_phase_with_known_outcome	areas	genetic_insight	target_status	launched
ACE-D006973	1	5	ACE-D006973	ACE	D006973	Hypertension	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE	2013	6586	D006973	Hypertension	OTG		Angiotensin-converting enzyme activity	https://genetics.opentargets.org/study/GCST000565	2010			0.477350539899921	0.72	1	ACE-D006973-D006973	Launched	0.72	1	GWAS	GWAS Catalog	2010		16.2	3	cardiovascular	both	genetically supported target	TRUE
ACVR2A-D007676	0.95	3	ACVR2A-D007676	ACVR2A	D007676	Kidney Failure, Chronic	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		9621	D051436	Renal Insufficiency, Chronic	OTG		Serum urea levels	https://genetics.opentargets.org/study/GCST90025991	2021			0.2869429241595	0.71	1	ACVR2A-D007676-D051436	Phase II	0.71	1	GWAS	GWAS Catalog	2021	0.0148957999999999		2	other	both	genetically supported target	FALSE
ACVRL1-D000740	1	3	ACVRL1-D000740	ACVRL1	D000740	Anemia		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		9673	D000740	Anemia	OTG		Hemoglobin	https://genetics.opentargets.org/study/GCST005995	2018			0.116363636363636	0.53	1	ACVRL1-D000740-D000740	Phase II	0.53	1	GWAS	GWAS Catalog	2018			1	hematology	both	genetically supported target	FALSE
ADORA1-D001249	1	3	ADORA1-D001249	ADORA1	D001249	Asthma		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		14867	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST003987	2016			0.344225022736131	0.58	1	ADORA1-D001249-D001249	Phase II	0.58	1	GWAS	GWAS Catalog	2016			1	respiratory, immune	both	genetically supported target	FALSE
ADORA1-D029424	0.807	3	ADORA1-D029424	ADORA1	D029424	Pulmonary Disease, Chronic Obstructive		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		14867	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST003987	2016			0.344225022736131	0.58	1	ADORA1-D029424-D001249	Phase II	0.58	1	GWAS	GWAS Catalog	2016			1	respiratory	both	genetically supported target	FALSE
ADRA1A-D006973	1	4	ADRA1A-D006973	ADRA1A	D006973	Hypertension	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		14999	D006973	Hypertension	OTG		Diastolic blood pressure	https://genetics.opentargets.org/study/GCST90025981	2021			0.396988186420875	0.81	1	ADRA1A-D006973-D006973	Phase III	0.81	1	GWAS	GWAS Catalog	2021	0.0120837		3	cardiovascular	both	genetically supported target	FALSE
ADRA2C-D006973	1	5	ADRA2C-D006973	ADRA2C	D006973	Hypertension	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		15124	D006973	Hypertension	OTG		Systolic blood pressure	https://genetics.opentargets.org/study/GCST007087	2018			0.438827361563518	0.88	1	ADRA2C-D006973-D006973	Launched	0.88	1	GWAS	GWAS Catalog	2018			3	cardiovascular	both	genetically supported target	TRUE
ADRB1-D000544	0.891	3	ADRB1-D000544	ADRB1	D000544	Alzheimer Disease		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		15257	D024801	Tauopathies	OTG		Neurofibrillary tangles (SNP x SNP interaction)	https://genetics.opentargets.org/study/GCST010343	2020			0.146577477594493	0.57	1	ADRB1-D000544-D024801	Phase II	0.57	1	GWAS	GWAS Catalog	2020			1	neurology, psychiatry	both	genetically supported target	FALSE
ADRB1-D006949	0.804	2	ADRB1-D006949	ADRB1	D006949	Hyperlipidemias	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		15270	D052456	Hypoalphalipoproteinemias	OTG		High density lipoprotein cholesterol levels	https://genetics.opentargets.org/study/GCST009148	2017			0.733727426269975	0.82	1	ADRB1-D006949-D052456	Phase I	0.82	1	GWAS	GWAS Catalog	2017	0.019		1	metabolic	both	genetically supported target	FALSE
ADRB1-D006973	1	5	ADRB1-D006973	ADRB1	D006973	Hypertension	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		15205	D006973	Hypertension	OTG		Blood pressure [Mean Arterial Pressure]	https://genetics.opentargets.org/study/GCST001236_2	2011			0.702169112871802	0.73	1	ADRB1-D006973-D006973	Launched	0.73	1	GWAS	GWAS Catalog	2011	0.338		3	cardiovascular	both	genetically supported target	TRUE
ADRB2-D001249	1	5	ADRB2-D001249	ADRB2	D001249	Asthma	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2004	15280	D001249	Asthma	OTG		Lung function (FEV1/FVC)	https://genetics.opentargets.org/study/GCST007431	2019			0.153561697158427	0.88	1	ADRB2-D001249-D001249	Launched	0.88	1	GWAS	GWAS Catalog	2019	0.0247		3	respiratory, immune	both	genetically supported target	TRUE
ADRB2-D006949	0.898	2	ADRB2-D006949	ADRB2	D006949	Hyperlipidemias	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		15372	D050171	Dyslipidemias	OTG		Apolipoprotein A1 levels	https://genetics.opentargets.org/study/GCST90025955	2021			0.0114063512637719	0.91	1	ADRB2-D006949-D050171	Phase I	0.91	1	GWAS	GWAS Catalog	2021	0.0505939		1	metabolic	both	genetically supported target	FALSE
ADRB2-D006973	1	5	ADRB2-D006973	ADRB2	D006973	Hypertension	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2007	15339	D006973	Hypertension	OTG		Diastolic blood pressure	https://genetics.opentargets.org/study/GCST90000059	2020			0.0114063512637719	0.91	1	ADRB2-D006973-D006973	Launched	0.91	1	GWAS	GWAS Catalog	2020	0.03775712		3	cardiovascular	both	genetically supported target	TRUE
ADRB2-D029424	0.807	5	ADRB2-D029424	ADRB2	D029424	Pulmonary Disease, Chronic Obstructive	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2009	15280	D001249	Asthma	OTG		Lung function (FEV1/FVC)	https://genetics.opentargets.org/study/GCST007431	2019			0.153561697158427	0.88	1	ADRB2-D029424-D001249	Launched	0.88	1	GWAS	GWAS Catalog	2019	0.0247		3	respiratory	both	genetically supported target	TRUE
AGT-D006973	1	5	AGT-D006973	AGT	D006973	Hypertension	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		17375	D006973	Hypertension	OTG		Mean arterial pressure	https://genetics.opentargets.org/study/GCST006231	2016			0.439781733142783	0.71	1	AGT-D006973-D006973	Launched	0.71	1	GWAS	GWAS Catalog	2016	0.32885453		3	cardiovascular	both	genetically supported target	TRUE
ALCAM-D001943	1	3	ALCAM-D001943	ALCAM	D001943	Breast Neoplasms		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		20171	D001943	Breast Neoplasms	OTG		Breast cancer	https://genetics.opentargets.org/study/GCST009665	2019			0.105952535339126	1	1	ALCAM-D001943-D001943	Phase II	1	1	GWAS	GWAS Catalog	2019		1.21574	1	oncology	both	genetically supported target	FALSE
ALDH2-D000437	0.852	2	ALDH2-D000437	ALDH2	D000437	Alcoholism		Phase I	Phase I		3	2	TRUE				FALSE		21182	D008104	Liver Cirrhosis, Alcoholic	OTG		Cirrhosis	https://genetics.opentargets.org/study/GCST90018826	2021			0	0.81	1	ALDH2-D000437-D008104	Phase I	0.81	1	GWAS	GWAS Catalog	2021	0.2797		0	psychiatry	gwas	genetically supported target	FALSE
ALDH2-D019973	0.859	3	ALDH2-D019973	ALDH2	D019973	Alcohol-Related Disorders	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		21182	D008104	Liver Cirrhosis, Alcoholic	OTG		Cirrhosis	https://genetics.opentargets.org/study/GCST90018826	2021			0	0.81	1	ALDH2-D019973-D008104	Phase II	0.81	1	GWAS	GWAS Catalog	2021	0.2797		2	psychiatry	gwas	genetically supported target	FALSE
ALPL-D061205	0.801	2	ALPL-D061205	ALPL	D061205	Vascular Calcification		Phase I	Phase I		3	2	TRUE				FALSE		22614	D002128	Calcium Metabolism Disorders	OTG		Calcium levels	https://genetics.opentargets.org/study/GCST012398	2021			0.420891437508145	0.6	1	ALPL-D061205-D002128	Phase I	0.6	1	GWAS	GWAS Catalog	2021	0.002386		0	metabolic	both	genetically supported target	FALSE
ANGPTL4-D015228	1	2	ANGPTL4-D015228	ANGPTL4	D015228	Hypertriglyceridemia		Phase I	Phase I		3	2	TRUE				FALSE		24720	D015228	Hypertriglyceridemia	OTG		Triglyceride levels	https://genetics.opentargets.org/study/GCST010244	2020			0.0620119729307652	0.7	1	ANGPTL4-D015228-D015228	Phase I	0.7	1	GWAS	GWAS Catalog	2020	0.0426643		0	metabolic	both	genetically supported target	FALSE
ANGPTL8-D006949	0.804	2	ANGPTL8-D006949	ANGPTL8	D006949	Hyperlipidemias	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		24884	D052456	Hypoalphalipoproteinemias	OTG		HDL cholesterol	https://genetics.opentargets.org/study/GCST001904	2013			0.050376525577772	0.5	1	ANGPTL8-D006949-D052456	Phase I	0.5	1	GWAS	GWAS Catalog	2013			1	metabolic	both	genetically supported target	FALSE
APOA1-D006937	0.874	3	APOA1-D006937	APOA1	D006937	Hypercholesterolemia	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		29809	D050171	Dyslipidemias	OTG		Apolipoprotein A1 levels	https://genetics.opentargets.org/study/GCST010241	2020			0.673179280799688	0.62	1	APOA1-D006937-D050171	Phase II	0.62	1	GWAS	GWAS Catalog	2020	0.0849428		2	metabolic	both	genetically supported target	FALSE
APOA1-D006938	0.83	3	APOA1-D006938	APOA1	D006938	Hyperlipoproteinemia Type II	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		29809	D050171	Dyslipidemias	OTG		Apolipoprotein A1 levels	https://genetics.opentargets.org/study/GCST010241	2020			0.673179280799688	0.62	1	APOA1-D006938-D050171	Phase II	0.62	1	GWAS	GWAS Catalog	2020	0.0849428		2	congenital, metabolic	both	genetically supported target	FALSE
APOE-D000544	1	3	APOE-D000544	APOE	D000544	Alzheimer Disease		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		32244	D000544	Alzheimer Disease	OTG		Alzheimer's disease (late onset)	https://genetics.opentargets.org/study/GCST002245	2013			0.0820817552566279	0.63	1	APOE-D000544-D000544	Phase II	0.63	1	GWAS	GWAS Catalog	2013		1.4727037542852917	1	neurology, psychiatry	both	genetically supported target	FALSE
APOE-D006938	0.844	3	APOE-D006938	APOE	D006938	Hyperlipoproteinemia Type II	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		32470	D006937	Hypercholesterolemia	OTG		LDL cholesterol	https://genetics.opentargets.org/study/GCST001645	2012			0.0820817552566279	0.59	1	APOE-D006938-D006937	Phase II	0.59	1	GWAS	GWAS Catalog	2012			2	congenital, metabolic	both	genetically supported target	FALSE
APOL1-D005923	1	4	APOL1-D005923	APOL1	D005923	Glomerulosclerosis, Focal Segmental		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		33176	D005923	Glomerulosclerosis, Focal Segmental	OTG		Glomerulosclerosis [AA]	https://genetics.opentargets.org/study/GCST000741	2010			0.803453200051928	0.77	1	APOL1-D005923-D005923	Phase III	0.77	1	GWAS	GWAS Catalog	2010			2	other	both	genetically supported target	FALSE
APOL1-D007676	1	2	APOL1-D007676	APOL1	D007676	Kidney Failure, Chronic		Phase I	Phase I		3	2	TRUE				FALSE		33178	D007676	Kidney Failure, Chronic	OTG		End-stage kidney disease	https://genetics.opentargets.org/study/GCST008395	2019			2.596391016487e-4	0.82	1	APOL1-D007676-D007676	Phase I	0.82	1	GWAS	GWAS Catalog	2019		1.51	0	other	both	genetically supported target	FALSE
APOL1-D051437	0.93	2	APOL1-D051437	APOL1	D051437	Renal Insufficiency		Phase I	Phase I		3	2	TRUE				FALSE		33178	D007676	Kidney Failure, Chronic	OTG		End-stage kidney disease	https://genetics.opentargets.org/study/GCST008395	2019			2.596391016487e-4	0.82	1	APOL1-D051437-D007676	Phase I	0.82	1	GWAS	GWAS Catalog	2019		1.51	0	other	both	genetically supported target	FALSE
AR-D011471	1	5	AR-D011471	AR	D011471	Prostatic Neoplasms	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2022	33806	D011471	Prostatic Neoplasms	OTG		Prostate cancer	https://genetics.opentargets.org/study/GCST011049	2021			0.843402973837756	0.83	1	AR-D011471-D011471	Launched	0.83	1	GWAS	GWAS Catalog	2021		1.06	3	oncology	both	genetically supported target	TRUE
AVPR1A-D018805	0.809	4	AVPR1A-D018805	AVPR1A	D018805	Sepsis	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		47786	D007249	Inflammation	OTG		C-reactive protein levels	https://genetics.opentargets.org/study/GCST009777	2020			0.271917273673257	0.66	1	AVPR1A-D018805-D007249	Phase III	0.66	1	GWAS	GWAS Catalog	2020	0.0130231		3	infection, signs/symptoms	gwas	genetically supported target	FALSE
BCL11A-D000755	0.868	2	BCL11A-D000755	BCL11A	D000755	Anemia, Sickle Cell		Phase I	Phase I		3	2	TRUE				FALSE		52491	D017086	beta-Thalassemia	OTG		Beta thalassemia/hemoglobin E disease	https://genetics.opentargets.org/study/GCST000532	2009			0.841425418668051	0.91	1	BCL11A-D000755-D017086	Phase I	0.91	1	GWAS	GWAS Catalog	2009			0	hematology, congenital	both	genetically supported target	FALSE
BCL11A-D013789	0.923	3	BCL11A-D013789	BCL11A	D013789	Thalassemia		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		52491	D017086	beta-Thalassemia	OTG		Beta thalassemia/hemoglobin E disease	https://genetics.opentargets.org/study/GCST000532	2009			0.841425418668051	0.91	1	BCL11A-D013789-D017086	Phase II	0.91	1	GWAS	GWAS Catalog	2009			1	hematology, congenital	both	genetically supported target	FALSE
BCL2-D000740	1	3	BCL2-D000740	BCL2	D000740	Anemia	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		52696	D000740	Anemia	OTG		Mean corpuscular volume	https://genetics.opentargets.org/study/GCST004602	2016			0.0377676833225178	0.85	1	BCL2-D000740-D000740	Phase II	0.85	1	GWAS	GWAS Catalog	2016	0.09760817		2	hematology	both	genetically supported target	FALSE
BCL2-D008224	1	3	BCL2-D008224	BCL2	D008224	Lymphoma, Follicular		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		52848	D008224	Lymphoma, Follicular	OTG		Follicular lymphoma	https://genetics.opentargets.org/study/GCST002643	2014			0.0845015576323987	0.82	1	BCL2-D008224-D008224	Phase II	0.82	1	GWAS	GWAS Catalog	2014		1.3399999999999999	1	oncology	gwas	genetically supported target	FALSE
BCL2-D015451	1	5	BCL2-D015451	BCL2	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE	2018	52906	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	OTG		Chronic lymphocytic leukemia	https://genetics.opentargets.org/study/GCST002073	2013			0.0856901920083031	0.82	1	BCL2-D015451-D015451	Launched	0.82	1	GWAS	GWAS Catalog	2013		1.470000000000001	3	oncology	both	genetically supported target	TRUE
BCL2-D054198	0.861	2	BCL2-D054198	BCL2	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma		Phase I	Phase I		3	2	TRUE				TRUE		52906	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	OTG		Chronic lymphocytic leukemia	https://genetics.opentargets.org/study/GCST002073	2013			0.0856901920083031	0.82	1	BCL2-D054198-D015451	Phase I	0.82	1	GWAS	GWAS Catalog	2013		1.470000000000001	0	oncology	both	genetically supported target	FALSE
C3-D008181	0.831	3	C3-D008181	C3	D008181	Lupus Nephritis		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		67810	D008180	Lupus Erythematosus, Systemic	OTG		Systemic lupus erythematosus	https://genetics.opentargets.org/study/GCST011956	2020			0.478885135135135	0.56	1	C3-D008181-D008180	Phase II	0.56	1	GWAS	GWAS Catalog	2020		1.19047619047619	1	dermatology, immune	both	genetically supported target	FALSE
CACNA2D1-D001008	0.883	4	CACNA2D1-D001008	CACNA2D1	D001008	Anxiety Disorders	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		71419	D009497	Neurotic Disorders	OTG		Feeling nervous	https://genetics.opentargets.org/study/GCST006948	2018			0.584363210615325	0.96	1	CACNA2D1-D001008-D009497	Phase III	0.96	1	GWAS	GWAS Catalog	2018	0.013417954095938		3	psychiatry	gwas	genetically supported target	FALSE
CALCB-D008881	1	5	CALCB-D008881	CALCB	D008881	Migraine Disorders	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		72459	D008881	Migraine Disorders	OTG		Migraine	https://genetics.opentargets.org/study/GCST90038646	2021			0.616465079984393	0.53	1	CALCB-D008881-D008881	Launched	0.53	1	GWAS	GWAS Catalog	2021		1.0020787876893946	3	neurology	both	genetically supported target	TRUE
CALCR-D003920	1	3	CALCR-D003920	CALCR	D003920	Diabetes Mellitus	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		72520	D003920	Diabetes Mellitus	OTG		Hemoglobin A1c levels	https://genetics.opentargets.org/study/GCST90025974	2021			0.500586854460094	0.55	1	CALCR-D003920-D003920	Phase II	0.55	1	GWAS	GWAS Catalog	2021	0.0119235		2	metabolic, endocrine	both	genetically supported target	FALSE
CALCR-D003924	1	3	CALCR-D003924	CALCR	D003924	Diabetes Mellitus, Type 2		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		72521	D003924	Diabetes Mellitus, Type 2	OTG		Type 2 diabetes	https://genetics.opentargets.org/study/GCST010118	2020			0.500914196160376	0.73	1	CALCR-D003924-D003924	Phase II	0.73	1	GWAS	GWAS Catalog	2020		1.0399999999999996	1	metabolic, endocrine	both	genetically supported target	FALSE
CALCR-D009765	1	3	CALCR-D009765	CALCR	D009765	Obesity		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		72528	D009765	Obesity	OTG		Hip circumference [EA]	https://genetics.opentargets.org/study/GCST004066_4	2015			0.395581546458739	0.85	1	CALCR-D009765-D009765	Phase II	0.85	1	GWAS	GWAS Catalog	2015	0.0254		1	metabolic, signs/symptoms	both	genetically supported target	FALSE
CASP8-D008107	1	2	CASP8-D008107	CASP8	D008107	Liver Diseases		Phase I	Phase I		3	2	TRUE				FALSE		75350	D008107	Liver Diseases	OTG		Gamma glutamyl transferase levels	https://genetics.opentargets.org/study/GCST90019507	2021			0.700954123643968	0.5	1	CASP8-D008107-D008107	Phase I	0.5	1	GWAS	GWAS Catalog	2021	0.017		0	digestive	both	genetically supported target	FALSE
CASP8-D008175	0.859	2	CASP8-D008175	CASP8	D008175	Lung Neoplasms	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		75321	D002289	Carcinoma, Non-Small-Cell Lung	OTG		Non-small cell lung cancer	https://genetics.opentargets.org/study/GCST008834	2019			0.668533472258401	0.53	1	CASP8-D008175-D002289	Phase I	0.53	1	GWAS	GWAS Catalog	2019		1.0799999999999998	1	oncology	both	genetically supported target	FALSE
CCL20-D003093	1	2	CCL20-D003093	CCL20	D003093	Colitis, Ulcerative	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		81452	D003093	Colitis, Ulcerative	OTG		Ulcerative colitis [EA]	https://genetics.opentargets.org/study/GCST003045	2015			0.675962038481539	0.7	1	CCL20-D003093-D003093	Phase I	0.7	1	GWAS	GWAS Catalog	2015		1.0762394778137	1	digestive	both	genetically supported target	FALSE
CCND1-D001943	1	2	CCND1-D001943	CCND1	D001943	Breast Neoplasms	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		82055	D001943	Breast Neoplasms	OTG		Breast cancer	https://genetics.opentargets.org/study/GCST004950	2015			0.0642189932537623	0.55	1	CCND1-D001943-D001943	Phase I	0.55	1	GWAS	GWAS Catalog	2015		1.31	1	oncology	both	genetically supported target	FALSE
CCNE1-D001943	1	2	CCNE1-D001943	CCNE1	D001943	Breast Neoplasms		Phase I	Phase I		3	2	TRUE				FALSE		82914	D001943	Breast Neoplasms	OTG		Breast cancer	https://genetics.opentargets.org/study/GCST005077	2017			0.326389792995704	0.82	1	CCNE1-D001943-D001943	Phase I	0.82	1	GWAS	GWAS Catalog	2017		1.07	0	oncology	both	genetically supported target	FALSE
CD200R1-D003876	0.851	2	CD200R1-D003876	CD200R1	D003876	Dermatitis, Atopic		Phase I	Phase I		3	2	TRUE				FALSE		84772	D004485	Eczema	OTG		Eczema	https://genetics.opentargets.org/study/GCST90044763	2021			0.547449045826301	0.83	1	CD200R1-D003876-D004485	Phase I	0.83	1	GWAS	GWAS Catalog	2021		1.0638297872340425	0	congenital, dermatology, immune	gwas	genetically supported target	FALSE
CD28-D001172	1	3	CD28-D001172	CD28	D001172	Arthritis, Rheumatoid		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		85214	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis	https://genetics.opentargets.org/study/GCST002318	2013			0.771311794472557	0.88	1	CD28-D001172-D001172	Phase II	0.88	1	GWAS	GWAS Catalog	2013		1.1199999999999999	1	musculoskeletal, dermatology, immune	gwas	genetically supported target	FALSE
CD28-D001327	1	2	CD28-D001327	CD28	D001327	Autoimmune Diseases		Phase I	Phase I		3	2	TRUE				FALSE		85222	D001327	Autoimmune Diseases	OTG		Autoimmune traits (pleiotropy)	https://genetics.opentargets.org/study/GCST009873	2018			0.771174330995064	0.84	1	CD28-D001327-D001327	Phase I	0.84	1	GWAS	GWAS Catalog	2018			0	immune	both	genetically supported target	FALSE
CD28-D011565	1	3	CD28-D011565	CD28	D011565	Psoriasis	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		85255	D011565	Psoriasis	OTG		Psoriasis	https://genetics.opentargets.org/study/GCST005527	2012			0.0222294232015554	0.85	1	CD28-D011565-D011565	Phase II	0.85	1	GWAS	GWAS Catalog	2012		37.03703703703717	2	dermatology	both	genetically supported target	FALSE
CD28-D012859	0.81	2	CD28-D012859	CD28	D012859	Sjogren's Syndrome	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		85214	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis	https://genetics.opentargets.org/study/GCST002318	2013			0.771311794472557	0.88	1	CD28-D012859-D001172	Phase I	0.88	1	GWAS	GWAS Catalog	2013		1.1199999999999999	1	musculoskeletal, ophthalmology, dermatology, immune	both	genetically supported target	FALSE
CD28-D015535	0.899	2	CD28-D015535	CD28	D015535	Arthritis, Psoriatic	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		85255	D011565	Psoriasis	OTG		Psoriasis	https://genetics.opentargets.org/study/GCST005527	2012			0.0222294232015554	0.85	1	CD28-D015535-D011565	Phase I	0.85	1	GWAS	GWAS Catalog	2012		37.03703703703717	1	musculoskeletal, dermatology	both	genetically supported target	FALSE
CD33-D000544	1	2	CD33-D000544	CD33	D000544	Alzheimer Disease	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		85622	D000544	Alzheimer Disease	OTG		Alzheimer's disease (late onset)	https://genetics.opentargets.org/study/GCST001026	2011			0.321168831168831	0.71	1	CD33-D000544-D000544	Phase I	0.71	1	GWAS	GWAS Catalog	2011			1	neurology, psychiatry	both	genetically supported target	FALSE
CD40-D001172	1	3	CD40-D001172	CD40	D001172	Arthritis, Rheumatoid		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		86064	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis	https://genetics.opentargets.org/study/GCST000232	2008			0.7545159194282	0.69	1	CD40-D001172-D001172	Phase II	0.69	1	GWAS	GWAS Catalog	2008		1.15	1	musculoskeletal, dermatology, immune	gwas	genetically supported target	FALSE
CD40-D003093	0.89	3	CD40-D003093	CD40	D003093	Colitis, Ulcerative	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		86109	D015212	Inflammatory Bowel Diseases	OTG		Inflammatory bowel disease	https://genetics.opentargets.org/study/GCST001725	2012			0.754772107518504	0.71	1	CD40-D003093-D015212	Phase II	0.71	1	GWAS	GWAS Catalog	2012		1.091	2	digestive	both	genetically supported target	FALSE
CD40-D003424	0.907	3	CD40-D003424	CD40	D003424	Crohn Disease	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		86109	D015212	Inflammatory Bowel Diseases	OTG		Inflammatory bowel disease	https://genetics.opentargets.org/study/GCST001725	2012			0.754772107518504	0.71	1	CD40-D003424-D015212	Phase II	0.71	1	GWAS	GWAS Catalog	2012		1.091	2	digestive	both	genetically supported target	FALSE
CD40-D008180	1	3	CD40-D008180	CD40	D008180	Lupus Erythematosus, Systemic		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		86091	D008180	Lupus Erythematosus, Systemic	OTG		Systemic lupus erythematosus	https://genetics.opentargets.org/study/GCST005752	2017			0.7545159194282	0.67	1	CD40-D008180-D008180	Phase II	0.67	1	GWAS	GWAS Catalog	2017			1	dermatology, immune	both	genetically supported target	FALSE
CD40-D008181	0.831	3	CD40-D008181	CD40	D008181	Lupus Nephritis		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		86091	D008180	Lupus Erythematosus, Systemic	OTG		Systemic lupus erythematosus	https://genetics.opentargets.org/study/GCST005752	2017			0.7545159194282	0.67	1	CD40-D008181-D008180	Phase II	0.67	1	GWAS	GWAS Catalog	2017			1	dermatology, immune	both	genetically supported target	FALSE
CD40-D012859	0.81	3	CD40-D012859	CD40	D012859	Sjogren's Syndrome		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		86064	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis	https://genetics.opentargets.org/study/GCST000232	2008			0.7545159194282	0.69	1	CD40-D012859-D001172	Phase II	0.69	1	GWAS	GWAS Catalog	2008		1.15	1	musculoskeletal, ophthalmology, dermatology, immune	both	genetically supported target	FALSE
CD6-D009103	1	2	CD6-D009103	CD6	D009103	Multiple Sclerosis	Phase I		Phase I	2		2	TRUE	FALSE			TRUE		86508	D009103	Multiple Sclerosis	OTG		Multiple sclerosis	https://genetics.opentargets.org/study/GCST009597	2019			0.36053799947767	0.5	1	CD6-D009103-D009103	Phase I	0.5	1	GWAS	GWAS Catalog	2019			1	neurology, immune	both	genetically supported target	FALSE
CD80-D008180	1	2	CD80-D008180	CD80	D008180	Lupus Erythematosus, Systemic	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		86707	D008180	Lupus Erythematosus, Systemic	OTG		Systemic lupus erythematosus	https://genetics.opentargets.org/study/GCST001795	2012			0.163839470417873	0.65	1	CD80-D008180-D008180	Phase I	0.65	1	GWAS	GWAS Catalog	2012		1.2657999999999994	1	dermatology, immune	both	genetically supported target	FALSE
CDK6-D011471	1	4	CDK6-D011471	CDK6	D011471	Prostatic Neoplasms		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		90322	D011471	Prostatic Neoplasms	OTG		Prostate cancer	https://genetics.opentargets.org/study/GCST011049	2021			0.0957598547717842	0.57	1	CDK6-D011471-D011471	Phase III	0.57	1	GWAS	GWAS Catalog	2021		1.056	2	oncology	both	genetically supported target	FALSE
CDKN1A-D015179	1	3	CDKN1A-D015179	CDKN1A	D015179	Colorectal Neoplasms	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		90908	D015179	Colorectal Neoplasms	OTG		Colorectal cancer	https://genetics.opentargets.org/study/GCST001544	2012			0.236695223260644	0.6	1	CDKN1A-D015179-D015179	Phase II	0.6	1	GWAS	GWAS Catalog	2012			2	oncology	both	genetically supported target	FALSE
CETP-D006937	0.874	4	CETP-D006937	CETP	D006937	Hypercholesterolemia	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		97849	D050171	Dyslipidemias	OTG		Lipid metabolism phenotypes [APOA1.assay, fasting]	https://genetics.opentargets.org/study/GCST000533	2009			0.445838751625488	0.68	1	CETP-D006937-D050171	Phase III	0.68	1	GWAS	GWAS Catalog	2009			3	metabolic	both	genetically supported target	FALSE
CETP-D006938	0.83	4	CETP-D006938	CETP	D006938	Hyperlipoproteinemia Type II	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		97849	D050171	Dyslipidemias	OTG		Lipid metabolism phenotypes [APOA1.assay, fasting]	https://genetics.opentargets.org/study/GCST000533	2009			0.445838751625488	0.68	1	CETP-D006938-D050171	Phase III	0.68	1	GWAS	GWAS Catalog	2009			3	congenital, metabolic	both	genetically supported target	FALSE
CETP-D006949	0.804	4	CETP-D006949	CETP	D006949	Hyperlipidemias		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		97928	D052456	Hypoalphalipoproteinemias	OTG		HDL cholesterol levels	https://genetics.opentargets.org/study/GCST004919	2007			0.497855750487329	0.72	1	CETP-D006949-D052456	Phase III	0.72	1	GWAS	GWAS Catalog	2007	2.1		2	metabolic	both	genetically supported target	FALSE
CETP-D050197	0.828	4	CETP-D050197	CETP	D050197	Atherosclerosis	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		97631	D003324	Coronary Artery Disease	OTG		Coronary artery disease	https://genetics.opentargets.org/study/GCST005194	2017			0.314125910509886	0.55	1	CETP-D050197-D003324	Phase III	0.55	1	GWAS	GWAS Catalog	2017		1.0381081810730044	3	cardiovascular	both	genetically supported target	FALSE
CHEK2-D006258	0.846	3	CHEK2-D006258	CHEK2	D006258	Head and Neck Neoplasms	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		101045	D004938	Esophageal Neoplasms	OTG		Esophageal cancer and gastric cancer [ESCC]	https://genetics.opentargets.org/study/GCST000777_2	2010			0.730474333983106	0.52	1	CHEK2-D006258-D004938	Phase II	0.52	1	GWAS	GWAS Catalog	2010		1.3000000000000003	2	oncology	both	genetically supported target	FALSE
CHEK2-D015179	0.807	3	CHEK2-D015179	CHEK2	D015179	Colorectal Neoplasms	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		101045	D004938	Esophageal Neoplasms	OTG		Esophageal cancer and gastric cancer [ESCC]	https://genetics.opentargets.org/study/GCST000777_2	2010			0.730474333983106	0.52	1	CHEK2-D015179-D004938	Phase II	0.52	1	GWAS	GWAS Catalog	2010		1.3000000000000003	2	oncology	both	genetically supported target	FALSE
CHRM3-D001249	1	2	CHRM3-D001249	CHRM3	D001249	Asthma		Phase I	Phase I		3	2	TRUE				FALSE		102048	D001249	Asthma	OTG		Lung function (FEV1/FVC)	https://genetics.opentargets.org/study/GCST004185	2017			0.48645304155269	0.84	1	CHRM3-D001249-D001249	Phase I	0.84	1	GWAS	GWAS Catalog	2017	0.038		0	respiratory, immune	both	genetically supported target	FALSE
CHRM3-D029424	0.807	5	CHRM3-D029424	CHRM3	D029424	Pulmonary Disease, Chronic Obstructive	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2012	102048	D001249	Asthma	OTG		Lung function (FEV1/FVC)	https://genetics.opentargets.org/study/GCST004185	2017			0.48645304155269	0.84	1	CHRM3-D029424-D001249	Launched	0.84	1	GWAS	GWAS Catalog	2017	0.038		3	respiratory	both	genetically supported target	TRUE
CHRM3-D029481	0.836	5	CHRM3-D029481	CHRM3	D029481	Bronchitis, Chronic	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2012	102069	D029424	Pulmonary Disease, Chronic Obstructive	OTG		Chronic obstructive pulmonary disease	https://genetics.opentargets.org/study/GCST007692	2019			0.421213302156404	0.82	1	CHRM3-D029481-D029424	Launched	0.82	1	GWAS	GWAS Catalog	2019			3	infection, respiratory	gwas	genetically supported target	TRUE
CHRM3-D065631	0.817	5	CHRM3-D065631	CHRM3	D065631	Rhinitis, Allergic	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2021	102048	D001249	Asthma	OTG		Lung function (FEV1/FVC)	https://genetics.opentargets.org/study/GCST004185	2017			0.48645304155269	0.84	1	CHRM3-D065631-D001249	Launched	0.84	1	GWAS	GWAS Catalog	2017	0.038		3	respiratory, immune	both	genetically supported target	TRUE
CHRNA4-D014029	1	5	CHRNA4-D014029	CHRNA4	D014029	Tobacco Use Disorder	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		102399	D014029	Tobacco Use Disorder	OTG		Nicotine dependence	https://genetics.opentargets.org/study/GCST003185	2015			0.155300077942323	0.74	1	CHRNA4-D014029-D014029	Launched	0.74	1	GWAS	GWAS Catalog	2015	0.058		3	psychiatry	gwas	genetically supported target	TRUE
CRP-D007249	1	2	CRP-D007249	CRP	D007249	Inflammation	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		118052	D007249	Inflammation	OTG		C-reactive protein levels	https://genetics.opentargets.org/study/GCST000965	2011			0.346809895833333	0.7	1	CRP-D007249-D007249	Phase I	0.7	1	GWAS	GWAS Catalog	2011	0.16		1	signs/symptoms	gwas	genetically supported target	FALSE
CSF3-D009503	1	5	CSF3-D009503	CSF3	D009503	Neutropenia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2021	119233	D009503	Neutropenia	OTG		Neutrophil count	https://genetics.opentargets.org/study/GCST004629	2016			0.0142838592390599	0.56	1	CSF3-D009503-D009503	Launched	0.56	1	GWAS	GWAS Catalog	2016	0.1324835		3	hematology	both	genetically supported target	TRUE
CSF3R-D007970	1	5	CSF3R-D007970	CSF3R	D007970	Leukopenia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		119313	D007970	Leukopenia	OTG		White blood cell count	https://genetics.opentargets.org/study/GCST004610	2016			0.577539755552635	0.78	1	CSF3R-D007970-D007970	Launched	0.78	1	GWAS	GWAS Catalog	2016	0.04220662		3	hematology	both	genetically supported target	TRUE
CTLA4-D001172	1	2	CTLA4-D001172	CTLA4	D001172	Arthritis, Rheumatoid		Phase I	Phase I		3	2	TRUE				FALSE		120987	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis	https://genetics.opentargets.org/study/GCST000420	2009			0.550637854725332	0.86	1	CTLA4-D001172-D001172	Phase I	0.86	1	GWAS	GWAS Catalog	2009		1.17	0	musculoskeletal, dermatology, immune	gwas	genetically supported target	FALSE
CTLA4-D008180	1	2	CTLA4-D008180	CTLA4	D008180	Lupus Erythematosus, Systemic	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		121057	D008180	Lupus Erythematosus, Systemic	OTG		Systemic lupus erythematosus	https://genetics.opentargets.org/study/GCST011096	2021			0.422232328482329	0.87	1	CTLA4-D008180-D008180	Phase I	0.87	1	GWAS	GWAS Catalog	2021		1.1235955056179776	1	dermatology, immune	both	genetically supported target	FALSE
CXCR4-D001778	1	2	CXCR4-D001778	CXCR4	D001778	Blood Coagulation Disorders		Phase I	Phase I		3	2	TRUE				FALSE		123878	D001778	Blood Coagulation Disorders	OTG		Hematocrit	https://genetics.opentargets.org/study/GCST90002304	2020			0.346608627858628	0.67	1	CXCR4-D001778-D001778	Phase I	0.67	1	GWAS	GWAS Catalog	2020	0.013639		0	hematology	both	genetically supported target	FALSE
CXCR4-D009103	1	3	CXCR4-D009103	CXCR4	D009103	Multiple Sclerosis	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		123942	D009103	Multiple Sclerosis	OTG		Multiple sclerosis	https://genetics.opentargets.org/study/GCST009597	2019			0.551188774847343	0.87	1	CXCR4-D009103-D009103	Phase II	0.87	1	GWAS	GWAS Catalog	2019		1.0836000000000003	2	neurology, immune	both	genetically supported target	FALSE
CYP11B2-D006973	1	3	CYP11B2-D006973	CYP11B2	D006973	Hypertension		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		124881	D006973	Hypertension	OTG		Systolic blood pressure	https://genetics.opentargets.org/study/GCST90025968	2021			0.418804531840083	0.51	1	CYP11B2-D006973-D006973	Phase II	0.51	1	GWAS	GWAS Catalog	2021	0.0177372999999999		1	cardiovascular	both	genetically supported target	FALSE
CYP2A6-D014029	1	2	CYP2A6-D014029	CYP2A6	D014029	Tobacco Use Disorder	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		126132	D014029	Tobacco Use Disorder	OTG		Nicotine dependence	https://genetics.opentargets.org/study/GCST011754	2020			0.574475022825095	0.72	1	CYP2A6-D014029-D014029	Phase I	0.72	1	GWAS	GWAS Catalog	2020	0.031		1	psychiatry	gwas	genetically supported target	FALSE
CYP7A1-D042882	0.911	3	CYP7A1-D042882	CYP7A1	D042882	Gallstones	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		126794	D002769	Cholelithiasis	OTG		Cholelithiasis	https://genetics.opentargets.org/study/GCST90018599	2021			0.0535227715064227	0.87	1	CYP7A1-D042882-D002769	Phase II	0.87	1	GWAS	GWAS Catalog	2021	0.1263853		2	digestive, signs/symptoms	both	genetically supported target	FALSE
DGAT2-D006949	0.906	2	DGAT2-D006949	DGAT2	D006949	Hyperlipidemias	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		133648	D006937	Hypercholesterolemia	OTG		Total cholesterol levels	https://genetics.opentargets.org/study/GCST006614	2018			0.112287310040265	0.54	1	DGAT2-D006949-D006937	Phase I	0.54	1	GWAS	GWAS Catalog	2018	0.0243		1	metabolic	both	genetically supported target	FALSE
DNMT3B-D058186	0.865	3	DNMT3B-D058186	DNMT3B	D058186	Acute Kidney Injury		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		140775	D051437	Renal Insufficiency	OTG		Serum creatinine levels	https://genetics.opentargets.org/study/GCST90018979	2021			0.414724645228486	0.61	1	DNMT3B-D058186-D051437	Phase II	0.61	1	GWAS	GWAS Catalog	2021	0.0101		1	other	gwas	genetically supported target	FALSE
DPEP1-D058186	0.865	3	DPEP1-D058186	DPEP1	D058186	Acute Kidney Injury		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		142289	D051437	Renal Insufficiency	OTG		Serum creatinine levels	https://genetics.opentargets.org/study/GCST90018979	2021			0.480412916887242	0.66	1	DPEP1-D058186-D051437	Phase II	0.66	1	GWAS	GWAS Catalog	2021	0.0194		1	other	gwas	genetically supported target	FALSE
DPP4-D001172	1	3	DPP4-D001172	DPP4	D001172	Arthritis, Rheumatoid	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		142661	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis [ACPA+ cases vs. all controls]	https://genetics.opentargets.org/study/GCST002433	2014			0.317945721334892	0.85	1	DPP4-D001172-D001172	Phase II	0.85	1	GWAS	GWAS Catalog	2014		1.5570000000000008	2	musculoskeletal, dermatology, immune	gwas	genetically supported target	FALSE
DRD2-D000437	1	3	DRD2-D000437	DRD2	D000437	Alcoholism	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		143528	D000437	Alcoholism	OTG		Alcohol use disorder	https://genetics.opentargets.org/study/GCST008259	2019			0.322874093605801	0.8	1	DRD2-D000437-D000437	Phase II	0.8	1	GWAS	GWAS Catalog	2019	5.59		2	psychiatry	gwas	genetically supported target	FALSE
DRD2-D001008	0.883	5	DRD2-D001008	DRD2	D001008	Anxiety Disorders	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		143561	D009497	Neurotic Disorders	OTG		Neuroticism	https://genetics.opentargets.org/study/GCST003770	2016			0.665843835260491	0.8	1	DRD2-D001008-D009497	Launched	0.8	1	GWAS	GWAS Catalog	2016	0.023		3	psychiatry	gwas	genetically supported target	TRUE
DRD2-D001714	1	5	DRD2-D001714	DRD2	D001714	Bipolar Disorder	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		143538	D001714	Bipolar Disorder	OTG		Bipolar disorder (MTAG)	https://genetics.opentargets.org/study/GCST010641	2020			0.319370365552231	0.78	1	DRD2-D001714-D001714	Launched	0.78	1	GWAS	GWAS Catalog	2020			3	psychiatry	gwas	genetically supported target	TRUE
DRD2-D003863	1	5	DRD2-D003863	DRD2	D003863	Depression	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		143541	D003863	Depression	OTG		Depressive symptoms (MTAG)	https://genetics.opentargets.org/study/GCST005323	2018			0.673251884585391	0.8	1	DRD2-D003863-D003863	Launched	0.8	1	GWAS	GWAS Catalog	2018	0.0145		3	psychiatry	gwas	genetically supported target	TRUE
DRD2-D003865	1	5	DRD2-D003865	DRD2	D003865	Depressive Disorder, Major	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		143547	D003865	Depressive Disorder, Major	OTG		Feeling miserable	https://genetics.opentargets.org/study/GCST006943	2018			0.395078561225815	0.8	1	DRD2-D003865-D003865	Launched	0.8	1	GWAS	GWAS Catalog	2018	0.014506465494737		3	psychiatry	gwas	genetically supported target	TRUE
DRD2-D011618	0.85	5	DRD2-D011618	DRD2	D011618	Psychotic Disorders	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2010	143579	D012559	Schizophrenia	OTG		Schizophrenia	https://genetics.opentargets.org/study/GCST002539	2014			0.319370365552231	0.78	1	DRD2-D011618-D012559	Launched	0.78	1	GWAS	GWAS Catalog	2014		1.0787486999999998	3	psychiatry	both	genetically supported target	TRUE
DRD2-D012559	1	5	DRD2-D012559	DRD2	D012559	Schizophrenia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2020	143579	D012559	Schizophrenia	OTG		Schizophrenia	https://genetics.opentargets.org/study/GCST002539	2014			0.319370365552231	0.78	1	DRD2-D012559-D012559	Launched	0.78	1	GWAS	GWAS Catalog	2014		1.0787486999999998	3	psychiatry	both	genetically supported target	TRUE
DYRK3-D000740	1	2	DYRK3-D000740	DYRK3	D000740	Anemia	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		145852	D000740	Anemia	OTG		Mean corpuscular hemoglobin	https://genetics.opentargets.org/study/GCST007068	2018			0.567702913631634	0.67	1	DYRK3-D000740-D000740	Phase I	0.67	1	GWAS	GWAS Catalog	2018			1	hematology	both	genetically supported target	FALSE
EDNRA-D006973	1	4	EDNRA-D006973	EDNRA	D006973	Hypertension		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		147846	D006973	Hypertension	OTG		Pulse pressure	https://genetics.opentargets.org/study/GCST004278	2017			0.132442599558957	0.84	1	EDNRA-D006973-D006973	Phase III	0.84	1	GWAS	GWAS Catalog	2017	0.2668		2	cardiovascular	both	genetically supported target	FALSE
EDNRB-D005770	0.867	2	EDNRB-D005770	EDNRB	D005770	Gastrointestinal Neoplasms	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		147964	D015179	Colorectal Neoplasms	OTG		Colorectal cancer	https://genetics.opentargets.org/study/GCST007992	2019			0.879052206743914	0.93	1	EDNRB-D005770-D015179	Phase I	0.93	1	GWAS	GWAS Catalog	2019		1.11	1	oncology	both	genetically supported target	FALSE
EGFR-D005909	1	4	EGFR-D005909	EGFR	D005909	Glioblastoma		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		TRUE		149757	D005909	Glioblastoma	OTG		Glioblastoma	https://genetics.opentargets.org/study/GCST003220	2015			0.0921999738254155	0.53	1	EGFR-D005909-D005909	Phase III	0.53	1	GWAS	GWAS Catalog	2015		1.59	2	oncology	gwas	genetically supported target	FALSE
EGFR-D007676	0.95	3	EGFR-D007676	EGFR	D007676	Kidney Failure, Chronic	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		149793	D051436	Renal Insufficiency, Chronic	OTG		Serum urea levels	https://genetics.opentargets.org/study/GCST90025991	2021			0.237012987012987	0.9	1	EGFR-D007676-D051436	Phase II	0.9	1	GWAS	GWAS Catalog	2021	0.0146606		2	other	both	genetically supported target	FALSE
EGFR-D008527	0.851	4	EGFR-D008527	EGFR	D008527	Medulloblastoma		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		TRUE		149770	D005910	Glioma	OTG		Glioma	https://genetics.opentargets.org/study/GCST003228	2015			0.0921999738254155	0.54	1	EGFR-D008527-D005910	Phase III	0.54	1	GWAS	GWAS Catalog	2015		1.42	2	oncology	gwas	genetically supported target	FALSE
EGFR-D018242	0.819	3	EGFR-D018242	EGFR	D018242	Neuroectodermal Tumors, Primitive	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		149770	D005910	Glioma	OTG		Glioma	https://genetics.opentargets.org/study/GCST003228	2015			0.0921999738254155	0.54	1	EGFR-D018242-D005910	Phase II	0.54	1	GWAS	GWAS Catalog	2015		1.42	2	oncology	both	genetically supported target	FALSE
EGLN1-D000740	1	5	EGLN1-D000740	EGLN1	D000740	Anemia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		149804	D000740	Anemia	OTG		Hemoglobin concentration	https://genetics.opentargets.org/study/GCST004615	2016			0.0149980002666311	0.81	1	EGLN1-D000740-D000740	Launched	0.81	1	GWAS	GWAS Catalog	2016	0.1277725		3	hematology	both	genetically supported target	TRUE
EGLN2-D000740	1	5	EGLN2-D000740	EGLN2	D000740	Anemia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		149842	D000740	Anemia	OTG		Hemoglobin concentration	https://genetics.opentargets.org/study/GCST004615	2016			0.0163785259326661	0.62	1	EGLN2-D000740-D000740	Launched	0.62	1	GWAS	GWAS Catalog	2016	0.08824054		3	hematology	both	genetically supported target	TRUE
EGLN3-D000740	1	5	EGLN3-D000740	EGLN3	D000740	Anemia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		149910	D000740	Anemia	OTG		Hemoglobin concentration	https://genetics.opentargets.org/study/GCST90002310	2020			0.707255233389676	0.84	1	EGLN3-D000740-D000740	Launched	0.84	1	GWAS	GWAS Catalog	2020	0.018941		3	hematology	both	genetically supported target	TRUE
ENPP1-D017674	1	3	ENPP1-D017674	ENPP1	D017674	Hypophosphatemia		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		154737	D017674	Hypophosphatemia	OTG		Phosphorus levels	https://genetics.opentargets.org/study/GCST005981	2018			0.0907320872274143	0.6	1	ENPP1-D017674-D017674	Phase II	0.6	1	GWAS	GWAS Catalog	2018			1	metabolic	both	genetically supported target	FALSE
EPAS1-D007680	0.913	5	EPAS1-D007680	EPAS1	D007680	Kidney Neoplasms	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE	2021	155678	D002292	Carcinoma, Renal Cell	OTG		Renal cell carcinoma	https://genetics.opentargets.org/study/GCST000907	2010			0.597388253638254	0.88	1	EPAS1-D007680-D002292	Launched	0.88	1	GWAS	GWAS Catalog	2010			3	oncology	both	genetically supported target	TRUE
EPOR-D000740	1	5	EPOR-D000740	EPOR	D000740	Anemia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		156948	D000740	Anemia	OTG		Mean corpuscular hemoglobin concentration	https://genetics.opentargets.org/study/GCST90025962	2021			0.0101961293674503	0.65	1	EPOR-D000740-D000740	Launched	0.65	1	GWAS	GWAS Catalog	2021	0.0619314		3	hematology	both	genetically supported target	TRUE
ERBB4-D001943	1	5	ERBB4-D001943	ERBB4	D001943	Breast Neoplasms	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2019	157631	D001943	Breast Neoplasms	OTG		Breast cancer	https://genetics.opentargets.org/study/GCST001457	2012			0.0889451148306734	1	1	ERBB4-D001943-D001943	Launched	1	1	GWAS	GWAS Catalog	2012		1.5300000000000002	3	oncology	both	genetically supported target	TRUE
ESR1-D001943	1	5	ESR1-D001943	ESR1	D001943	Breast Neoplasms	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE		159663	D001943	Breast Neoplasms	OTG		Breast cancer	https://genetics.opentargets.org/study/GCST001683	2012			0.0795174471397068	0.81	1	ESR1-D001943-D001943	Launched	0.81	1	GWAS	GWAS Catalog	2012		1.28	3	oncology	both	genetically supported target	TRUE
ESR1-D004700	1	3	ESR1-D004700	ESR1	D004700	Endocrine System Diseases		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		159703	D004700	Endocrine System Diseases	OTG		Bioavailable testosterone levels	https://genetics.opentargets.org/study/GCST90012103	2020			0.337861233186842	0.95	1	ESR1-D004700-D004700	Phase II	0.95	1	GWAS	GWAS Catalog	2020	0.0187752		1	endocrine	gwas	genetically supported target	FALSE
ESR1-D006177	0.816	2	ESR1-D006177	ESR1	D006177	Gynecomastia		Phase I	Phase I		3	2	TRUE				FALSE		159663	D001943	Breast Neoplasms	OTG		Breast cancer	https://genetics.opentargets.org/study/GCST001683	2012			0.0795174471397068	0.81	1	ESR1-D006177-D001943	Phase I	0.81	1	GWAS	GWAS Catalog	2012		1.28	0	dermatology	both	genetically supported target	FALSE
ESR1-D009369	1	3	ESR1-D009369	ESR1	D009369	Neoplasms		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		159748	D009369	Neoplasms	OTG		Cancer (pleiotropy)	https://genetics.opentargets.org/study/GCST90011822	2020			0.0623184578822287	0.56	1	ESR1-D009369-D009369	Phase II	0.56	1	GWAS	GWAS Catalog	2020		1.1737089	1	oncology	gwas	genetically supported target	FALSE
ESR1-D010024	0.809	5	ESR1-D010024	ESR1	D010024	Osteoporosis	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE		159824	D018488	Bone Demineralization, Pathologic	OTG		Bone mineral density (spine)	https://genetics.opentargets.org/study/GCST000180	2008			0.599922037422037	0.86	1	ESR1-D010024-D018488	Launched	0.86	1	GWAS	GWAS Catalog	2008	0.09		3	musculoskeletal, metabolic	both	genetically supported target	TRUE
F10-D001778	1	2	F10-D001778	F10	D001778	Blood Coagulation Disorders		Phase I	Phase I		3	2	TRUE				FALSE		163433	D001778	Blood Coagulation Disorders	OTG		End-stage coagulation [FVII:C]	https://genetics.opentargets.org/study/GCST001798_3	2013			0.109228971962617	0.69	1	F10-D001778-D001778	Phase I	0.69	1	GWAS	GWAS Catalog	2013	0.534		0	hematology	both	genetically supported target	FALSE
F11-D001778	1	2	F11-D001778	F11	D001778	Blood Coagulation Disorders		Phase I	Phase I		3	2	TRUE				FALSE		163509	D001778	Blood Coagulation Disorders	OTG		Activated partial thromboplastin time	https://genetics.opentargets.org/study/GCST001574	2012			0.882135443694863	0.77	1	F11-D001778-D001778	Phase I	0.77	1	GWAS	GWAS Catalog	2012			0	hematology	both	genetically supported target	FALSE
F11-D013927	1	3	F11-D013927	F11	D013927	Thrombosis		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		163541	D013927	Thrombosis	OTG		Thrombosis	https://genetics.opentargets.org/study/GCST003390	2016			0.400839312305401	0.85	1	F11-D013927-D013927	Phase II	0.85	1	GWAS	GWAS Catalog	2016		1.2345679	1	cardiovascular	both	genetically supported target	FALSE
F11-D020246	0.858	3	F11-D020246	F11	D020246	Venous Thrombosis		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		163541	D013927	Thrombosis	OTG		Thrombosis	https://genetics.opentargets.org/study/GCST003390	2016			0.400839312305401	0.85	1	F11-D020246-D013927	Phase II	0.85	1	GWAS	GWAS Catalog	2016		1.2345679	1	cardiovascular	both	genetically supported target	FALSE
F2-D013927	0.858	5	F2-D013927	F2	D013927	Thrombosis	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		163826	D020246	Venous Thrombosis	OTG		Deep venous thrombosis	https://genetics.opentargets.org/study/GCST90038615	2021			0.0124497471145117	0.78	1	F2-D013927-D020246	Launched	0.78	1	GWAS	GWAS Catalog	2021		1.01585934539419	3	cardiovascular	both	genetically supported target	TRUE
F2-D020246	1	5	F2-D020246	F2	D020246	Venous Thrombosis	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		163826	D020246	Venous Thrombosis	OTG		Deep venous thrombosis	https://genetics.opentargets.org/study/GCST90038615	2021			0.0124497471145117	0.78	1	F2-D020246-D020246	Launched	0.78	1	GWAS	GWAS Catalog	2021		1.01585934539419	3	cardiovascular	both	genetically supported target	TRUE
FBP1-D003924	1	3	FBP1-D003924	FBP1	D003924	Diabetes Mellitus, Type 2		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		174462	D003924	Diabetes Mellitus, Type 2	OTG		Type 2 diabetes [conditional]	https://genetics.opentargets.org/study/GCST010555_2	2020			0.786595661774256	0.81	1	FBP1-D003924-D003924	Phase II	0.81	1	GWAS	GWAS Catalog	2020			1	metabolic, endocrine	both	genetically supported target	FALSE
FCGR2A-D014657	0.819	2	FCGR2A-D014657	FCGR2A	D014657	Vasculitis	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		176306	D009080	Mucocutaneous Lymph Node Syndrome	OTG		Kawasaki disease	https://genetics.opentargets.org/study/GCST001322	2011			0.501365587202497	0.66	1	FCGR2A-D014657-D009080	Phase I	0.66	1	GWAS	GWAS Catalog	2011		1.3199999999999992	1	cardiovascular	both	genetically supported target	FALSE
FCGRT-D013921	1	4	FCGRT-D013921	FCGRT	D013921	Thrombocytopenia	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	TRUE		176784	D013921	Thrombocytopenia	OTG		Red blood cell count	https://genetics.opentargets.org/study/GCST90002363	2020			0.00725952813067151	0.51	1	FCGRT-D013921-D013921	Phase III	0.51	1	GWAS	GWAS Catalog	2020	0.078719		3	hematology	both	genetically supported target	FALSE
FCGRT-D016553	0.855	4	FCGRT-D016553	FCGRT	D016553	Purpura, Thrombocytopenic, Idiopathic		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		TRUE		176784	D013921	Thrombocytopenia	OTG		Red blood cell count	https://genetics.opentargets.org/study/GCST90002363	2020			0.00725952813067151	0.51	1	FCGRT-D016553-D013921	Phase III	0.51	1	GWAS	GWAS Catalog	2020	0.078719		2	hematology, immune, signs/symptoms	both	genetically supported target	FALSE
FDFT1-D006949	0.881	4	FDFT1-D006949	FDFT1	D006949	Hyperlipidemias	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		177237	D015228	Hypertriglyceridemia	OTG		Triglyceride levels	https://genetics.opentargets.org/study/GCST010173	2020			0.383461088735871	0.5	1	FDFT1-D006949-D015228	Phase III	0.5	1	GWAS	GWAS Catalog	2020			3	metabolic	both	genetically supported target	FALSE
FGF21-D015228	1	3	FGF21-D015228	FGF21	D015228	Hypertriglyceridemia		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		179219	D015228	Hypertriglyceridemia	OTG		Triglyceride levels	https://genetics.opentargets.org/study/GCST010244	2020			0.592676899063476	0.54	1	FGF21-D015228-D015228	Phase II	0.54	1	GWAS	GWAS Catalog	2020	0.0248079		1	metabolic	both	genetically supported target	FALSE
FGFR1-D003924	1	2	FGFR1-D003924	FGFR1	D003924	Diabetes Mellitus, Type 2	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		179790	D003924	Diabetes Mellitus, Type 2	OTG		Type 2 diabetes	https://genetics.opentargets.org/study/GCST010118	2020			0.610698945724326	0.79	1	FGFR1-D003924-D003924	Phase I	0.79	1	GWAS	GWAS Catalog	2020		1.0399999999999996	1	metabolic, endocrine	both	genetically supported target	FALSE
FGFR1-D009765	1	2	FGFR1-D009765	FGFR1	D009765	Obesity		Phase I	Phase I		3	2	TRUE				FALSE		179814	D009765	Obesity	OTG		Body mass index	https://genetics.opentargets.org/study/GCST007039	2018			0.594659226783579	0.81	1	FGFR1-D009765-D009765	Phase I	0.81	1	GWAS	GWAS Catalog	2018			0	metabolic, signs/symptoms	both	genetically supported target	FALSE
FGFR2-D001943	1	4	FGFR2-D001943	FGFR2	D001943	Breast Neoplasms		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		179968	D001943	Breast Neoplasms	OTG		Breast cancer	https://genetics.opentargets.org/study/GCST000035	2007			0.620528164433459	0.93	1	FGFR2-D001943-D001943	Phase III	0.93	1	GWAS	GWAS Catalog	2007		1.2599999999999993	2	oncology	both	genetically supported target	FALSE
FGFR2-D009369	1	5	FGFR2-D009369	FGFR2	D009369	Neoplasms	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE		180059	D009369	Neoplasms	OTG		Cancer (pleiotropy) [subset analysis]	https://genetics.opentargets.org/study/GCST003588_2	2016			0.393066215688825	0.94	1	FGFR2-D009369-D009369	Launched	0.94	1	GWAS	GWAS Catalog	2016			3	oncology	gwas	genetically supported target	TRUE
FGFR2-D011471	1	3	FGFR2-D011471	FGFR2	D011471	Prostatic Neoplasms	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		180075	D011471	Prostatic Neoplasms	OTG		Serum prostate-specific antigen levels	https://genetics.opentargets.org/study/GCST000919	2010			0.25953802232027	0.68	1	FGFR2-D011471-D011471	Phase II	0.68	1	GWAS	GWAS Catalog	2010	10.2		2	oncology	both	genetically supported target	FALSE
FGFR2-D013736	0.902	3	FGFR2-D013736	FGFR2	D013736	Testicular Neoplasms	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		180075	D011471	Prostatic Neoplasms	OTG		Serum prostate-specific antigen levels	https://genetics.opentargets.org/study/GCST000919	2010			0.25953802232027	0.68	1	FGFR2-D013736-D011471	Phase II	0.68	1	GWAS	GWAS Catalog	2010	10.2		2	oncology	both	genetically supported target	FALSE
FGFR3-D001249	1	4	FGFR3-D001249	FGFR3	D001249	Asthma		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		180137	D001249	Asthma	OTG		Lung function (FEV1/FVC)	https://genetics.opentargets.org/study/GCST007080	2018			0.0668785677218474	0.8	1	FGFR3-D001249-D001249	Phase III	0.8	1	GWAS	GWAS Catalog	2018			2	respiratory, immune	both	genetically supported target	FALSE
FGFR4-D003924	1	3	FGFR4-D003924	FGFR4	D003924	Diabetes Mellitus, Type 2	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		180218	D003924	Diabetes Mellitus, Type 2	OTG		Type 2 diabetes	https://genetics.opentargets.org/study/GCST007847	2019			0.287970140683319	0.69	1	FGFR4-D003924-D003924	Phase II	0.69	1	GWAS	GWAS Catalog	2019		1.06	2	metabolic, endocrine	both	genetically supported target	FALSE
FGFR4-D009765	1	3	FGFR4-D009765	FGFR4	D009765	Obesity	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		180235	D009765	Obesity	OTG		Hip circumference adjusted for BMI	https://genetics.opentargets.org/study/GCST90020028	2021			0.234450384665537	0.7	1	FGFR4-D009765-D009765	Phase II	0.7	1	GWAS	GWAS Catalog	2021	0.0245634		2	metabolic, signs/symptoms	both	genetically supported target	FALSE
FLT1-D009216	1	5	FLT1-D009216	FLT1	D009216	Myopia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		182402	D009216	Myopia	OTG		Myopia (age of diagnosis)	https://genetics.opentargets.org/study/GCST006290	2018			0.304505908323594	0.87	1	FLT1-D009216-D009216	Launched	0.87	1	GWAS	GWAS Catalog	2018	0.0451		3	ophthalmology	both	genetically supported target	TRUE
FLT3-D013921	0.877	5	FLT3-D013921	FLT3	D013921	Thrombocytopenia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		182439	D001791	Blood Platelet Disorders	OTG		Platelet count	https://genetics.opentargets.org/study/GCST90002357	2020			0.62125553529565	0.77	1	FLT3-D013921-D001791	Launched	0.77	1	GWAS	GWAS Catalog	2020	0.010784		3	hematology	both	genetically supported target	TRUE
FLT3-D013922	0.825	5	FLT3-D013922	FLT3	D013922	Thrombocytosis	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		182439	D001791	Blood Platelet Disorders	OTG		Platelet count	https://genetics.opentargets.org/study/GCST90002357	2020			0.62125553529565	0.77	1	FLT3-D013922-D001791	Launched	0.77	1	GWAS	GWAS Catalog	2020	0.010784		3	hematology	both	genetically supported target	TRUE
FLT4-D006258	0.82	4	FLT4-D006258	FLT4	D006258	Head and Neck Neoplasms		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		182608	D009303	Nasopharyngeal Neoplasms	OTG		Nasopharyngeal carcinoma (SNP x SNP interaction)	https://genetics.opentargets.org/study/GCST006524	2013			0.11891786687427	0.82	1	FLT4-D006258-D009303	Phase III	0.82	1	GWAS	GWAS Catalog	2013			2	oncology	both	genetically supported target	FALSE
FLT4-D009303	1	4	FLT4-D009303	FLT4	D009303	Nasopharyngeal Neoplasms		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		182608	D009303	Nasopharyngeal Neoplasms	OTG		Nasopharyngeal carcinoma (SNP x SNP interaction)	https://genetics.opentargets.org/study/GCST006524	2013			0.11891786687427	0.82	1	FLT4-D009303-D009303	Phase III	0.82	1	GWAS	GWAS Catalog	2013			2	oncology	both	genetically supported target	FALSE
FSHR-D010051	0.812	2	FSHR-D010051	FSHR	D010051	Ovarian Neoplasms		Phase I	Phase I		3	2	TRUE				FALSE		187798	D011085	Polycystic Ovary Syndrome	OTG		Polycystic ovary syndrome	https://genetics.opentargets.org/study/GCST001634	2012			0.644583008573655	0.86	1	FSHR-D010051-D011085	Phase I	0.86	1	GWAS	GWAS Catalog	2012		1.1500000000000006	0	oncology	gwas	genetically supported target	FALSE
FYN-D010300	1	3	FYN-D010300	FYN	D010300	Parkinson Disease	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		190217	D010300	Parkinson Disease	OTG		Parkinson's disease or first degree relation to individual with Parkinson's disease	https://genetics.opentargets.org/study/GCST009325	2019			0.175707241110823	0.83	1	FYN-D010300-D010300	Phase II	0.83	1	GWAS	GWAS Catalog	2019	0.0714		2	neurology	both	genetically supported target	FALSE
GATA3-D001249	1	3	GATA3-D001249	GATA3	D001249	Asthma		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		193429	D001249	Asthma	OTG		Asthma (moderate or severe)	https://genetics.opentargets.org/study/GCST006911	2018			0.583929733246584	0.92	1	GATA3-D001249-D001249	Phase II	0.92	1	GWAS	GWAS Catalog	2018		1.1111111999999996	1	respiratory, immune	both	genetically supported target	FALSE
GATA3-D003876	0.851	3	GATA3-D003876	GATA3	D003876	Dermatitis, Atopic		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		193469	D004485	Eczema	OTG		Eczema	https://genetics.opentargets.org/study/GCST007075	2018			0.274558212058212	1	1	GATA3-D003876-D004485	Phase II	1	1	GWAS	GWAS Catalog	2018			1	congenital, dermatology, immune	gwas	genetically supported target	FALSE
GATA3-D029424	0.807	3	GATA3-D029424	GATA3	D029424	Pulmonary Disease, Chronic Obstructive		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		193429	D001249	Asthma	OTG		Asthma (moderate or severe)	https://genetics.opentargets.org/study/GCST006911	2018			0.583929733246584	0.92	1	GATA3-D029424-D001249	Phase II	0.92	1	GWAS	GWAS Catalog	2018		1.1111111999999996	1	respiratory	both	genetically supported target	FALSE
GCH1-D010300	1	3	GCH1-D010300	GCH1	D010300	Parkinson Disease		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		194768	D010300	Parkinson Disease	OTG		Parkinson's disease	https://genetics.opentargets.org/study/GCST002544	2014			0.3346538511495	0.71	1	GCH1-D010300-D010300	Phase II	0.71	1	GWAS	GWAS Catalog	2014		1.1099999999999999	1	neurology	both	genetically supported target	FALSE
GFRAL-D009765	1	2	GFRAL-D009765	GFRAL	D009765	Obesity	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		197059	D009765	Obesity	OTG		Body mass index	https://genetics.opentargets.org/study/GCST008129	2017			0.365679397246038	0.92	1	GFRAL-D009765-D009765	Phase I	0.92	1	GWAS	GWAS Catalog	2017	0.0111		1	metabolic, signs/symptoms	both	genetically supported target	FALSE
GHSR-D011218	0.805	2	GHSR-D011218	GHSR	D011218	Prader-Willi Syndrome		Phase I	Phase I		3	2	TRUE				TRUE		197856	D009765	Obesity	OTG		Weight	https://genetics.opentargets.org/study/GCST90018729	2021			0.396377093883911	0.87	1	GHSR-D011218-D009765	Phase I	0.87	1	GWAS	GWAS Catalog	2021	0.0190497		0	neurology, congenital, metabolic	both	genetically supported target	FALSE
GIPR-D003924	1	5	GIPR-D003924	GIPR	D003924	Diabetes Mellitus, Type 2	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		198775	D003924	Diabetes Mellitus, Type 2	OTG		Type 2 diabetes	https://genetics.opentargets.org/study/GCST004894	2017			0.109155844155844	0.7	1	GIPR-D003924-D003924	Launched	0.7	1	GWAS	GWAS Catalog	2017	0.076		3	metabolic, endocrine	both	genetically supported target	TRUE
GIPR-D009765	1	4	GIPR-D009765	GIPR	D009765	Obesity		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		198807	D009765	Obesity	OTG		Body mass index	https://genetics.opentargets.org/study/GCST001415	2012			0.109155844155844	0.7	1	GIPR-D009765-D009765	Phase III	0.7	1	GWAS	GWAS Catalog	2012	4.22		2	metabolic, signs/symptoms	both	genetically supported target	FALSE
GLP1R-D003920	1	2	GLP1R-D003920	GLP1R	D003920	Diabetes Mellitus		Phase I	Phase I		3	2	TRUE				FALSE		200546	D003920	Diabetes Mellitus	OTG		Hemoglobin A1c levels	https://genetics.opentargets.org/study/GCST90025974	2021			0.0964206977045779	0.9	1	GLP1R-D003920-D003920	Phase I	0.9	1	GWAS	GWAS Catalog	2021	0.0257273999999999		0	metabolic, endocrine	both	genetically supported target	FALSE
GLP1R-D003924	1	5	GLP1R-D003924	GLP1R	D003924	Diabetes Mellitus, Type 2	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE		200548	D003924	Diabetes Mellitus, Type 2	OTG		Type 2 diabetes	https://genetics.opentargets.org/study/GCST007847	2019			0.00194741966893866	0.89	1	GLP1R-D003924-D003924	Launched	0.89	1	GWAS	GWAS Catalog	2019		1.0900000000000005	3	metabolic, endocrine	both	genetically supported target	TRUE
GLP1R-D009765	1	5	GLP1R-D009765	GLP1R	D009765	Obesity	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		200558	D009765	Obesity	OTG		Body mass index	https://genetics.opentargets.org/study/GCST90018947	2021			0.518853205044858	0.87	1	GLP1R-D009765-D009765	Launched	0.87	1	GWAS	GWAS Catalog	2021			3	metabolic, signs/symptoms	both	genetically supported target	TRUE
GLP2R-D003924	1	2	GLP2R-D003924	GLP2R	D003924	Diabetes Mellitus, Type 2	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		200566	D003924	Diabetes Mellitus, Type 2	OTG		Type 2 diabetes	https://genetics.opentargets.org/study/GCST004773	2017			0.322109770338653	0.62	1	GLP2R-D003924-D003924	Phase I	0.62	1	GWAS	GWAS Catalog	2017		1.06	1	metabolic, endocrine	both	genetically supported target	FALSE
GNRH1-D007889	1	5	GNRH1-D007889	GNRH1	D007889	Leiomyoma	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		203325	D007889	Leiomyoma	OTG		Uterine fibroids	https://genetics.opentargets.org/study/GCST90018934	2021			0.263892495455726	0.53	1	GNRH1-D007889-D007889	Launched	0.53	1	GWAS	GWAS Catalog	2021	0.052		3	oncology	gwas	genetically supported target	TRUE
GP6-D013927	1	3	GP6-D013927	GP6	D013927	Thrombosis		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		204306	D013927	Thrombosis	OTG		Platelet aggregation [collagen]	https://genetics.opentargets.org/study/GCST000693_2	2010			0.858654474199869	0.65	1	GP6-D013927-D013927	Phase II	0.65	1	GWAS	GWAS Catalog	2010			1	cardiovascular	both	genetically supported target	FALSE
GRIA1-D012559	1	3	GRIA1-D012559	GRIA1	D012559	Schizophrenia	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		208181	D012559	Schizophrenia	OTG		Schizophrenia	https://genetics.opentargets.org/study/GCST002149	2013			0.521903028727415	1	1	GRIA1-D012559-D012559	Phase II	1	1	GWAS	GWAS Catalog	2013		1.0799999999999998	2	psychiatry	both	genetically supported target	FALSE
GRIA1-D012893	0.867	3	GRIA1-D012893	GRIA1	D012893	Sleep Wake Disorders	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		208159	D007319	Sleep Initiation and Maintenance Disorders	OTG		Insomnia	https://genetics.opentargets.org/study/GCST007988	2019			0.640669608097586	0.71	1	GRIA1-D012893-D007319	Phase II	0.71	1	GWAS	GWAS Catalog	2019		1.0395011000000003	2	neurology, signs/symptoms, psychiatry	both	genetically supported target	FALSE
GRIN2B-D000544	1	4	GRIN2B-D000544	GRIN2B	D000544	Alzheimer Disease	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	TRUE		208627	D000544	Alzheimer Disease	OTG		Cerebrospinal AB1-42 levels in normal cognition	https://genetics.opentargets.org/study/GCST007001	2017			0.063051375194603	0.96	1	GRIN2B-D000544-D000544	Phase III	0.96	1	GWAS	GWAS Catalog	2017	1.02		3	neurology, psychiatry	both	genetically supported target	FALSE
GRM3-D001008	0.883	4	GRM3-D001008	GRM3	D001008	Anxiety Disorders	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		209030	D009497	Neurotic Disorders	OTG		Neuroticism	https://genetics.opentargets.org/study/GCST005232	2017			0.403513337670787	0.93	1	GRM3-D001008-D009497	Phase III	0.93	1	GWAS	GWAS Catalog	2017	0.0328479999999999		3	psychiatry	gwas	genetically supported target	FALSE
GRM3-D011618	0.85	2	GRM3-D011618	GRM3	D011618	Psychotic Disorders	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		209040	D012559	Schizophrenia	OTG		Schizophrenia	https://genetics.opentargets.org/study/GCST002539	2014			0.128734736295142	0.86	1	GRM3-D011618-D012559	Phase I	0.86	1	GWAS	GWAS Catalog	2014		1.1061947	1	psychiatry	both	genetically supported target	FALSE
GRM3-D012559	1	2	GRM3-D012559	GRM3	D012559	Schizophrenia		Phase I	Phase I		3	2	TRUE				FALSE		209040	D012559	Schizophrenia	OTG		Schizophrenia	https://genetics.opentargets.org/study/GCST002539	2014			0.128734736295142	0.86	1	GRM3-D012559-D012559	Phase I	0.86	1	GWAS	GWAS Catalog	2014		1.1061947	0	psychiatry	both	genetically supported target	FALSE
GRM5-D001008	0.883	2	GRM5-D001008	GRM5	D001008	Anxiety Disorders		Phase I	Phase I		3	2	TRUE				TRUE		209132	D009497	Neurotic Disorders	OTG		Neuroticism	https://genetics.opentargets.org/study/GCST005232	2017			0.467171387547318	0.61	1	GRM5-D001008-D009497	Phase I	0.61	1	GWAS	GWAS Catalog	2017	0.034727		0	psychiatry	gwas	genetically supported target	FALSE
GRM5-D003865	1	3	GRM5-D003865	GRM5	D003865	Depressive Disorder, Major	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		209119	D003865	Depressive Disorder, Major	OTG		Major depressive disorder (MTAG)	https://genetics.opentargets.org/study/GCST012090	2021			0.457653132412446	0.91	1	GRM5-D003865-D003865	Phase II	0.91	1	GWAS	GWAS Catalog	2021	0.028490389		2	psychiatry	gwas	genetically supported target	FALSE
GRM5-D009771	0.843	3	GRM5-D009771	GRM5	D009771	Obsessive-Compulsive Disorder	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		209132	D009497	Neurotic Disorders	OTG		Neuroticism	https://genetics.opentargets.org/study/GCST005232	2017			0.467171387547318	0.61	1	GRM5-D009771-D009497	Phase II	0.61	1	GWAS	GWAS Catalog	2017	0.034727		2	psychiatry	gwas	genetically supported target	FALSE
GUCY1A1-D050197	0.828	3	GUCY1A1-D050197	GUCY1A1	D050197	Atherosclerosis	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		211770	D003324	Coronary Artery Disease	OTG		Coronary artery disease	https://genetics.opentargets.org/study/GCST003116	2015			0.193824597820446	0.64	1	GUCY1A1-D050197-D003324	Phase II	0.64	1	GWAS	GWAS Catalog	2015		1.0700000000000005	2	cardiovascular	both	genetically supported target	FALSE
GUCY1B1-D050197	0.828	3	GUCY1B1-D050197	GUCY1B1	D050197	Atherosclerosis	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		211905	D003324	Coronary Artery Disease	OTG		Coronary artery disease	https://genetics.opentargets.org/study/GCST010867	2020			0.0285084877543087	0.86	1	GUCY1B1-D050197-D003324	Phase II	0.86	1	GWAS	GWAS Catalog	2020			2	cardiovascular	both	genetically supported target	FALSE
HCAR3-D006937	0.874	3	HCAR3-D006937	HCAR3	D006937	Hypercholesterolemia	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		217103	D050171	Dyslipidemias	OTG		Apolipoprotein A1 levels	https://genetics.opentargets.org/study/GCST90019495	2021			0.576721654883477	0.54	1	HCAR3-D006937-D050171	Phase II	0.54	1	GWAS	GWAS Catalog	2021			2	metabolic	both	genetically supported target	FALSE
HCAR3-D006949	0.804	3	HCAR3-D006949	HCAR3	D006949	Hyperlipidemias	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		217107	D052456	Hypoalphalipoproteinemias	OTG		HDL cholesterol levels	https://genetics.opentargets.org/study/GCST010242	2020			0.175049730036942	0.51	1	HCAR3-D006949-D052456	Phase II	0.51	1	GWAS	GWAS Catalog	2020	0.0377999		2	metabolic	both	genetically supported target	FALSE
HCN4-D001281	1	3	HCN4-D001281	HCN4	D001281	Atrial Fibrillation	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		217275	D001281	Atrial Fibrillation	OTG		Atrial fibrillation	https://genetics.opentargets.org/study/GCST001499	2012			0.17298209187646	0.9	1	HCN4-D001281-D001281	Phase II	0.9	1	GWAS	GWAS Catalog	2012		1.19	2	cardiovascular, signs/symptoms	both	genetically supported target	FALSE
HCRTR1-D007319	0.867	5	HCRTR1-D007319	HCRTR1	D007319	Sleep Initiation and Maintenance Disorders	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		217342	D012893	Sleep Wake Disorders	OTG		Daytime nap	https://genetics.opentargets.org/study/GCST011494	2021			0.621599784540803	0.59	1	HCRTR1-D007319-D012893	Launched	0.59	1	GWAS	GWAS Catalog	2021	0.0072472		3	neurology, psychiatry	both	genetically supported target	TRUE
HCRTR1-D012893	1	3	HCRTR1-D012893	HCRTR1	D012893	Sleep Wake Disorders	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		217342	D012893	Sleep Wake Disorders	OTG		Daytime nap	https://genetics.opentargets.org/study/GCST011494	2021			0.621599784540803	0.59	1	HCRTR1-D012893-D012893	Phase II	0.59	1	GWAS	GWAS Catalog	2021	0.0072472		2	neurology, signs/symptoms, psychiatry	both	genetically supported target	FALSE
HCRTR1-D029424	0.807	2	HCRTR1-D029424	HCRTR1	D029424	Pulmonary Disease, Chronic Obstructive		Phase I	Phase I		3	2	TRUE				FALSE		217328	D001249	Asthma	OTG		Lung function (FEV1/FVC)	https://genetics.opentargets.org/study/GCST007080	2018			0.544869293796332	0.56	1	HCRTR1-D029424-D001249	Phase I	0.56	1	GWAS	GWAS Catalog	2018			0	respiratory	both	genetically supported target	FALSE
HCRTR2-D007319	0.867	5	HCRTR2-D007319	HCRTR2	D007319	Sleep Initiation and Maintenance Disorders	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		217379	D012893	Sleep Wake Disorders	OTG		Sleep duration (short sleep)	https://genetics.opentargets.org/study/GCST007559	2019			0.580507919884802	0.89	1	HCRTR2-D007319-D012893	Launched	0.89	1	GWAS	GWAS Catalog	2019			3	neurology, psychiatry	both	genetically supported target	TRUE
HCRTR2-D009290	0.873	3	HCRTR2-D009290	HCRTR2	D009290	Narcolepsy		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		217379	D012893	Sleep Wake Disorders	OTG		Sleep duration (short sleep)	https://genetics.opentargets.org/study/GCST007559	2019			0.580507919884802	0.89	1	HCRTR2-D009290-D012893	Phase II	0.89	1	GWAS	GWAS Catalog	2019			1	neurology, psychiatry	both	genetically supported target	FALSE
HCRTR2-D012893	1	3	HCRTR2-D012893	HCRTR2	D012893	Sleep Wake Disorders	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		217379	D012893	Sleep Wake Disorders	OTG		Sleep duration (short sleep)	https://genetics.opentargets.org/study/GCST007559	2019			0.580507919884802	0.89	1	HCRTR2-D012893-D012893	Phase II	0.89	1	GWAS	GWAS Catalog	2019			2	neurology, signs/symptoms, psychiatry	both	genetically supported target	FALSE
HCRTR2-D020177	0.807	2	HCRTR2-D020177	HCRTR2	D020177	Idiopathic Hypersomnia		Phase I	Phase I		3	2	TRUE				TRUE		217379	D012893	Sleep Wake Disorders	OTG		Sleep duration (short sleep)	https://genetics.opentargets.org/study/GCST007559	2019			0.580507919884802	0.89	1	HCRTR2-D020177-D012893	Phase I	0.89	1	GWAS	GWAS Catalog	2019			0	neurology, psychiatry	both	genetically supported target	FALSE
HLA-DRB1-D001172	1	2	HLA-DRB1-D001172	HLA-DRB1	D001172	Arthritis, Rheumatoid		Phase I	Phase I		3	2	TRUE				FALSE		223524	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis	https://genetics.opentargets.org/study/GCST000040	2007			0.373907371167645	0.53	1	HLA-DRB1-D001172-D001172	Phase I	0.53	1	GWAS	GWAS Catalog	2007			0	musculoskeletal, dermatology, immune	gwas	genetically supported target	FALSE
HMGCR-D006937	1	5	HMGCR-D006937	HMGCR	D006937	Hypercholesterolemia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		225094	D006937	Hypercholesterolemia	OTG		LDL cholesterol	https://genetics.opentargets.org/study/GCST000134	2008			0.394942140163828	0.62	1	HMGCR-D006937-D006937	Launched	0.62	1	GWAS	GWAS Catalog	2008			3	metabolic	both	genetically supported target	TRUE
HMGCR-D006949	0.906	5	HMGCR-D006949	HMGCR	D006949	Hyperlipidemias	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		225094	D006937	Hypercholesterolemia	OTG		LDL cholesterol	https://genetics.opentargets.org/study/GCST000134	2008			0.394942140163828	0.62	1	HMGCR-D006949-D006937	Launched	0.62	1	GWAS	GWAS Catalog	2008			3	metabolic	both	genetically supported target	TRUE
HMGCR-D050171	0.874	5	HMGCR-D050171	HMGCR	D050171	Dyslipidemias	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		225094	D006937	Hypercholesterolemia	OTG		LDL cholesterol	https://genetics.opentargets.org/study/GCST000134	2008			0.394942140163828	0.62	1	HMGCR-D050171-D006937	Launched	0.62	1	GWAS	GWAS Catalog	2008			3	metabolic	both	genetically supported target	TRUE
HSD17B13-D065626	1	3	HSD17B13-D065626	HSD17B13	D065626	Non-alcoholic Fatty Liver Disease		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		230960	D065626	Non-alcoholic Fatty Liver Disease	OTG		Nonalcoholic fatty liver disease (imputed)	https://genetics.opentargets.org/study/GCST90094908	2021			0.260046820132657	0.72	1	HSD17B13-D065626-D065626	Phase II	0.72	1	GWAS	GWAS Catalog	2021			1	digestive	both	genetically supported target	FALSE
HTR1A-D007319	0.867	3	HTR1A-D007319	HTR1A	D007319	Sleep Initiation and Maintenance Disorders	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		232286	D012893	Sleep Wake Disorders	OTG		Daytime nap	https://genetics.opentargets.org/study/GCST011494	2021			0.324986992715921	1	1	HTR1A-D007319-D012893	Phase II	1	1	GWAS	GWAS Catalog	2021	0.00818319		2	neurology, psychiatry	both	genetically supported target	FALSE
HTR1A-D009765	1	2	HTR1A-D009765	HTR1A	D009765	Obesity	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		232274	D009765	Obesity	OTG		Body mass index	https://genetics.opentargets.org/study/GCST005951	2015			0.496346555323591	0.79	1	HTR1A-D009765-D009765	Phase I	0.79	1	GWAS	GWAS Catalog	2015	0.015505578		1	metabolic, signs/symptoms	both	genetically supported target	FALSE
HTR6-D001714	1	2	HTR6-D001714	HTR6	D001714	Bipolar Disorder		Phase I	Phase I		3	2	TRUE				FALSE		232517	D001714	Bipolar Disorder	OTG		Bipolar I disorder	https://genetics.opentargets.org/study/GCST012464	2021			0.623897300855826	0.57	1	HTR6-D001714-D001714	Phase I	0.57	1	GWAS	GWAS Catalog	2021		1.0766999999999993	0	psychiatry	gwas	genetically supported target	FALSE
ICOSLG-D001172	1	2	ICOSLG-D001172	ICOSLG	D001172	Arthritis, Rheumatoid	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		233859	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis	https://genetics.opentargets.org/study/GCST90013534	2020			0.256884905170174	0.72	1	ICOSLG-D001172-D001172	Phase I	0.72	1	GWAS	GWAS Catalog	2020			1	musculoskeletal, dermatology, immune	gwas	genetically supported target	FALSE
ICOSLG-D012859	0.81	3	ICOSLG-D012859	ICOSLG	D012859	Sjogren's Syndrome	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		233859	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis	https://genetics.opentargets.org/study/GCST90013534	2020			0.256884905170174	0.72	1	ICOSLG-D012859-D001172	Phase II	0.72	1	GWAS	GWAS Catalog	2020			2	musculoskeletal, ophthalmology, dermatology, immune	both	genetically supported target	FALSE
IFNAR2-D000086382	1	5	IFNAR2-D000086382	IFNAR2	D000086382	COVID-19	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2021	235343	D000086382	COVID-19	OTG		COVID-19 (critical illness vs population)	https://genetics.opentargets.org/study/GCST010936	2020			0.677513985536908	0.62	1	IFNAR2-D000086382-D000086382	Launched	0.62	1	GWAS	GWAS Catalog	2020		1.2000000000000004	3	infection, respiratory	gwas	genetically supported target	TRUE
IFNG-D003424	0.875	3	IFNG-D003424	IFNG	D003424	Crohn Disease	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		235393	D003093	Colitis, Ulcerative	OTG		Ulcerative colitis	https://genetics.opentargets.org/study/GCST000311	2009			0.40404106029106	0.8	1	IFNG-D003424-D003093	Phase II	0.8	1	GWAS	GWAS Catalog	2009		1.35	2	digestive	both	genetically supported target	FALSE
IFNG-D011565	1	2	IFNG-D011565	IFNG	D011565	Psoriasis	Phase I		Phase I	2		2	TRUE	FALSE			TRUE		235419	D011565	Psoriasis	OTG		Psoriasis	https://genetics.opentargets.org/study/GCST005527	2012			0.0254632629260075	0.79	1	IFNG-D011565-D011565	Phase I	0.79	1	GWAS	GWAS Catalog	2012		11.261261261261273	1	dermatology	both	genetically supported target	FALSE
IGF1-D024821	0.89	3	IGF1-D024821	IGF1	D024821	Metabolic Syndrome	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		235985	D007333	Insulin Resistance	OTG		Homeostasis model assessment of insulin resistance	https://genetics.opentargets.org/study/GCST005179	2010			0.839580730251284	0.87	1	IGF1-D024821-D007333	Phase II	0.87	1	GWAS	GWAS Catalog	2010	0.013		2	metabolic	both	genetically supported target	FALSE
IL12B-D001327	1	3	IL12B-D001327	IL12B	D001327	Autoimmune Diseases	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		238729	D001327	Autoimmune Diseases	OTG		Autoimmune traits	https://genetics.opentargets.org/study/GCST007071	2018			0.485625081306101	0.78	1	IL12B-D001327-D001327	Phase II	0.78	1	GWAS	GWAS Catalog	2018			2	immune	both	genetically supported target	FALSE
IL12B-D003093	0.875	5	IL12B-D003093	IL12B	D003093	Colitis, Ulcerative	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		238740	D003424	Crohn Disease	OTG		Crohn's disease	https://genetics.opentargets.org/study/GCST000207	2008			0.713858165256994	0.76	1	IL12B-D003093-D003424	Launched	0.76	1	GWAS	GWAS Catalog	2008		1.11	3	digestive	both	genetically supported target	TRUE
IL12B-D003424	1	5	IL12B-D003424	IL12B	D003424	Crohn Disease	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2020	238740	D003424	Crohn Disease	OTG		Crohn's disease	https://genetics.opentargets.org/study/GCST000207	2008			0.713858165256994	0.76	1	IL12B-D003424-D003424	Launched	0.76	1	GWAS	GWAS Catalog	2008		1.11	3	digestive	both	genetically supported target	TRUE
IL12B-D008105	0.848	3	IL12B-D008105	IL12B	D008105	Liver Cirrhosis, Biliary		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		238732	D002761	Cholangitis	OTG		Primary biliary cholangitis	https://genetics.opentargets.org/study/GCST90061440	2021			0.470962712745225	0.76	1	IL12B-D008105-D002761	Phase II	0.76	1	GWAS	GWAS Catalog	2021	0.144233		1	digestive, signs/symptoms	both	genetically supported target	FALSE
IL12B-D009103	1	3	IL12B-D009103	IL12B	D009103	Multiple Sclerosis	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		238753	D009103	Multiple Sclerosis	OTG		Multiple sclerosis	https://genetics.opentargets.org/study/GCST009597	2019			0.470962712745225	0.76	1	IL12B-D009103-D009103	Phase II	0.76	1	GWAS	GWAS Catalog	2019		1.0877999999999999	2	neurology, immune	both	genetically supported target	FALSE
IL12B-D011565	1	5	IL12B-D011565	IL12B	D011565	Psoriasis	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2009	238756	D011565	Psoriasis	OTG		Psoriasis	https://genetics.opentargets.org/study/GCST000321	2009			0.197373553504096	0.86	1	IL12B-D011565-D011565	Launched	0.86	1	GWAS	GWAS Catalog	2009		1.28	3	dermatology	both	genetically supported target	TRUE
IL12B-D012507	1	3	IL12B-D012507	IL12B	D012507	Sarcoidosis	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		238783	D012507	Sarcoidosis	OTG		Sarcoidosis [EA]	https://genetics.opentargets.org/study/GCST005538	2015			0.357607282184655	0.68	1	IL12B-D012507-D012507	Phase II	0.68	1	GWAS	GWAS Catalog	2015		1.2	2	hematology	gwas	genetically supported target	FALSE
IL12B-D013167	0.956	4	IL12B-D013167	IL12B	D013167	Spondylitis, Ankylosing	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		238803	D015535	Arthritis, Psoriatic	OTG		Psoriatic arthritis	https://genetics.opentargets.org/study/GCST000835	2010			0.0839719444083647	0.72	1	IL12B-D013167-D015535	Phase III	0.72	1	GWAS	GWAS Catalog	2010			3	musculoskeletal	both	genetically supported target	FALSE
IL12B-D013625	1	4	IL12B-D013625	IL12B	D013625	Takayasu Arteritis		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		238787	D013625	Takayasu Arteritis	OTG		Takayasu arteritis	https://genetics.opentargets.org/study/GCST011938	2020			0.324866831232948	0.8	1	IL12B-D013625-D013625	Phase III	0.8	1	GWAS	GWAS Catalog	2020			2	cardiovascular, dermatology	both	genetically supported target	FALSE
IL12B-D015535	0.899	5	IL12B-D015535	IL12B	D015535	Arthritis, Psoriatic	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		238756	D011565	Psoriasis	OTG		Psoriasis	https://genetics.opentargets.org/study/GCST000321	2009			0.197373553504096	0.86	1	IL12B-D015535-D011565	Launched	0.86	1	GWAS	GWAS Catalog	2009		1.28	3	musculoskeletal, dermatology	both	genetically supported target	TRUE
IL12RB2-D001172	1	2	IL12RB2-D001172	IL12RB2	D001172	Arthritis, Rheumatoid	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		238884	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis	https://genetics.opentargets.org/study/GCST010730	2020			0.146928970263602	0.85	1	IL12RB2-D001172-D001172	Phase I	0.85	1	GWAS	GWAS Catalog	2020		1.1	1	musculoskeletal, dermatology, immune	gwas	genetically supported target	FALSE
IL13-D001249	0.849	2	IL13-D001249	IL13	D001249	Asthma		Phase I	Phase I		3	2	TRUE				TRUE		239001	D006969	Hypersensitivity, Immediate	OTG		IgE levels	https://genetics.opentargets.org/study/GCST001316	2011			0.762180070157204	0.76	1	IL13-D001249-D006969	Phase I	0.76	1	GWAS	GWAS Catalog	2011	0.08		0	respiratory, immune	both	genetically supported target	FALSE
IL13-D003876	1	5	IL13-D003876	IL13	D003876	Dermatitis, Atopic	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE		238961	D003876	Dermatitis, Atopic	OTG		Atopic dermatitis	https://genetics.opentargets.org/study/GCST002100	2013			0.759136428664326	0.76	1	IL13-D003876-D003876	Launched	0.76	1	GWAS	GWAS Catalog	2013		1.3829999999999998	3	congenital, dermatology, immune	gwas	genetically supported target	TRUE
IL13-D006689	1	3	IL13-D006689	IL13	D006689	Hodgkin Disease	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		238993	D006689	Hodgkin Disease	OTG		Hodgkin's lymphoma [EBV-negative cHL]	https://genetics.opentargets.org/study/GCST001387	2012			0.762180070157204	0.76	1	IL13-D006689-D006689	Phase II	0.76	1	GWAS	GWAS Catalog	2012			2	oncology	gwas	genetically supported target	FALSE
IL13-D011565	1	2	IL13-D011565	IL13	D011565	Psoriasis	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		239008	D011565	Psoriasis	OTG		Psoriasis	https://genetics.opentargets.org/study/GCST000322	2009			0.762180070157204	0.76	1	IL13-D011565-D011565	Phase I	0.76	1	GWAS	GWAS Catalog	2009		1.27	1	dermatology	both	genetically supported target	FALSE
IL13-D029424	0.807	3	IL13-D029424	IL13	D029424	Pulmonary Disease, Chronic Obstructive	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		238938	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST005212	2017			0.762180070157204	0.76	1	IL13-D029424-D001249	Phase II	0.76	1	GWAS	GWAS Catalog	2017		1.1235955	2	respiratory	both	genetically supported target	FALSE
IL13-D057765	0.806	4	IL13-D057765	IL13	D057765	Eosinophilic Esophagitis		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		TRUE		239001	D006969	Hypersensitivity, Immediate	OTG		IgE levels	https://genetics.opentargets.org/study/GCST001316	2011			0.762180070157204	0.76	1	IL13-D057765-D006969	Phase III	0.76	1	GWAS	GWAS Catalog	2011	0.08		2	digestive, hematology, immune	both	genetically supported target	FALSE
IL18-D007249	1	2	IL18-D007249	IL18	D007249	Inflammation	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		239400	D007249	Inflammation	OTG		Interleukin-18 levels	https://genetics.opentargets.org/study/GCST000590	2010			0.243399661854597	0.55	1	IL18-D007249-D007249	Phase I	0.55	1	GWAS	GWAS Catalog	2010			1	signs/symptoms	gwas	genetically supported target	FALSE
IL1B-D000152	1	4	IL1B-D000152	IL1B	D000152	Acne Vulgaris		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		TRUE		239907	D000152	Acne Vulgaris	OTG		acne vulgaris	https://genetics.opentargets.org/study/GCST90092000	2022			0.661208576998051	0.66	1	IL1B-D000152-D000152	Phase III	0.66	1	GWAS	GWAS Catalog	2022		1.0700000000000005	2	dermatology	both	genetically supported target	FALSE
IL1B-D006967	1	4	IL1B-D006967	IL1B	D006967	Hypersensitivity	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		239912	D006967	Hypersensitivity	OTG		Allergic disease (asthma, hay fever or eczema)	https://genetics.opentargets.org/study/GCST009716	2019			0.354859667359667	0.74	1	IL1B-D006967-D006967	Phase III	0.74	1	GWAS	GWAS Catalog	2019		1.0362694	3	immune	gwas	genetically supported target	FALSE
IL1R1-D029424	1	3	IL1R1-D029424	IL1R1	D029424	Pulmonary Disease, Chronic Obstructive	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		240027	D029424	Pulmonary Disease, Chronic Obstructive	OTG		Fibrinogen levels	https://genetics.opentargets.org/study/GCST003194	2015			0.628278369254739	0.82	1	IL1R1-D029424-D029424	Phase II	0.82	1	GWAS	GWAS Catalog	2015	0.0058		2	respiratory	both	genetically supported target	FALSE
IL1RN-D007249	1	3	IL1RN-D007249	IL1RN	D007249	Inflammation	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		240419	D007249	Inflammation	OTG		C-reactive protein levels	https://genetics.opentargets.org/study/GCST000965	2011			0.370005189413596	0.52	1	IL1RN-D007249-D007249	Phase II	0.52	1	GWAS	GWAS Catalog	2011	0.05		2	signs/symptoms	gwas	genetically supported target	FALSE
IL2-D011565	1	3	IL2-D011565	IL2	D011565	Psoriasis		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		240596	D011565	Psoriasis	OTG		Psoriasis	https://genetics.opentargets.org/study/GCST005527	2012			0.0299078759569223	0.57	1	IL2-D011565-D011565	Phase II	0.57	1	GWAS	GWAS Catalog	2012		5.047955577990914	1	dermatology	both	genetically supported target	FALSE
IL23R-D003093	0.875	3	IL23R-D003093	IL23R	D003093	Colitis, Ulcerative		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		240918	D003424	Crohn Disease	OTG		Crohn's disease	https://genetics.opentargets.org/study/GCST000014	2007			0.0638863665845116	0.53	1	IL23R-D003093-D003424	Phase II	0.53	1	GWAS	GWAS Catalog	2007			1	digestive	both	genetically supported target	FALSE
IL23R-D003424	1	2	IL23R-D003424	IL23R	D003424	Crohn Disease		Phase I	Phase I		3	2	TRUE				FALSE		240918	D003424	Crohn Disease	OTG		Crohn's disease	https://genetics.opentargets.org/study/GCST000014	2007			0.0638863665845116	0.53	1	IL23R-D003424-D003424	Phase I	0.53	1	GWAS	GWAS Catalog	2007			0	digestive	both	genetically supported target	FALSE
IL23R-D011565	1	4	IL23R-D011565	IL23R	D011565	Psoriasis		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		240957	D011565	Psoriasis	OTG		Psoriasis	https://genetics.opentargets.org/study/GCST005527	2012			0.065854290899663	0.52	1	IL23R-D011565-D011565	Phase III	0.52	1	GWAS	GWAS Catalog	2012		1.5620118712902218	2	dermatology	both	genetically supported target	FALSE
IL23R-D015212	0.907	2	IL23R-D015212	IL23R	D015212	Inflammatory Bowel Diseases		Phase I	Phase I		3	2	TRUE				FALSE		240918	D003424	Crohn Disease	OTG		Crohn's disease	https://genetics.opentargets.org/study/GCST000014	2007			0.0638863665845116	0.53	1	IL23R-D015212-D003424	Phase I	0.53	1	GWAS	GWAS Catalog	2007			0	digestive	both	genetically supported target	FALSE
IL23R-D015535	0.956	2	IL23R-D015535	IL23R	D015535	Arthritis, Psoriatic	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		240965	D013167	Spondylitis, Ankylosing	OTG		Ankylosing spondylitis	https://genetics.opentargets.org/study/GCST000563	2010			0.0638863665845116	0.52	1	IL23R-D015535-D013167	Phase I	0.52	1	GWAS	GWAS Catalog	2010			1	musculoskeletal, dermatology	both	genetically supported target	FALSE
IL2RA-D001172	1	5	IL2RA-D001172	IL2RA	D001172	Arthritis, Rheumatoid	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE		241133	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis (ACPA-positive)	https://genetics.opentargets.org/study/GCST005568	2012			0.430606139438085	0.84	1	IL2RA-D001172-D001172	Launched	0.84	1	GWAS	GWAS Catalog	2012		1.1047	3	musculoskeletal, dermatology, immune	gwas	genetically supported target	TRUE
IL2RA-D001327	1	2	IL2RA-D001327	IL2RA	D001327	Autoimmune Diseases		Phase I	Phase I		3	2	TRUE				FALSE		241147	D001327	Autoimmune Diseases	OTG		Autoimmune traits	https://genetics.opentargets.org/study/GCST007071	2018			0.4234228362878	0.85	1	IL2RA-D001327-D001327	Phase I	0.85	1	GWAS	GWAS Catalog	2018			0	immune	both	genetically supported target	FALSE
IL2RA-D003093	0.875	3	IL2RA-D003093	IL2RA	D003093	Colitis, Ulcerative		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		241151	D003424	Crohn Disease	OTG		Crohn's disease	https://genetics.opentargets.org/study/GCST000879	2010			0.154919522326064	0.79	1	IL2RA-D003093-D003424	Phase II	0.79	1	GWAS	GWAS Catalog	2010		1.1099999999999999	1	digestive	both	genetically supported target	FALSE
IL2RA-D003876	0.851	2	IL2RA-D003876	IL2RA	D003876	Dermatitis, Atopic		Phase I	Phase I		3	2	TRUE				FALSE		241177	D004485	Eczema	OTG		Eczema	https://genetics.opentargets.org/study/GCST007075	2018			0.0793506493506494	0.83	1	IL2RA-D003876-D004485	Phase I	0.83	1	GWAS	GWAS Catalog	2018			0	congenital, dermatology, immune	gwas	genetically supported target	FALSE
IL2RA-D003922	1	2	IL2RA-D003922	IL2RA	D003922	Diabetes Mellitus, Type 1		Phase I	Phase I		3	2	TRUE				FALSE		241161	D003922	Diabetes Mellitus, Type 1	OTG		Type 1 diabetes	https://genetics.opentargets.org/study/GCST001191	2011			0.0959117456197275	0.76	1	IL2RA-D003922-D003922	Phase I	0.76	1	GWAS	GWAS Catalog	2011		1.6100000000000008	0	metabolic, endocrine, immune	both	genetically supported target	FALSE
IL2RA-D012859	0.81	5	IL2RA-D012859	IL2RA	D012859	Sjogren's Syndrome	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		241133	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis (ACPA-positive)	https://genetics.opentargets.org/study/GCST005568	2012			0.430606139438085	0.84	1	IL2RA-D012859-D001172	Launched	0.84	1	GWAS	GWAS Catalog	2012		1.1047	3	musculoskeletal, ophthalmology, dermatology, immune	both	genetically supported target	TRUE
IL33-D001249	1	3	IL33-D001249	IL33	D001249	Asthma		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		241454	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST000804	2010			0.150921359979237	0.8	1	IL33-D001249-D001249	Phase II	0.8	1	GWAS	GWAS Catalog	2010		1.2	1	respiratory, immune	both	genetically supported target	FALSE
IL33-D001327	1	2	IL33-D001327	IL33	D001327	Autoimmune Diseases	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		241497	D001327	Autoimmune Diseases	OTG		Immunological or systemic disorder	https://genetics.opentargets.org/study/GCST90038603	2021			0.758907518993974	0.83	1	IL33-D001327-D001327	Phase I	0.83	1	GWAS	GWAS Catalog	2021		1.0048984081665284	1	immune	both	genetically supported target	FALSE
IL33-D003876	0.851	3	IL33-D003876	IL33	D003876	Dermatitis, Atopic		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		241503	D004485	Eczema	OTG		Eczema	https://genetics.opentargets.org/study/GCST007075	2018			0.150921359979237	0.8	1	IL33-D003876-D004485	Phase II	0.8	1	GWAS	GWAS Catalog	2018			1	congenital, dermatology, immune	gwas	genetically supported target	FALSE
IL33-D009298	1	2	IL33-D009298	IL33	D009298	Nasal Polyps	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		241560	D009298	Nasal Polyps	OTG		Nasal polyps	https://genetics.opentargets.org/study/GCST007443	2019			0.758907518993974	0.84	1	IL33-D009298-D009298	Phase I	0.84	1	GWAS	GWAS Catalog	2019		1.3399999999999999	1	respiratory, signs/symptoms	gwas	genetically supported target	FALSE
IL33-D012852	1	3	IL33-D012852	IL33	D012852	Sinusitis	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		241574	D012852	Sinusitis	OTG		Chronic sinusitis	https://genetics.opentargets.org/study/GCST90018823	2021			0.156760965481443	0.79	1	IL33-D012852-D012852	Phase II	0.79	1	GWAS	GWAS Catalog	2021	0.1375		2	infection, respiratory	gwas	genetically supported target	FALSE
IL33-D029424	0.807	4	IL33-D029424	IL33	D029424	Pulmonary Disease, Chronic Obstructive		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		241454	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST000804	2010			0.150921359979237	0.8	1	IL33-D029424-D001249	Phase III	0.8	1	GWAS	GWAS Catalog	2010		1.2	2	respiratory	both	genetically supported target	FALSE
IL33-D065631	0.817	2	IL33-D065631	IL33	D065631	Rhinitis, Allergic	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		241454	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST000804	2010			0.150921359979237	0.8	1	IL33-D065631-D001249	Phase I	0.8	1	GWAS	GWAS Catalog	2010		1.2	1	respiratory, immune	both	genetically supported target	FALSE
IL4R-D001249	1	5	IL4R-D001249	IL4R	D001249	Asthma	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE	2021	241694	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST007798	2019			0.932234194469687	0.71	1	IL4R-D001249-D001249	Launched	0.71	1	GWAS	GWAS Catalog	2019		1.139	3	respiratory, immune	both	genetically supported target	TRUE
IL4R-D003876	0.851	5	IL4R-D003876	IL4R	D003876	Dermatitis, Atopic	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE		241722	D004485	Eczema	OTG		Eczema	https://genetics.opentargets.org/study/GCST007075	2018			0.932063450786634	0.73	1	IL4R-D003876-D004485	Launched	0.73	1	GWAS	GWAS Catalog	2018			3	congenital, dermatology, immune	gwas	genetically supported target	TRUE
IL4R-D006967	1	4	IL4R-D006967	IL4R	D006967	Hypersensitivity	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	TRUE		241750	D006967	Hypersensitivity	OTG		Allergic disease (asthma, hay fever or eczema)	https://genetics.opentargets.org/study/GCST005038	2017			0.934175882043181	0.67	1	IL4R-D006967-D006967	Phase III	0.67	1	GWAS	GWAS Catalog	2017		1.06790629721624	3	immune	gwas	genetically supported target	FALSE
IL4R-D029424	0.807	4	IL4R-D029424	IL4R	D029424	Pulmonary Disease, Chronic Obstructive		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		TRUE		241694	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST007798	2019			0.932234194469687	0.71	1	IL4R-D029424-D001249	Phase III	0.71	1	GWAS	GWAS Catalog	2019		1.139	2	respiratory	both	genetically supported target	FALSE
IL4R-D057765	0.912	5	IL4R-D057765	IL4R	D057765	Eosinophilic Esophagitis	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE	2022	241723	D004802	Eosinophilia	OTG		Eosinophil counts	https://genetics.opentargets.org/study/GCST004606	2016			0.287108104592169	0.83	1	IL4R-D057765-D004802	Launched	0.83	1	GWAS	GWAS Catalog	2016	0.02771053		3	digestive, hematology, immune	both	genetically supported target	TRUE
IL4R-D065631	0.817	2	IL4R-D065631	IL4R	D065631	Rhinitis, Allergic		Phase I	Phase I		3	2	TRUE				FALSE		241694	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST007798	2019			0.932234194469687	0.71	1	IL4R-D065631-D001249	Phase I	0.71	1	GWAS	GWAS Catalog	2019		1.139	0	respiratory, immune	both	genetically supported target	FALSE
IL5RA-D017681	0.86	4	IL5RA-D017681	IL5RA	D017681	Hypereosinophilic Syndrome		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		TRUE		241839	D004802	Eosinophilia	OTG		Eosinophil counts	https://genetics.opentargets.org/study/GCST004606	2016			0.618628601225394	0.7	1	IL5RA-D017681-D004802	Phase III	0.7	1	GWAS	GWAS Catalog	2016	0.03026724		2	hematology	both	genetically supported target	FALSE
IL5RA-D057765	0.912	4	IL5RA-D057765	IL5RA	D057765	Eosinophilic Esophagitis		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		TRUE		241839	D004802	Eosinophilia	OTG		Eosinophil counts	https://genetics.opentargets.org/study/GCST004606	2016			0.618628601225394	0.7	1	IL5RA-D057765-D004802	Phase III	0.7	1	GWAS	GWAS Catalog	2016	0.03026724		2	digestive, hematology, immune	both	genetically supported target	FALSE
IL6-D001249	1	3	IL6-D001249	IL6	D001249	Asthma		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		241925	D001249	Asthma	OTG		Asthma (childhood onset)	https://genetics.opentargets.org/study/GCST007800	2019			0.293195420244601	0.52	1	IL6-D001249-D001249	Phase II	0.52	1	GWAS	GWAS Catalog	2019			1	respiratory, immune	both	genetically supported target	FALSE
IL6-D007249	1	4	IL6-D007249	IL6	D007249	Inflammation		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		TRUE		241971	D007249	Inflammation	OTG		C-reactive protein levels	https://genetics.opentargets.org/study/GCST90019499	2021			0.0476839237057221	0.59	1	IL6-D007249-D007249	Phase III	0.59	1	GWAS	GWAS Catalog	2021	0.0528		2	signs/symptoms	gwas	genetically supported target	FALSE
IL6R-D001172	1	5	IL6R-D001172	IL6R	D001172	Arthritis, Rheumatoid	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE		242053	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis	https://genetics.opentargets.org/study/GCST005569	2012			0.377549686192469	0.65	1	IL6R-D001172-D001172	Launched	0.65	1	GWAS	GWAS Catalog	2012		1.1148272017837235	3	musculoskeletal, dermatology, immune	gwas	genetically supported target	TRUE
IL6R-D013167	1	4	IL6R-D013167	IL6R	D013167	Spondylitis, Ankylosing	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		242142	D013167	Spondylitis, Ankylosing	OTG		Ankylosing spondylitis	https://genetics.opentargets.org/study/GCST005529	2013			0.375928096912857	0.66	1	IL6R-D013167-D013167	Phase III	0.66	1	GWAS	GWAS Catalog	2013		1.1400000000000006	3	musculoskeletal	both	genetically supported target	FALSE
IL7R-D001327	1	2	IL7R-D001327	IL7R	D001327	Autoimmune Diseases		Phase I	Phase I		3	2	TRUE				FALSE		242341	D001327	Autoimmune Diseases	OTG		Immunological or systemic disorder	https://genetics.opentargets.org/study/GCST90038603	2021			0.267225689027561	0.83	1	IL7R-D001327-D001327	Phase I	0.83	1	GWAS	GWAS Catalog	2021		1.0052718475414864	0	immune	both	genetically supported target	FALSE
IL7R-D003922	1	2	IL7R-D003922	IL7R	D003922	Diabetes Mellitus, Type 1	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		242357	D003922	Diabetes Mellitus, Type 1	OTG		Type 1 diabetes	https://genetics.opentargets.org/study/GCST90013791	2021			0.269280706310049	0.78	1	IL7R-D003922-D003922	Phase I	0.78	1	GWAS	GWAS Catalog	2021		1.113054034711086	1	metabolic, endocrine, immune	both	genetically supported target	FALSE
IL7R-D009103	1	2	IL7R-D009103	IL7R	D009103	Multiple Sclerosis	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		242424	D009103	Multiple Sclerosis	OTG		Multiple sclerosis	https://genetics.opentargets.org/study/GCST005531	2013			0.267991686152247	0.84	1	IL7R-D009103-D009103	Phase I	0.84	1	GWAS	GWAS Catalog	2013		1.1169440411035407	1	neurology, immune	both	genetically supported target	FALSE
INPP5D-D003876	0.851	4	INPP5D-D003876	INPP5D	D003876	Dermatitis, Atopic	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		244019	D004485	Eczema	OTG		Eczema	https://genetics.opentargets.org/study/GCST007075	2018			0.190652626105044	0.63	1	INPP5D-D003876-D004485	Phase III	0.63	1	GWAS	GWAS Catalog	2018			3	congenital, dermatology, immune	gwas	genetically supported target	FALSE
INSR-D003924	1	5	INSR-D003924	INSR	D003924	Diabetes Mellitus, Type 2	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2008	244890	D003924	Diabetes Mellitus, Type 2	OTG		Type 2 diabetes	https://genetics.opentargets.org/study/GCST009379	2018			0.18041504539559	0.72	1	INSR-D003924-D003924	Launched	0.72	1	GWAS	GWAS Catalog	2018		1.05	3	metabolic, endocrine	both	genetically supported target	TRUE
INSR-D009765	1	3	INSR-D009765	INSR	D009765	Obesity		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		244967	D009765	Obesity	OTG		Hip circumference adjusted for BMI [EA]	https://genetics.opentargets.org/study/GCST004067_3	2015			0.263780551222049	0.63	1	INSR-D009765-D009765	Phase II	0.63	1	GWAS	GWAS Catalog	2015	0.0259		1	metabolic, signs/symptoms	both	genetically supported target	FALSE
ITGA4-D003093	0.89	5	ITGA4-D003093	ITGA4	D003093	Colitis, Ulcerative	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		250301	D015212	Inflammatory Bowel Diseases	OTG		Inflammatory bowel disease	https://genetics.opentargets.org/study/GCST004131	2017			0.563272207049031	0.74	1	ITGA4-D003093-D015212	Launched	0.74	1	GWAS	GWAS Catalog	2017		1.096803455730531	3	digestive	both	genetically supported target	TRUE
ITGA4-D015212	1	2	ITGA4-D015212	ITGA4	D015212	Inflammatory Bowel Diseases		Phase I	Phase I		3	2	TRUE				FALSE		250301	D015212	Inflammatory Bowel Diseases	OTG		Inflammatory bowel disease	https://genetics.opentargets.org/study/GCST004131	2017			0.563272207049031	0.74	1	ITGA4-D015212-D015212	Phase I	0.74	1	GWAS	GWAS Catalog	2017		1.096803455730531	0	digestive	both	genetically supported target	FALSE
ITGAV-D003424	0.907	3	ITGAV-D003424	ITGAV	D003424	Crohn Disease	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		250566	D015212	Inflammatory Bowel Diseases	OTG		Inflammatory bowel disease	https://genetics.opentargets.org/study/GCST004131	2017			0.0990400830198469	0.51	1	ITGAV-D003424-D015212	Phase II	0.51	1	GWAS	GWAS Catalog	2017		1.1210884009605073	2	digestive	both	genetically supported target	FALSE
ITGB8-D011471	1	3	ITGB8-D011471	ITGB8	D011471	Prostatic Neoplasms	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		250949	D011471	Prostatic Neoplasms	OTG		Prostate cancer	https://genetics.opentargets.org/study/GCST006085	2018			0.500990752972259	0.85	1	ITGB8-D011471-D011471	Phase II	0.85	1	GWAS	GWAS Catalog	2018		1.0509557623495804	2	oncology	both	genetically supported target	FALSE
JAK1-D013922	0.825	4	JAK1-D013922	JAK1	D013922	Thrombocytosis		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		252673	D001791	Blood Platelet Disorders	OTG		Platelet count	https://genetics.opentargets.org/study/GCST90002357	2020			0.219950674974039	0.59	1	JAK1-D013922-D001791	Phase III	0.59	1	GWAS	GWAS Catalog	2020	0.015759		2	hematology	both	genetically supported target	FALSE
JAK2-D003093	0.875	4	JAK2-D003093	JAK2	D003093	Colitis, Ulcerative	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		252804	D003424	Crohn Disease	OTG		Crohn's disease	https://genetics.opentargets.org/study/GCST000207	2008			0.649662074343644	0.85	1	JAK2-D003093-D003424	Phase III	0.85	1	GWAS	GWAS Catalog	2008		1.1199999999999999	3	digestive	both	genetically supported target	FALSE
JAK2-D003424	1	3	JAK2-D003424	JAK2	D003424	Crohn Disease	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		252804	D003424	Crohn Disease	OTG		Crohn's disease	https://genetics.opentargets.org/study/GCST000207	2008			0.649662074343644	0.85	1	JAK2-D003424-D003424	Phase II	0.85	1	GWAS	GWAS Catalog	2008		1.1199999999999999	2	digestive	both	genetically supported target	FALSE
JAK2-D008180	1	4	JAK2-D008180	JAK2	D008180	Lupus Erythematosus, Systemic	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		252835	D008180	Lupus Erythematosus, Systemic	OTG		Systemic lupus erythematosus	https://genetics.opentargets.org/study/GCST003622	2016			0.621229849193968	0.86	1	JAK2-D008180-D008180	Phase III	0.86	1	GWAS	GWAS Catalog	2016			3	dermatology, immune	both	genetically supported target	FALSE
JAK2-D011565	1	3	JAK2-D011565	JAK2	D011565	Psoriasis		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		252849	D011565	Psoriasis	OTG		Psoriasis	https://genetics.opentargets.org/study/GCST005527	2012			0.0164635727249157	0.82	1	JAK2-D011565-D011565	Phase II	0.82	1	GWAS	GWAS Catalog	2012		8.389261744966444	1	dermatology	both	genetically supported target	FALSE
JAK2-D013921	0.877	5	JAK2-D013921	JAK2	D013921	Thrombocytopenia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		252770	D001791	Blood Platelet Disorders	OTG		Platelet count	https://genetics.opentargets.org/study/GCST004603	2016			0.523210327291694	0.76	1	JAK2-D013921-D001791	Launched	0.76	1	GWAS	GWAS Catalog	2016	0.04031984		3	hematology	both	genetically supported target	TRUE
JAK2-D015535	0.899	4	JAK2-D015535	JAK2	D015535	Arthritis, Psoriatic	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		252849	D011565	Psoriasis	OTG		Psoriasis	https://genetics.opentargets.org/study/GCST005527	2012			0.0164635727249157	0.82	1	JAK2-D015535-D011565	Phase III	0.82	1	GWAS	GWAS Catalog	2012		8.389261744966444	3	musculoskeletal, dermatology	both	genetically supported target	FALSE
JAK2-D019337	0.957	2	JAK2-D019337	JAK2	D019337	Hematologic Neoplasms	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		252845	D011087	Polycythemia Vera	OTG		Myeloproliferative neoplasms	https://genetics.opentargets.org/study/GCST000357	2009			0.279495841995842	0.5	1	JAK2-D019337-D011087	Phase I	0.5	1	GWAS	GWAS Catalog	2009			1	oncology	gwas	genetically supported target	FALSE
KCND3-D001281	1	2	KCND3-D001281	KCND3	D001281	Atrial Fibrillation	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		256128	D001281	Atrial Fibrillation	OTG		Atrial fibrillation	https://genetics.opentargets.org/study/GCST004373	2017			0.0906850025947068	0.57	1	KCND3-D001281-D001281	Phase I	0.57	1	GWAS	GWAS Catalog	2017		1.11	1	cardiovascular, signs/symptoms	both	genetically supported target	FALSE
KCNH2-D001281	1	5	KCNH2-D001281	KCNH2	D001281	Atrial Fibrillation	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2021	256717	D001281	Atrial Fibrillation	OTG		Atrial fibrillation	https://genetics.opentargets.org/study/GCST006061	2018			0.181735515718368	0.56	1	KCNH2-D001281-D001281	Launched	0.56	1	GWAS	GWAS Catalog	2018		1.0600000000000003	3	cardiovascular, signs/symptoms	both	genetically supported target	TRUE
KCNJ1-D051437	0.934	2	KCNJ1-D051437	KCNJ1	D051437	Renal Insufficiency	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		257061	D051436	Renal Insufficiency, Chronic	OTG		Serum urea levels	https://genetics.opentargets.org/study/GCST90025991	2021			0.152492858997663	0.79	1	KCNJ1-D051437-D051436	Phase I	0.79	1	GWAS	GWAS Catalog	2021	0.0208169		1	other	both	genetically supported target	FALSE
KCNJ11-D003924	1	5	KCNJ11-D003924	KCNJ11	D003924	Diabetes Mellitus, Type 2	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		257097	D003924	Diabetes Mellitus, Type 2	OTG		Type 2 diabetes [DGI+FUSION+WTCCC]	https://genetics.opentargets.org/study/GCST000024_2	2007			0.636866059817945	0.55	1	KCNJ11-D003924-D003924	Launched	0.55	1	GWAS	GWAS Catalog	2007		1.1400000000000006	3	metabolic, endocrine	both	genetically supported target	TRUE
KCNJ5-D001281	1	3	KCNJ5-D001281	KCNJ5	D001281	Atrial Fibrillation	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		257810	D001281	Atrial Fibrillation	OTG		Atrial fibrillation	https://genetics.opentargets.org/study/GCST004297	2017			0.0865871059800234	0.66	1	KCNJ5-D001281-D001281	Phase II	0.66	1	GWAS	GWAS Catalog	2017		1.18	2	cardiovascular, signs/symptoms	both	genetically supported target	FALSE
KIT-D013921	1	5	KIT-D013921	KIT	D013921	Thrombocytopenia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		264304	D013921	Thrombocytopenia	OTG		Red blood cell count	https://genetics.opentargets.org/study/GCST000588	2010			0.13069435431538	0.84	1	KIT-D013921-D013921	Launched	0.84	1	GWAS	GWAS Catalog	2010	0.111		3	hematology	both	genetically supported target	TRUE
KIT-D017681	0.86	3	KIT-D017681	KIT	D017681	Hypereosinophilic Syndrome		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		264202	D004802	Eosinophilia	OTG		Eosinophil counts	https://genetics.opentargets.org/study/GCST007065	2018			0.350136594250033	0.96	1	KIT-D017681-D004802	Phase II	0.96	1	GWAS	GWAS Catalog	2018			1	hematology	both	genetically supported target	FALSE
KLK2-D011471	1	2	KLK2-D011471	KLK2	D011471	Prostatic Neoplasms		Phase I	Phase I		3	2	TRUE				FALSE		267483	D011471	Prostatic Neoplasms	OTG		Prostate-specific antigen levels (conditioned on lead SNPs) [conditional on Round 6 SNPs]	https://genetics.opentargets.org/study/GCST004094_5	2017			0.575828460038986	0.64	1	KLK2-D011471-D011471	Phase I	0.64	1	GWAS	GWAS Catalog	2017			0	oncology	both	genetically supported target	FALSE
KLK3-D011471	1	2	KLK3-D011471	KLK3	D011471	Prostatic Neoplasms		Phase I	Phase I		3	2	TRUE				FALSE		267512	D011471	Prostatic Neoplasms	OTG		Serum prostate-specific antigen levels	https://genetics.opentargets.org/study/GCST000919	2010			0.0686656282450675	0.5	1	KLK3-D011471-D011471	Phase I	0.5	1	GWAS	GWAS Catalog	2010	39.1		0	oncology	both	genetically supported target	FALSE
LHCGR-D010051	0.812	3	LHCGR-D010051	LHCGR	D010051	Ovarian Neoplasms	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		274386	D011085	Polycystic Ovary Syndrome	OTG		Polycystic ovary syndrome	https://genetics.opentargets.org/study/GCST000914	2010			0.0720492866407263	0.55	1	LHCGR-D010051-D011085	Phase II	0.55	1	GWAS	GWAS Catalog	2010		1.4100000000000008	2	oncology	gwas	genetically supported target	FALSE
LHCGR-D011085	1	5	LHCGR-D011085	LHCGR	D011085	Polycystic Ovary Syndrome	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		274386	D011085	Polycystic Ovary Syndrome	OTG		Polycystic ovary syndrome	https://genetics.opentargets.org/study/GCST000914	2010			0.0720492866407263	0.55	1	LHCGR-D011085-D011085	Launched	0.55	1	GWAS	GWAS Catalog	2010		1.4100000000000008	3	oncology	gwas	genetically supported target	TRUE
LOXL2-D005901	1	3	LOXL2-D005901	LOXL2	D005901	Glaucoma	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		279100	D005901	Glaucoma	OTG		Central corneal thickness	https://genetics.opentargets.org/study/GCST005667	2018			0.203405250844814	0.63	1	LOXL2-D005901-D005901	Phase II	0.63	1	GWAS	GWAS Catalog	2018			2	ophthalmology	both	genetically supported target	FALSE
LPA-D002318	1	4	LPA-D002318	LPA	D002318	Cardiovascular Diseases		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		279235	D002318	Cardiovascular Diseases	OTG		Cardiovascular disease	https://genetics.opentargets.org/study/GCST007072	2018			0.0181488203266788	0.88	1	LPA-D002318-D002318	Phase III	0.88	1	GWAS	GWAS Catalog	2018			2	cardiovascular	gwas	genetically supported target	FALSE
LPA-D006949	0.889	4	LPA-D006949	LPA	D006949	Hyperlipidemias		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		279311	D006951	Hyperlipoproteinemias	OTG		Lp (a) levels	https://genetics.opentargets.org/study/GCST000312	2009			0.825318429945412	0.55	1	LPA-D006949-D006951	Phase III	0.55	1	GWAS	GWAS Catalog	2009			2	metabolic	both	genetically supported target	FALSE
LPA-D050197	0.828	3	LPA-D050197	LPA	D050197	Atherosclerosis	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		279240	D003324	Coronary Artery Disease	OTG		Coronary artery disease	https://genetics.opentargets.org/study/GCST003116	2015			0.0716328653146126	0.84	1	LPA-D050197-D003324	Phase II	0.84	1	GWAS	GWAS Catalog	2015		1.37	2	cardiovascular	both	genetically supported target	FALSE
LRRK2-D010300	1	4	LRRK2-D010300	LRRK2	D010300	Parkinson Disease		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		283948	D010300	Parkinson Disease	OTG		Parkinson's disease	https://genetics.opentargets.org/study/GCST000959	2011			0.177935248992329	0.9	1	LRRK2-D010300-D010300	Phase III	0.9	1	GWAS	GWAS Catalog	2011			2	neurology	both	genetically supported target	FALSE
MAP3K1-D001943	1	3	MAP3K1-D001943	MAP3K1	D001943	Breast Neoplasms	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		290730	D001943	Breast Neoplasms	OTG		Breast cancer	https://genetics.opentargets.org/study/GCST000035	2007			0.712996624253441	0.77	1	MAP3K1-D001943-D001943	Phase II	0.77	1	GWAS	GWAS Catalog	2007		1.1300000000000006	2	oncology	both	genetically supported target	FALSE
MAP3K1-D009369	1	3	MAP3K1-D009369	MAP3K1	D009369	Neoplasms	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		290890	D009369	Neoplasms	OTG		Cancer (pleiotropy) [subset analysis]	https://genetics.opentargets.org/study/GCST003588_2	2016			0.710752408227024	0.76	1	MAP3K1-D009369-D009369	Phase II	0.76	1	GWAS	GWAS Catalog	2016			2	oncology	gwas	genetically supported target	FALSE
MAP3K8-D003093	0.89	3	MAP3K8-D003093	MAP3K8	D003093	Colitis, Ulcerative	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		291440	D015212	Inflammatory Bowel Diseases	OTG		Inflammatory bowel disease	https://genetics.opentargets.org/study/GCST001725	2012			0.619137326230999	0.89	1	MAP3K8-D003093-D015212	Phase II	0.89	1	GWAS	GWAS Catalog	2012		1.075	2	digestive	both	genetically supported target	FALSE
MAP3K8-D015212	1	2	MAP3K8-D015212	MAP3K8	D015212	Inflammatory Bowel Diseases		Phase I	Phase I		3	2	TRUE				FALSE		291440	D015212	Inflammatory Bowel Diseases	OTG		Inflammatory bowel disease	https://genetics.opentargets.org/study/GCST001725	2012			0.619137326230999	0.89	1	MAP3K8-D015212-D015212	Phase I	0.89	1	GWAS	GWAS Catalog	2012		1.075	0	digestive	both	genetically supported target	FALSE
MAPK1-D009765	1	3	MAPK1-D009765	MAPK1	D009765	Obesity	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		291719	D009765	Obesity	OTG		Body mass index	https://genetics.opentargets.org/study/GCST006368	2018			0.134295371814873	0.61	1	MAPK1-D009765-D009765	Phase II	0.61	1	GWAS	GWAS Catalog	2018	0.014		2	metabolic, signs/symptoms	both	genetically supported target	FALSE
MAPK14-D003929	0.979	2	MAPK14-D003929	MAPK14	D003929	Diabetic Neuropathies	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		291815	D017719	Diabetic Foot	OTG		Foot ulcer in diabetes and neuropathy	https://genetics.opentargets.org/study/GCST004724	2017			0.100737910133087	0.61	1	MAPK14-D003929-D017719	Phase I	0.61	1	GWAS	GWAS Catalog	2017		1.71	1	neurology, endocrine	both	genetically supported target	FALSE
MAPK14-D017719	1	2	MAPK14-D017719	MAPK14	D017719	Diabetic Foot	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		291815	D017719	Diabetic Foot	OTG		Foot ulcer in diabetes and neuropathy	https://genetics.opentargets.org/study/GCST004724	2017			0.100737910133087	0.61	1	MAPK14-D017719-D017719	Phase I	0.61	1	GWAS	GWAS Catalog	2017		1.71	1	cardiovascular, dermatology, endocrine	gwas	genetically supported target	FALSE
MC1R-D000417	0.824	2	MC1R-D000417	MC1R	D000417	Albinism	Phase I		Phase I	2		2	TRUE	FALSE			TRUE		295466	D008548	Melanosis	OTG		Freckles	https://genetics.opentargets.org/study/GCST000119	2007			0.0721047853715471	0.61	1	MC1R-D000417-D008548	Phase I	0.61	1	GWAS	GWAS Catalog	2007		4.37	1	ophthalmology, congenital, dermatology, metabolic	both	genetically supported target	FALSE
MC1R-D010787	0.968	3	MC1R-D010787	MC1R	D010787	Photosensitivity Disorders	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		295502	D013471	Sunburn	OTG		Sunburns	https://genetics.opentargets.org/study/GCST007086	2018			0.0772225827384815	0.58	1	MC1R-D010787-D013471	Phase II	0.58	1	GWAS	GWAS Catalog	2018			2	dermatology	both	genetically supported target	FALSE
MC1R-D014983	0.952	2	MC1R-D014983	MC1R	D014983	Xeroderma Pigmentosum		Phase I	Phase I		3	2	TRUE				TRUE		295502	D013471	Sunburn	OTG		Sunburns	https://genetics.opentargets.org/study/GCST007086	2018			0.0772225827384815	0.58	1	MC1R-D014983-D013471	Phase I	0.58	1	GWAS	GWAS Catalog	2018			0	oncology	both	genetically supported target	FALSE
MC1R-D018307	0.915	3	MC1R-D018307	MC1R	D018307	Neoplasms, Squamous Cell	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		295398	D002294	Carcinoma, Squamous Cell	OTG		Cutaneous squamous cell carcinoma	https://genetics.opentargets.org/study/GCST010148	2020			0.0721047853715471	0.52	1	MC1R-D018307-D002294	Phase II	0.52	1	GWAS	GWAS Catalog	2020	0.38		2	oncology	both	genetically supported target	FALSE
MC4R-D003920	1	2	MC4R-D003920	MC4R	D003920	Diabetes Mellitus	Phase I		Phase I	2		2	TRUE	FALSE			TRUE		295761	D003920	Diabetes Mellitus	OTG		Hemoglobin A1c levels	https://genetics.opentargets.org/study/GCST90018958	2021			0.0214035087719298	1	1	MC4R-D003920-D003920	Phase I	1	1	GWAS	GWAS Catalog	2021	0.0452		1	metabolic, endocrine	both	genetically supported target	FALSE
MC4R-D003924	1	2	MC4R-D003924	MC4R	D003924	Diabetes Mellitus, Type 2	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		295764	D003924	Diabetes Mellitus, Type 2	OTG		Type 2 diabetes	https://genetics.opentargets.org/study/GCST002352	2014			0.251461228731004	0.84	1	MC4R-D003924-D003924	Phase I	0.84	1	GWAS	GWAS Catalog	2014		1.08	1	metabolic, endocrine	both	genetically supported target	FALSE
MC4R-D009765	1	5	MC4R-D009765	MC4R	D009765	Obesity	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE	2022	295832	D009765	Obesity	OTG		Body mass index	https://genetics.opentargets.org/study/GCST000185	2008			0.22279859940345	0.68	1	MC4R-D009765-D009765	Launched	0.68	1	GWAS	GWAS Catalog	2008	0.05		3	metabolic, signs/symptoms	both	genetically supported target	TRUE
MC4R-D011218	0.805	3	MC4R-D011218	MC4R	D011218	Prader-Willi Syndrome	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		295832	D009765	Obesity	OTG		Body mass index	https://genetics.opentargets.org/study/GCST000185	2008			0.22279859940345	0.68	1	MC4R-D011218-D009765	Phase II	0.68	1	GWAS	GWAS Catalog	2008	0.05		2	neurology, congenital, metabolic	both	genetically supported target	FALSE
MC4R-D024821	1	2	MC4R-D024821	MC4R	D024821	Metabolic Syndrome	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		295980	D024821	Metabolic Syndrome	OTG		Metabolic syndrome	https://genetics.opentargets.org/study/GCST009602	2019			0.222690710949663	0.69	1	MC4R-D024821-D024821	Phase I	0.69	1	GWAS	GWAS Catalog	2019	0.0678461		1	metabolic	both	genetically supported target	FALSE
MDM4-D001943	1	2	MDM4-D001943	MDM4	D001943	Breast Neoplasms		Phase I	Phase I		3	2	TRUE				FALSE		297516	D001943	Breast Neoplasms	OTG		Breast cancer	https://genetics.opentargets.org/study/GCST001930	2013			0.753440664762399	0.51	1	MDM4-D001943-D001943	Phase I	0.51	1	GWAS	GWAS Catalog	2013			0	oncology	both	genetically supported target	FALSE
METAP2-D003924	1	3	METAP2-D003924	METAP2	D003924	Diabetes Mellitus, Type 2	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		300590	D003924	Diabetes Mellitus, Type 2	OTG		Type 2 diabetes	https://genetics.opentargets.org/study/GCST010555	2020			0.063700051894136	0.73	1	METAP2-D003924-D003924	Phase II	0.73	1	GWAS	GWAS Catalog	2020	0.0601		2	metabolic, endocrine	both	genetically supported target	FALSE
MME-D006973	1	3	MME-D006973	MME	D006973	Hypertension	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		306653	D006973	Hypertension	OTG		Diastolic blood pressure	https://genetics.opentargets.org/study/GCST007094	2016			0.109885832900882	0.89	1	MME-D006973-D006973	Phase II	0.89	1	GWAS	GWAS Catalog	2016	0.288		2	cardiovascular	both	genetically supported target	FALSE
MMP12-D001249	0.807	3	MMP12-D001249	MMP12	D001249	Asthma		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		306808	D029424	Pulmonary Disease, Chronic Obstructive	OTG		Chronic obstructive pulmonary disease (severe)	https://genetics.opentargets.org/study/GCST002350	2014			0.188051948051948	0.57	1	MMP12-D001249-D029424	Phase II	0.57	1	GWAS	GWAS Catalog	2014			1	respiratory, immune	both	genetically supported target	FALSE
MMP9-D003093	0.875	4	MMP9-D003093	MMP9	D003093	Colitis, Ulcerative	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	TRUE		307183	D003424	Crohn Disease	OTG		Crohn's disease	https://genetics.opentargets.org/study/GCST004132	2017			0.406416764284785	0.51	1	MMP9-D003093-D003424	Phase III	0.51	1	GWAS	GWAS Catalog	2017		1.1160548371688523	3	digestive	both	genetically supported target	FALSE
MMP9-D003424	1	4	MMP9-D003424	MMP9	D003424	Crohn Disease	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	TRUE		307183	D003424	Crohn Disease	OTG		Crohn's disease	https://genetics.opentargets.org/study/GCST004132	2017			0.406416764284785	0.51	1	MMP9-D003424-D003424	Phase III	0.51	1	GWAS	GWAS Catalog	2017		1.1160548371688523	3	digestive	both	genetically supported target	FALSE
MSLN-D009369	1	3	MSLN-D009369	MSLN	D009369	Neoplasms		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		312152	D009369	Neoplasms	OTG		Serum cancer antigen 125 levels	https://genetics.opentargets.org/study/GCST009647	2019			0.277387457715327	0.51	1	MSLN-D009369-D009369	Phase II	0.51	1	GWAS	GWAS Catalog	2019	0.15		1	oncology	gwas	genetically supported target	FALSE
MTNR1B-D007319	0.867	5	MTNR1B-D007319	MTNR1B	D007319	Sleep Initiation and Maintenance Disorders	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2015	314543	D012893	Sleep Wake Disorders	OTG		Daytime nap	https://genetics.opentargets.org/study/GCST011494	2021			0.754709627127452	0.63	1	MTNR1B-D007319-D012893	Launched	0.63	1	GWAS	GWAS Catalog	2021	0.00866783		3	neurology, psychiatry	both	genetically supported target	TRUE
MTNR1B-D012893	1	5	MTNR1B-D012893	MTNR1B	D012893	Sleep Wake Disorders	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2020	314543	D012893	Sleep Wake Disorders	OTG		Daytime nap	https://genetics.opentargets.org/study/GCST011494	2021			0.754709627127452	0.63	1	MTNR1B-D012893-D012893	Launched	0.63	1	GWAS	GWAS Catalog	2021	0.00866783		3	neurology, signs/symptoms, psychiatry	both	genetically supported target	TRUE
MTNR1B-D020178	0.971	5	MTNR1B-D020178	MTNR1B	D020178	Sleep Disorders, Circadian Rhythm	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		314557	D021081	Chronobiology Disorders	OTG		Chronotype	https://genetics.opentargets.org/study/GCST007576	2019			0.541628723819435	0.92	1	MTNR1B-D020178-D021081	Launched	0.92	1	GWAS	GWAS Catalog	2019	0.0107238		3	neurology, psychiatry	both	genetically supported target	TRUE
MTNR1B-D058496	0.994	5	MTNR1B-D058496	MTNR1B	D058496	Smith-Magenis Syndrome	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2020	314557	D021081	Chronobiology Disorders	OTG		Chronotype	https://genetics.opentargets.org/study/GCST007576	2019			0.541628723819435	0.92	1	MTNR1B-D058496-D021081	Launched	0.92	1	GWAS	GWAS Catalog	2019	0.0107238		3	neurology, congenital	both	genetically supported target	TRUE
MYC-D001943	1	3	MYC-D001943	MYC	D001943	Breast Neoplasms		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		316558	D001943	Breast Neoplasms	OTG		Breast cancer	https://genetics.opentargets.org/study/GCST001937	2013			0.171124383277071	1	1	MYC-D001943-D001943	Phase II	1	1	GWAS	GWAS Catalog	2013		1.07	1	oncology	both	genetically supported target	FALSE
MYC-D008223	1	3	MYC-D008223	MYC	D008223	Lymphoma	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		316631	D008223	Lymphoma	OTG		Malignant lymphoma	https://genetics.opentargets.org/study/GCST90018878	2021			0.317532467532468	1	1	MYC-D008223-D008223	Phase II	1	1	GWAS	GWAS Catalog	2021	0.1546		2	oncology	gwas	genetically supported target	FALSE
MYC-D011471	1	3	MYC-D011471	MYC	D011471	Prostatic Neoplasms	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		316662	D011471	Prostatic Neoplasms	OTG		Prostate cancer	https://genetics.opentargets.org/study/GCST006085	2018			0.165627435697584	0.56	1	MYC-D011471-D011471	Phase II	0.56	1	GWAS	GWAS Catalog	2018		1.0760533044884926	2	oncology	both	genetically supported target	FALSE
NFE2L2-D007676	0.93	4	NFE2L2-D007676	NFE2L2	D007676	Kidney Failure, Chronic		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		TRUE		327940	D051437	Renal Insufficiency	OTG		Creatinine levels	https://genetics.opentargets.org/study/GCST90019502	2021			0.319251267385935	0.66	1	NFE2L2-D007676-D051437	Phase III	0.66	1	GWAS	GWAS Catalog	2021	0.0257		2	other	both	genetically supported target	FALSE
NFE2L2-D051437	1	4	NFE2L2-D051437	NFE2L2	D051437	Renal Insufficiency		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		TRUE		327940	D051437	Renal Insufficiency	OTG		Creatinine levels	https://genetics.opentargets.org/study/GCST90019502	2021			0.319251267385935	0.66	1	NFE2L2-D051437-D051437	Phase III	0.66	1	GWAS	GWAS Catalog	2021	0.0257		2	other	both	genetically supported target	FALSE
NFKB1-D001249	0.877	3	NFKB1-D001249	NFKB1	D001249	Asthma	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		328948	D012130	Respiratory Hypersensitivity	OTG		Allergic rhinitis	https://genetics.opentargets.org/study/GCST006409	2018			0.326595606395424	0.73	1	NFKB1-D001249-D012130	Phase II	0.73	1	GWAS	GWAS Catalog	2018		1.0416667	2	respiratory, immune	both	genetically supported target	FALSE
NFKB1-D003093	1	3	NFKB1-D003093	NFKB1	D003093	Colitis, Ulcerative	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		328884	D003093	Colitis, Ulcerative	OTG		Ulcerative colitis	https://genetics.opentargets.org/study/GCST001728	2012			0.366047055764981	0.78	1	NFKB1-D003093-D003093	Phase II	0.78	1	GWAS	GWAS Catalog	2012		1.118	2	digestive	both	genetically supported target	FALSE
NFKB1-D003424	0.875	2	NFKB1-D003424	NFKB1	D003424	Crohn Disease		Phase I	Phase I		3	2	TRUE				TRUE		328884	D003093	Colitis, Ulcerative	OTG		Ulcerative colitis	https://genetics.opentargets.org/study/GCST001728	2012			0.366047055764981	0.78	1	NFKB1-D003424-D003093	Phase I	0.78	1	GWAS	GWAS Catalog	2012		1.118	0	digestive	both	genetically supported target	FALSE
NFKB1-D003876	0.851	4	NFKB1-D003876	NFKB1	D003876	Dermatitis, Atopic	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		328886	D004485	Eczema	OTG		Eczema	https://genetics.opentargets.org/study/GCST007075	2018			0.654420355705569	0.76	1	NFKB1-D003876-D004485	Phase III	0.76	1	GWAS	GWAS Catalog	2018			3	congenital, dermatology, immune	gwas	genetically supported target	FALSE
NFKB1-D005923	0.821	3	NFKB1-D005923	NFKB1	D005923	Glomerulosclerosis, Focal Segmental	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		328960	D015433	Glomerulonephritis, Membranous	OTG		Membranous nephropathy	https://genetics.opentargets.org/study/GCST010004	2020			0.656807817589577	0.79	1	NFKB1-D005923-D015433	Phase II	0.79	1	GWAS	GWAS Catalog	2020		1.25	2	other	both	genetically supported target	FALSE
NFKB1-D006967	1	3	NFKB1-D006967	NFKB1	D006967	Hypersensitivity	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		328918	D006967	Hypersensitivity	OTG		Allergic sensitization	https://genetics.opentargets.org/study/GCST006408	2018			0.340054637700013	0.76	1	NFKB1-D006967-D006967	Phase II	0.76	1	GWAS	GWAS Catalog	2018		1.1363636	2	immune	gwas	genetically supported target	FALSE
NFKB1-D008181	0.835	2	NFKB1-D008181	NFKB1	D008181	Lupus Nephritis	Phase I		Phase I	2		2	TRUE	FALSE			TRUE		328960	D015433	Glomerulonephritis, Membranous	OTG		Membranous nephropathy	https://genetics.opentargets.org/study/GCST010004	2020			0.656807817589577	0.79	1	NFKB1-D008181-D015433	Phase I	0.79	1	GWAS	GWAS Catalog	2020		1.25	1	dermatology, immune	both	genetically supported target	FALSE
NKX3-1-D011471	1	2	NKX3-1-D011471	NKX3-1	D011471	Prostatic Neoplasms	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		330829	D011471	Prostatic Neoplasms	OTG		Prostate cancer	https://genetics.opentargets.org/study/GCST000488	2009			0.574678278954894	0.68	1	NKX3-1-D011471-D011471	Phase I	0.68	1	GWAS	GWAS Catalog	2009			1	oncology	both	genetically supported target	FALSE
NLRP3-D007249	1	2	NLRP3-D007249	NLRP3	D007249	Inflammation		Phase I	Phase I		3	2	TRUE				FALSE		331578	D007249	Inflammation	OTG		C-reactive protein levels	https://genetics.opentargets.org/study/GCST000965	2011			0.619762433102728	0.59	1	NLRP3-D007249-D007249	Phase I	0.59	1	GWAS	GWAS Catalog	2011	0.047		0	signs/symptoms	gwas	genetically supported target	FALSE
NOS3-D020521	1	3	NOS3-D020521	NOS3	D020521	Stroke	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		333674	D020521	Stroke	OTG		Stroke [EA]	https://genetics.opentargets.org/study/GCST007248_2	2018			0.6909114651345	0.59	1	NOS3-D020521-D020521	Phase II	0.59	1	GWAS	GWAS Catalog	2018		1.0500000000000005	2	neurology, cardiovascular	gwas	genetically supported target	FALSE
NOTCH2-D001943	1	3	NOTCH2-D001943	NOTCH2	D001943	Breast Neoplasms	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		333861	D001943	Breast Neoplasms	OTG		Invasive breast cancer [mixed effect]	https://genetics.opentargets.org/study/GCST010099_2	2020			0.0784962991819244	0.77	1	NOTCH2-D001943-D001943	Phase II	0.77	1	GWAS	GWAS Catalog	2020			2	oncology	both	genetically supported target	FALSE
NOTCH4-D015179	1	2	NOTCH4-D015179	NOTCH4	D015179	Colorectal Neoplasms	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		333968	D015179	Colorectal Neoplasms	OTG		Colorectal cancer	https://genetics.opentargets.org/study/GCST007552	2018			0.079745024066606	0.67	1	NOTCH4-D015179-D015179	Phase I	0.67	1	GWAS	GWAS Catalog	2018		1.16	1	oncology	both	genetically supported target	FALSE
NOX4-D003928	0.811	3	NOX4-D003928	NOX4	D003928	Diabetic Nephropathies		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		334086	D003930	Diabetic Retinopathy	OTG		Severe diabetic retinopathy in type 2 diabetes	https://genetics.opentargets.org/study/GCST006424	2018			0.32501948558067	0.9	1	NOX4-D003928-D003930	Phase II	0.9	1	GWAS	GWAS Catalog	2018		1.55	1	endocrine	gwas	genetically supported target	FALSE
NPC1L1-D006949	0.906	3	NPC1L1-D006949	NPC1L1	D006949	Hyperlipidemias	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		334550	D006937	Hypercholesterolemia	OTG		LDL cholesterol	https://genetics.opentargets.org/study/GCST000759	2010			0.413490308312736	0.56	1	NPC1L1-D006949-D006937	Phase II	0.56	1	GWAS	GWAS Catalog	2010	0.0366		2	metabolic	both	genetically supported target	FALSE
NPC1L1-D050171	0.874	5	NPC1L1-D050171	NPC1L1	D050171	Dyslipidemias	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		334550	D006937	Hypercholesterolemia	OTG		LDL cholesterol	https://genetics.opentargets.org/study/GCST000759	2010			0.413490308312736	0.56	1	NPC1L1-D050171-D006937	Launched	0.56	1	GWAS	GWAS Catalog	2010	0.0366		3	metabolic	both	genetically supported target	TRUE
NPR1-D006973	1	2	NPR1-D006973	NPR1	D006973	Hypertension		Phase I	Phase I		3	2	TRUE				FALSE		335538	D006973	Hypertension	OTG		Diastolic blood pressure	https://genetics.opentargets.org/study/GCST90000059	2020			0.01778989741592	0.59	1	NPR1-D006973-D006973	Phase I	0.59	1	GWAS	GWAS Catalog	2020	0.06447421		0	cardiovascular	both	genetically supported target	FALSE
NPY-D009765	1	3	NPY-D009765	NPY	D009765	Obesity	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		335980	D009765	Obesity	OTG		Body mass index	https://genetics.opentargets.org/study/GCST007039	2018			0.46870882740448	0.89	1	NPY-D009765-D009765	Phase II	0.89	1	GWAS	GWAS Catalog	2018			2	metabolic, signs/symptoms	both	genetically supported target	FALSE
NR1H3-D006937	0.861	2	NR1H3-D006937	NR1H3	D006937	Hypercholesterolemia	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		336328	D015228	Hypertriglyceridemia	OTG		Triglyceride levels	https://genetics.opentargets.org/study/GCST90025957	2021			0.694816162141094	0.53	1	NR1H3-D006937-D015228	Phase I	0.53	1	GWAS	GWAS Catalog	2021	0.0240850999999999		1	metabolic	both	genetically supported target	FALSE
NR1H4-D006937	1	3	NR1H4-D006937	NR1H4	D006937	Hypercholesterolemia	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		336375	D006937	Hypercholesterolemia	OTG		LDL cholesterol	https://genetics.opentargets.org/study/GCST90018741	2021			0.00324086077262121	0.8	1	NR1H4-D006937-D006937	Phase II	0.8	1	GWAS	GWAS Catalog	2021	0.030061		2	metabolic	both	genetically supported target	FALSE
NR1H4-D006949	0.906	2	NR1H4-D006949	NR1H4	D006949	Hyperlipidemias	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		336375	D006937	Hypercholesterolemia	OTG		LDL cholesterol	https://genetics.opentargets.org/study/GCST90018741	2021			0.00324086077262121	0.8	1	NR1H4-D006949-D006937	Phase I	0.8	1	GWAS	GWAS Catalog	2021	0.030061		1	metabolic	both	genetically supported target	FALSE
NR1H4-D007249	1	2	NR1H4-D007249	NR1H4	D007249	Inflammation		Phase I	Phase I		3	2	TRUE				FALSE		336379	D007249	Inflammation	OTG		C-reactive protein levels	https://genetics.opentargets.org/study/GCST009777	2020			0.0222380705394191	0.86	1	NR1H4-D007249-D007249	Phase I	0.86	1	GWAS	GWAS Catalog	2020	0.0431909		0	signs/symptoms	gwas	genetically supported target	FALSE
NR1H4-D008107	1	3	NR1H4-D008107	NR1H4	D008107	Liver Diseases	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		336382	D008107	Liver Diseases	OTG		Liver enzyme levels (gamma-glutamyl transferase)	https://genetics.opentargets.org/study/GCST90013407	2021			0.0649544863459038	0.85	1	NR1H4-D008107-D008107	Phase II	0.85	1	GWAS	GWAS Catalog	2021	0.00768656		2	digestive	both	genetically supported target	FALSE
NR1H4-D015228	0.861	2	NR1H4-D015228	NR1H4	D015228	Hypertriglyceridemia	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		336375	D006937	Hypercholesterolemia	OTG		LDL cholesterol	https://genetics.opentargets.org/study/GCST90018741	2021			0.00324086077262121	0.8	1	NR1H4-D015228-D006937	Phase I	0.8	1	GWAS	GWAS Catalog	2021	0.030061		1	metabolic	both	genetically supported target	FALSE
NR3C1-D001249	1	5	NR3C1-D001249	NR3C1	D001249	Asthma	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE	2001	336768	D001249	Asthma	OTG		Lung function (FEV1/FVC)	https://genetics.opentargets.org/study/GCST007080	2018			0.555368038426587	0.93	1	NR3C1-D001249-D001249	Launched	0.93	1	GWAS	GWAS Catalog	2018			3	respiratory, immune	both	genetically supported target	TRUE
NR3C1-D009765	1	3	NR3C1-D009765	NR3C1	D009765	Obesity	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		336827	D009765	Obesity	OTG		Hip circumference adjusted for BMI	https://genetics.opentargets.org/study/GCST012227	2021			0.17163499088779	0.94	1	NR3C1-D009765-D009765	Phase II	0.94	1	GWAS	GWAS Catalog	2021	0.0241466		2	metabolic, signs/symptoms	both	genetically supported target	FALSE
NR3C1-D029424	0.807	5	NR3C1-D029424	NR3C1	D029424	Pulmonary Disease, Chronic Obstructive	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2012	336768	D001249	Asthma	OTG		Lung function (FEV1/FVC)	https://genetics.opentargets.org/study/GCST007080	2018			0.555368038426587	0.93	1	NR3C1-D029424-D001249	Launched	0.93	1	GWAS	GWAS Catalog	2018			3	respiratory	both	genetically supported target	TRUE
NR3C1-D057765	0.912	5	NR3C1-D057765	NR3C1	D057765	Eosinophilic Esophagitis	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE		336796	D004802	Eosinophilia	OTG		Eosinophil counts	https://genetics.opentargets.org/study/GCST90002298	2020			0.560488126649077	0.66	1	NR3C1-D057765-D004802	Launched	0.66	1	GWAS	GWAS Catalog	2020	0.0136809999999999		3	digestive, hematology, immune	both	genetically supported target	TRUE
NR3C1-D065631	0.817	3	NR3C1-D065631	NR3C1	D065631	Rhinitis, Allergic	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		336768	D001249	Asthma	OTG		Lung function (FEV1/FVC)	https://genetics.opentargets.org/study/GCST007080	2018			0.555368038426587	0.93	1	NR3C1-D065631-D001249	Phase II	0.93	1	GWAS	GWAS Catalog	2018			2	respiratory, immune	both	genetically supported target	FALSE
OPRM1-D009293	1	5	OPRM1-D009293	OPRM1	D009293	Opioid-Related Disorders	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		345204	D009293	Opioid-Related Disorders	OTG		Opioid use disorder	https://genetics.opentargets.org/study/GCST010510	2020			0.130454545454545	0.97	1	OPRM1-D009293-D009293	Launched	0.97	1	GWAS	GWAS Catalog	2020	0.07		3	psychiatry	gwas	genetically supported target	TRUE
OPRM1-D009765	1	3	OPRM1-D009765	OPRM1	D009765	Obesity	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		345205	D009765	Obesity	OTG		Body mass index	https://genetics.opentargets.org/study/GCST007039	2018			0.172749707754254	0.96	1	OPRM1-D009765-D009765	Phase II	0.96	1	GWAS	GWAS Catalog	2018			2	metabolic, signs/symptoms	both	genetically supported target	FALSE
OPRM1-D019966	0.814	2	OPRM1-D019966	OPRM1	D019966	Substance-Related Disorders		Phase I	Phase I		3	2	TRUE				FALSE		345204	D009293	Opioid-Related Disorders	OTG		Opioid use disorder	https://genetics.opentargets.org/study/GCST010510	2020			0.130454545454545	0.97	1	OPRM1-D019966-D009293	Phase I	0.97	1	GWAS	GWAS Catalog	2020	0.07		0	psychiatry	gwas	genetically supported target	FALSE
PARP1-D008545	1	3	PARP1-D008545	PARP1	D008545	Melanoma		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		352412	D008545	Melanoma	OTG		Cutaneous malignant melanoma	https://genetics.opentargets.org/study/GCST010304	2020			0.337015856511567	0.8	1	PARP1-D008545-D008545	Phase II	0.8	1	GWAS	GWAS Catalog	2020		1.0946999999999996	1	oncology	both	genetically supported target	FALSE
PCSK9-D006937	1	5	PCSK9-D006937	PCSK9	D006937	Hypercholesterolemia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE	2018	356103	D006937	Hypercholesterolemia	OTG		LDL cholesterol	https://genetics.opentargets.org/study/GCST000132	2008			0.167315427533411	0.63	1	PCSK9-D006937-D006937	Launched	0.63	1	GWAS	GWAS Catalog	2008	3.04		3	metabolic	both	genetically supported target	TRUE
PCSK9-D006938	0.844	5	PCSK9-D006938	PCSK9	D006938	Hyperlipoproteinemia Type II	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE		356103	D006937	Hypercholesterolemia	OTG		LDL cholesterol	https://genetics.opentargets.org/study/GCST000132	2008			0.167315427533411	0.63	1	PCSK9-D006938-D006937	Launched	0.63	1	GWAS	GWAS Catalog	2008	3.04		3	congenital, metabolic	both	genetically supported target	TRUE
PCSK9-D006949	0.906	5	PCSK9-D006949	PCSK9	D006949	Hyperlipidemias	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE	2019	356103	D006937	Hypercholesterolemia	OTG		LDL cholesterol	https://genetics.opentargets.org/study/GCST000132	2008			0.167315427533411	0.63	1	PCSK9-D006949-D006937	Launched	0.63	1	GWAS	GWAS Catalog	2008	3.04		3	metabolic	both	genetically supported target	TRUE
PCSK9-D050197	0.828	5	PCSK9-D050197	PCSK9	D050197	Atherosclerosis	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE		356094	D003324	Coronary Artery Disease	OTG		Coronary artery disease	https://genetics.opentargets.org/study/GCST003116	2015			0.167315427533411	0.67	1	PCSK9-D050197-D003324	Launched	0.67	1	GWAS	GWAS Catalog	2015		1.0799999999999998	3	cardiovascular	both	genetically supported target	TRUE
PDE10A-D001714	1	3	PDE10A-D001714	PDE10A	D001714	Bipolar Disorder	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		356700	D001714	Bipolar Disorder	OTG		Bipolar disorder [Latent Class 1]	https://genetics.opentargets.org/study/GCST001359	2011			0.0597198806899235	0.94	1	PDE10A-D001714-D001714	Phase II	0.94	1	GWAS	GWAS Catalog	2011			2	psychiatry	gwas	genetically supported target	FALSE
PDE3A-D001249	1	3	PDE3A-D001249	PDE3A	D001249	Asthma		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		357151	D001249	Asthma	OTG		Lung function (FEV1/FVC)	https://genetics.opentargets.org/study/GCST007080	2018			0.414477107180021	0.96	1	PDE3A-D001249-D001249	Phase II	0.96	1	GWAS	GWAS Catalog	2018			1	respiratory, immune	both	genetically supported target	FALSE
PDE3A-D015228	1	3	PDE3A-D015228	PDE3A	D015228	Hypertriglyceridemia		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		357296	D015228	Hypertriglyceridemia	OTG		Triglycerides	https://genetics.opentargets.org/study/GCST007142	2018			0.203270721134901	0.91	1	PDE3A-D015228-D015228	Phase II	0.91	1	GWAS	GWAS Catalog	2018	0.04		1	metabolic	both	genetically supported target	FALSE
PDE3A-D020521	1	4	PDE3A-D020521	PDE3A	D020521	Stroke	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		357306	D020521	Stroke	OTG		Ischemic stroke	https://genetics.opentargets.org/study/GCST90018864	2021			0.388607430501429	0.91	1	PDE3A-D020521-D020521	Phase III	0.91	1	GWAS	GWAS Catalog	2021	0.0604		3	neurology, cardiovascular	gwas	genetically supported target	FALSE
PDE3A-D029424	0.807	4	PDE3A-D029424	PDE3A	D029424	Pulmonary Disease, Chronic Obstructive		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		357151	D001249	Asthma	OTG		Lung function (FEV1/FVC)	https://genetics.opentargets.org/study/GCST007080	2018			0.414477107180021	0.96	1	PDE3A-D029424-D001249	Phase III	0.96	1	GWAS	GWAS Catalog	2018			2	respiratory	both	genetically supported target	FALSE
PDE3A-D050197	0.828	3	PDE3A-D050197	PDE3A	D050197	Atherosclerosis	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		357190	D003324	Coronary Artery Disease	OTG		Coronary artery disease	https://genetics.opentargets.org/study/GCST005194	2017			0.699283854166667	0.83	1	PDE3A-D050197-D003324	Phase II	0.83	1	GWAS	GWAS Catalog	2017		1.04707441095694	2	cardiovascular	both	genetically supported target	FALSE
PDE4B-D003093	1	3	PDE4B-D003093	PDE4B	D003093	Colitis, Ulcerative	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		357590	D003093	Colitis, Ulcerative	OTG		Ulcerative colitis	https://genetics.opentargets.org/study/GCST000964	2011			0.0106465853025188	0.94	1	PDE4B-D003093-D003093	Phase II	0.94	1	GWAS	GWAS Catalog	2011		1.7500000000000016	2	digestive	both	genetically supported target	FALSE
PDE4B-D003424	0.875	2	PDE4B-D003424	PDE4B	D003424	Crohn Disease	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		357590	D003093	Colitis, Ulcerative	OTG		Ulcerative colitis	https://genetics.opentargets.org/study/GCST000964	2011			0.0106465853025188	0.94	1	PDE4B-D003424-D003093	Phase I	0.94	1	GWAS	GWAS Catalog	2011		1.7500000000000016	1	digestive	both	genetically supported target	FALSE
PDE4B-D015212	0.89	2	PDE4B-D015212	PDE4B	D015212	Inflammatory Bowel Diseases	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		357590	D003093	Colitis, Ulcerative	OTG		Ulcerative colitis	https://genetics.opentargets.org/study/GCST000964	2011			0.0106465853025188	0.94	1	PDE4B-D015212-D003093	Phase I	0.94	1	GWAS	GWAS Catalog	2011		1.7500000000000016	1	digestive	both	genetically supported target	FALSE
PDE4B-D015228	0.861	3	PDE4B-D015228	PDE4B	D015228	Hypertriglyceridemia		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		357612	D006937	Hypercholesterolemia	OTG		Total cholesterol levels	https://genetics.opentargets.org/study/GCST90019501	2021			0.566410323253389	0.62	1	PDE4B-D015228-D006937	Phase II	0.62	1	GWAS	GWAS Catalog	2021	0.0147		1	metabolic	both	genetically supported target	FALSE
PDE4D-D001249	1	3	PDE4D-D001249	PDE4D	D001249	Asthma		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		357796	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST000389	2009			0.304798539574912	1	1	PDE4D-D001249-D001249	Phase II	1	1	GWAS	GWAS Catalog	2009		1.18	1	respiratory, immune	both	genetically supported target	FALSE
PDE4D-D029424	0.807	4	PDE4D-D029424	PDE4D	D029424	Pulmonary Disease, Chronic Obstructive		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		357796	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST000389	2009			0.304798539574912	1	1	PDE4D-D029424-D001249	Phase III	1	1	GWAS	GWAS Catalog	2009		1.18	2	respiratory	both	genetically supported target	FALSE
PDE4D-D065631	0.817	3	PDE4D-D065631	PDE4D	D065631	Rhinitis, Allergic	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		357796	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST000389	2009			0.304798539574912	1	1	PDE4D-D065631-D001249	Phase II	1	1	GWAS	GWAS Catalog	2009		1.18	2	respiratory, immune	both	genetically supported target	FALSE
PDE5A-D006973	1	3	PDE5A-D006973	PDE5A	D006973	Hypertension	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		357877	D006973	Hypertension	OTG		Diastolic blood pressure	https://genetics.opentargets.org/study/GCST007094	2016			0.487895838785658	0.88	1	PDE5A-D006973-D006973	Phase II	0.88	1	GWAS	GWAS Catalog	2016	0.206		2	cardiovascular	both	genetically supported target	FALSE
PDGFRA-D008269	0.816	3	PDGFRA-D008269	PDGFRA	D008269	Macular Edema	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		358666	D008268	Macular Degeneration	OTG		Macular thickness	https://genetics.opentargets.org/study/GCST006976	2018			0.218831337844872	0.84	1	PDGFRA-D008269-D008268	Phase II	0.84	1	GWAS	GWAS Catalog	2018			2	ophthalmology	both	genetically supported target	FALSE
PGR-D008593	1	5	PGR-D008593	PGR	D008593	Menopause	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		362942	D008593	Menopause	OTG		Age at menopause	https://genetics.opentargets.org/study/GCST90026597	2021			0.327183833116036	0.94	1	PGR-D008593-D008593	Launched	0.94	1	GWAS	GWAS Catalog	2021	0.08		3	other	gwas	genetically supported target	TRUE
PIK3C2B-D009369	1	2	PIK3C2B-D009369	PIK3C2B	D009369	Neoplasms		Phase I	Phase I		3	2	TRUE				FALSE		366259	D009369	Neoplasms	OTG		Cancer (pleiotropy)	https://genetics.opentargets.org/study/GCST90011822	2020			0.738364534581383	0.52	1	PIK3C2B-D009369-D009369	Phase I	0.52	1	GWAS	GWAS Catalog	2020			0	oncology	gwas	genetically supported target	FALSE
PIK3CA-D013922	0.808	2	PIK3CA-D013922	PIK3CA	D013922	Thrombocytosis	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		366419	D013921	Thrombocytopenia	OTG		Red blood cell count	https://genetics.opentargets.org/study/GCST007069	2018			0.039722654224987	0.79	1	PIK3CA-D013922-D013921	Phase I	0.79	1	GWAS	GWAS Catalog	2018			1	hematology	both	genetically supported target	FALSE
PIK3CB-D013922	0.825	2	PIK3CB-D013922	PIK3CB	D013922	Thrombocytosis	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		366437	D001791	Blood Platelet Disorders	OTG		Mean platelet volume	https://genetics.opentargets.org/study/GCST90002346	2020			0.467437570942111	0.69	1	PIK3CB-D013922-D001791	Phase I	0.69	1	GWAS	GWAS Catalog	2020	0.0151989999999999		1	hematology	both	genetically supported target	FALSE
PIK3CD-D008545	0.8	3	PIK3CD-D008545	PIK3CD	D008545	Melanoma	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		366479	D009373	Neoplasms, Germ Cell and Embryonal	OTG		Testicular germ cell tumor	https://genetics.opentargets.org/study/GCST004635	2017			0.418903074517978	0.82	1	PIK3CD-D008545-D009373	Phase II	0.82	1	GWAS	GWAS Catalog	2017		1.14	2	oncology	both	genetically supported target	FALSE
PLG-D009203	1	5	PLG-D009203	PLG	D009203	Myocardial Infarction	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2003	373059	D009203	Myocardial Infarction	OTG		Myocardial infarction	https://genetics.opentargets.org/study/GCST003117	2015			0.0906083798157997	0.81	1	PLG-D009203-D009203	Launched	0.81	1	GWAS	GWAS Catalog	2015		1.3	3	cardiovascular, signs/symptoms	gwas	genetically supported target	TRUE
PNPLA3-D065626	1	2	PNPLA3-D065626	PNPLA3	D065626	Non-alcoholic Fatty Liver Disease		Phase I	Phase I		3	2	TRUE				FALSE		376083	D065626	Non-alcoholic Fatty Liver Disease	OTG		Nonalcoholic fatty liver disease [GOLD]	https://genetics.opentargets.org/study/GCST001008	2011			0.224288697468024	0.83	1	PNPLA3-D065626-D065626	Phase I	0.83	1	GWAS	GWAS Catalog	2011			0	digestive	both	genetically supported target	FALSE
PPARA-D006937	0.861	5	PPARA-D006937	PPARA	D006937	Hypercholesterolemia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		379505	D015228	Hypertriglyceridemia	OTG		Triglyceride levels	https://genetics.opentargets.org/study/GCST010244	2020			0.210960032962505	0.55	1	PPARA-D006937-D015228	Launched	0.55	1	GWAS	GWAS Catalog	2020	0.0179778		3	metabolic	both	genetically supported target	TRUE
PPARA-D006938	0.825	3	PPARA-D006938	PPARA	D006938	Hyperlipoproteinemia Type II		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		379505	D015228	Hypertriglyceridemia	OTG		Triglyceride levels	https://genetics.opentargets.org/study/GCST010244	2020			0.210960032962505	0.55	1	PPARA-D006938-D015228	Phase II	0.55	1	GWAS	GWAS Catalog	2020	0.0179778		1	congenital, metabolic	both	genetically supported target	FALSE
PPARA-D006949	0.881	5	PPARA-D006949	PPARA	D006949	Hyperlipidemias	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2008	379505	D015228	Hypertriglyceridemia	OTG		Triglyceride levels	https://genetics.opentargets.org/study/GCST010244	2020			0.210960032962505	0.55	1	PPARA-D006949-D015228	Launched	0.55	1	GWAS	GWAS Catalog	2020	0.0179778		3	metabolic	both	genetically supported target	TRUE
PPARA-D009765	1	5	PPARA-D009765	PPARA	D009765	Obesity	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		379489	D009765	Obesity	OTG		Weight	https://genetics.opentargets.org/study/GCST90018729	2021			0.203619615983394	0.55	1	PPARA-D009765-D009765	Launched	0.55	1	GWAS	GWAS Catalog	2021	0.0349198		3	metabolic, signs/symptoms	both	genetically supported target	TRUE
PPARA-D015228	1	5	PPARA-D015228	PPARA	D015228	Hypertriglyceridemia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		379505	D015228	Hypertriglyceridemia	OTG		Triglyceride levels	https://genetics.opentargets.org/study/GCST010244	2020			0.210960032962505	0.55	1	PPARA-D015228-D015228	Launched	0.55	1	GWAS	GWAS Catalog	2020	0.0179778		3	metabolic	both	genetically supported target	TRUE
PPARA-D050171	0.849	5	PPARA-D050171	PPARA	D050171	Dyslipidemias	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		379505	D015228	Hypertriglyceridemia	OTG		Triglyceride levels	https://genetics.opentargets.org/study/GCST010244	2020			0.210960032962505	0.55	1	PPARA-D050171-D015228	Launched	0.55	1	GWAS	GWAS Catalog	2020	0.0179778		3	metabolic	both	genetically supported target	TRUE
PPARD-D009765	1	2	PPARD-D009765	PPARD	D009765	Obesity	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		379551	D009765	Obesity	OTG		Hip circumference adjusted for BMI	https://genetics.opentargets.org/study/GCST012227	2021			0.118605556998182	0.7	1	PPARD-D009765-D009765	Phase I	0.7	1	GWAS	GWAS Catalog	2021	0.0560704		1	metabolic, signs/symptoms	both	genetically supported target	FALSE
PPARG-D003924	1	5	PPARG-D003924	PPARG	D003924	Diabetes Mellitus, Type 2	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		379712	D003924	Diabetes Mellitus, Type 2	OTG		Type 2 diabetes	https://genetics.opentargets.org/study/GCST005047	2012			0.132429275888918	0.7	1	PPARG-D003924-D003924	Launched	0.7	1	GWAS	GWAS Catalog	2012		1.1400000000000006	3	metabolic, endocrine	both	genetically supported target	TRUE
PPARG-D006073	1	3	PPARG-D006073	PPARG	D006073	Gout	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		379772	D006073	Gout	OTG		Urate levels	https://genetics.opentargets.org/study/GCST011119	2020			0.132439119677041	0.83	1	PPARG-D006073-D006073	Phase II	0.83	1	GWAS	GWAS Catalog	2020	0.0218		2	musculoskeletal, congenital, metabolic	both	genetically supported target	FALSE
PPARG-D006949	0.906	5	PPARG-D006949	PPARG	D006949	Hyperlipidemias	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2013	379797	D006937	Hypercholesterolemia	OTG		Cholesterol, total	https://genetics.opentargets.org/study/GCST002221	2013			0.409138177564019	0.73	1	PPARG-D006949-D006937	Launched	0.73	1	GWAS	GWAS Catalog	2013	0.0315		3	metabolic	both	genetically supported target	TRUE
PPARG-D009765	1	5	PPARG-D009765	PPARG	D009765	Obesity	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		379871	D009765	Obesity	OTG		Body mass index	https://genetics.opentargets.org/study/GCST004904	2017			0.133450110289347	0.85	1	PPARG-D009765-D009765	Launched	0.85	1	GWAS	GWAS Catalog	2017	0.024		3	metabolic, signs/symptoms	both	genetically supported target	TRUE
PPARG-D015228	0.861	5	PPARG-D015228	PPARG	D015228	Hypertriglyceridemia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2013	379797	D006937	Hypercholesterolemia	OTG		Cholesterol, total	https://genetics.opentargets.org/study/GCST002221	2013			0.409138177564019	0.73	1	PPARG-D015228-D006937	Launched	0.73	1	GWAS	GWAS Catalog	2013	0.0315		3	metabolic	both	genetically supported target	TRUE
PPARG-D024821	0.879	4	PPARG-D024821	PPARG	D024821	Metabolic Syndrome	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		379811	D006946	Hyperinsulinism	OTG		Fasting blood insulin	https://genetics.opentargets.org/study/GCST007898	2015			0.133000129819551	0.84	1	PPARG-D024821-D006946	Phase III	0.84	1	GWAS	GWAS Catalog	2015	0.031257037		3	metabolic	both	genetically supported target	FALSE
PPARG-D065626	1	5	PPARG-D065626	PPARG	D065626	Non-alcoholic Fatty Liver Disease	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2020	379988	D065626	Non-alcoholic Fatty Liver Disease	OTG		Nonalcoholic fatty liver disease (imputed)	https://genetics.opentargets.org/study/GCST90094908	2021			0.193137509747855	0.63	1	PPARG-D065626-D065626	Launched	0.63	1	GWAS	GWAS Catalog	2021			3	digestive	both	genetically supported target	TRUE
PRKCB-D001172	1	2	PRKCB-D001172	PRKCB	D001172	Arthritis, Rheumatoid	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		386304	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis	https://genetics.opentargets.org/study/GCST90013534	2020			0.533572314904178	0.81	1	PRKCB-D001172-D001172	Phase I	0.81	1	GWAS	GWAS Catalog	2020		1.0989010989011	1	musculoskeletal, dermatology, immune	gwas	genetically supported target	FALSE
PRKCB-D003093	0.89	3	PRKCB-D003093	PRKCB	D003093	Colitis, Ulcerative	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		386333	D015212	Inflammatory Bowel Diseases	OTG		Inflammatory bowel disease	https://genetics.opentargets.org/study/GCST001725	2012			0.567865956617743	0.82	1	PRKCB-D003093-D015212	Phase II	0.82	1	GWAS	GWAS Catalog	2012		1.06	2	digestive	both	genetically supported target	FALSE
PRKCB-D008180	1	2	PRKCB-D008180	PRKCB	D008180	Lupus Erythematosus, Systemic	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		386316	D008180	Lupus Erythematosus, Systemic	OTG		Systemic lupus erythematosus	https://genetics.opentargets.org/study/GCST011956	2020			0.00126162018592297	0.79	1	PRKCB-D008180-D008180	Phase I	0.79	1	GWAS	GWAS Catalog	2020		1.1719999999999995	1	dermatology, immune	both	genetically supported target	FALSE
PTGER4-D003093	0.89	3	PTGER4-D003093	PTGER4	D003093	Colitis, Ulcerative	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		394131	D015212	Inflammatory Bowel Diseases	OTG		Inflammatory bowel disease [EA]	https://genetics.opentargets.org/study/GCST003043	2015			0.280945577347707	0.69	1	PTGER4-D003093-D015212	Phase II	0.69	1	GWAS	GWAS Catalog	2015		1.072444154427016	2	digestive	both	genetically supported target	FALSE
PTGER4-D006967	1	2	PTGER4-D006967	PTGER4	D006967	Hypersensitivity	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		394096	D006967	Hypersensitivity	OTG		Self-reported allergy	https://genetics.opentargets.org/study/GCST002083	2013			0.568568828805407	0.53	1	PTGER4-D006967-D006967	Phase I	0.53	1	GWAS	GWAS Catalog	2013	0.0785		1	immune	gwas	genetically supported target	FALSE
PTPN1-D005901	0.925	3	PTPN1-D005901	PTPN1	D005901	Glaucoma	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		395132	D009798	Ocular Hypertension	OTG		Intraocular pressure	https://genetics.opentargets.org/study/GCST005580	2018			0.40933455353641	0.58	1	PTPN1-D005901-D009798	Phase II	0.58	1	GWAS	GWAS Catalog	2018	0.0768		2	ophthalmology	both	genetically supported target	FALSE
PTPN1-D015179	1	3	PTPN1-D015179	PTPN1	D015179	Colorectal Neoplasms	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		395155	D015179	Colorectal Neoplasms	OTG		Colorectal cancer	https://genetics.opentargets.org/study/GCST007992	2019			0.454250064985703	0.6	1	PTPN1-D015179-D015179	Phase II	0.6	1	GWAS	GWAS Catalog	2019		1.0700000000000005	2	oncology	both	genetically supported target	FALSE
PTPRS-D000544	0.891	2	PTPRS-D000544	PTPRS	D000544	Alzheimer Disease		Phase I	Phase I		3	2	TRUE				TRUE		397032	D024801	Tauopathies	OTG		Neurofibrillary tangles (SNP x SNP interaction)	https://genetics.opentargets.org/study/GCST010343	2020			0.131883116883117	0.81	1	PTPRS-D000544-D024801	Phase I	0.81	1	GWAS	GWAS Catalog	2020			0	neurology, psychiatry	both	genetically supported target	FALSE
RARG-D029424	0.807	2	RARG-D029424	RARG	D029424	Pulmonary Disease, Chronic Obstructive	Phase I		Phase I	2		2	TRUE	FALSE			TRUE		403999	D001249	Asthma	OTG		Lung function (FVC)	https://genetics.opentargets.org/study/GCST007081	2018			0.072874756651525	0.5	1	RARG-D029424-D001249	Phase I	0.5	1	GWAS	GWAS Catalog	2018			1	respiratory	both	genetically supported target	FALSE
REN-D006973	1	5	REN-D006973	REN	D006973	Hypertension	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		409364	D006973	Hypertension	OTG		Systolic blood pressure	https://genetics.opentargets.org/study/GCST007087	2018			0.0324860588769291	0.67	1	REN-D006973-D006973	Launched	0.67	1	GWAS	GWAS Catalog	2018			3	cardiovascular	both	genetically supported target	TRUE
S1PR1-D057765	0.912	3	S1PR1-D057765	S1PR1	D057765	Eosinophilic Esophagitis		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		427149	D004802	Eosinophilia	OTG		Eosinophil counts	https://genetics.opentargets.org/study/GCST004606	2016			0.466608084358524	0.8	1	S1PR1-D057765-D004802	Phase II	0.8	1	GWAS	GWAS Catalog	2016	0.03170811		1	digestive, hematology, immune	both	genetically supported target	FALSE
S1PR4-D057765	0.912	3	S1PR4-D057765	S1PR4	D057765	Eosinophilic Esophagitis		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		427519	D004802	Eosinophilia	OTG		Eosinophil counts	https://genetics.opentargets.org/study/GCST004606	2016			0.011870783601453	0.67	1	S1PR4-D057765-D004802	Phase II	0.67	1	GWAS	GWAS Catalog	2016	0.1410479		1	digestive, hematology, immune	both	genetically supported target	FALSE
SCN1A-D004828	1	5	SCN1A-D004828	SCN1A	D004828	Epilepsies, Partial	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2019	433172	D004828	Epilepsies, Partial	OTG		Focal epilepsy	https://genetics.opentargets.org/study/GCST007352	2018			0.251137397634213	0.9	1	SCN1A-D004828-D004828	Launched	0.9	1	GWAS	GWAS Catalog	2018	5.78		3	neurology	both	genetically supported target	TRUE
SCN2A-D001714	1	5	SCN2A-D001714	SCN2A	D001714	Bipolar Disorder	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		433201	D001714	Bipolar Disorder	OTG		Bipolar disorder	https://genetics.opentargets.org/study/GCST008103	2019			0.0684736091298146	0.64	1	SCN2A-D001714-D001714	Launched	0.64	1	GWAS	GWAS Catalog	2019		1.1416829000000006	3	psychiatry	gwas	genetically supported target	TRUE
SCN5A-D001145	1	3	SCN5A-D001145	SCN5A	D001145	Arrhythmias, Cardiac	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		433336	D001145	Arrhythmias, Cardiac	OTG		PR interval	https://genetics.opentargets.org/study/GCST000562	2010			0.139187962122195	0.76	1	SCN5A-D001145-D001145	Phase II	0.76	1	GWAS	GWAS Catalog	2010			2	cardiovascular, signs/symptoms	both	genetically supported target	FALSE
SCN5A-D017180	0.884	5	SCN5A-D017180	SCN5A	D017180	Tachycardia, Ventricular	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2009	433521	D013610	Tachycardia	OTG		Electrocardiographic conduction measures [QRS duration - CHARGE]	https://genetics.opentargets.org/study/GCST001893	2013			0.323299960993369	0.66	1	SCN5A-D017180-D013610	Launched	0.66	1	GWAS	GWAS Catalog	2013	0.6568		3	cardiovascular, signs/symptoms	both	genetically supported target	TRUE
SLC10A2-D006937	0.874	3	SLC10A2-D006937	SLC10A2	D006937	Hypercholesterolemia	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		447731	D050171	Dyslipidemias	OTG		Apolipoprotein A1 levels	https://genetics.opentargets.org/study/GCST90025955	2021			0.0127673363577447	0.91	1	SLC10A2-D006937-D050171	Phase II	0.91	1	GWAS	GWAS Catalog	2021	0.0767204		2	metabolic	both	genetically supported target	FALSE
SLC10A2-D006949	0.898	3	SLC10A2-D006949	SLC10A2	D006949	Hyperlipidemias	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		447731	D050171	Dyslipidemias	OTG		Apolipoprotein A1 levels	https://genetics.opentargets.org/study/GCST90025955	2021			0.0127673363577447	0.91	1	SLC10A2-D006949-D050171	Phase II	0.91	1	GWAS	GWAS Catalog	2021	0.0767204		2	metabolic	both	genetically supported target	FALSE
SLC12A2-D006973	1	3	SLC12A2-D006973	SLC12A2	D006973	Hypertension	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		447953	D006973	Hypertension	OTG		Systolic blood pressure	https://genetics.opentargets.org/study/GCST006624	2018			0.117925752855659	0.92	1	SLC12A2-D006973-D006973	Phase II	0.92	1	GWAS	GWAS Catalog	2018			2	cardiovascular	both	genetically supported target	FALSE
SLC22A12-D006073	1	5	SLC22A12-D006073	SLC22A12	D006073	Gout	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		450276	D006073	Gout	OTG		Urate levels	https://genetics.opentargets.org/study/GCST001791	2012			0.68276220145379	0.53	1	SLC22A12-D006073-D006073	Launched	0.53	1	GWAS	GWAS Catalog	2012	0.07		3	musculoskeletal, congenital, metabolic	both	genetically supported target	TRUE
SLC40A1-D000740	1	3	SLC40A1-D000740	SLC40A1	D000740	Anemia	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		456209	D000740	Anemia	OTG		Mean corpuscular hemoglobin concentration	https://genetics.opentargets.org/study/GCST004605	2016			0.359817945383615	0.82	1	SLC40A1-D000740-D000740	Phase II	0.82	1	GWAS	GWAS Catalog	2016	0.0209683999999999		2	hematology	both	genetically supported target	FALSE
SLC5A1-D003920	1	2	SLC5A1-D003920	SLC5A1	D003920	Diabetes Mellitus		Phase I	Phase I		3	2	TRUE				FALSE		458138	D003920	Diabetes Mellitus	OTG		Hemoglobin A1c levels	https://genetics.opentargets.org/study/GCST90018958	2021			0.0689124028931155	0.5	1	SLC5A1-D003920-D003920	Phase I	0.5	1	GWAS	GWAS Catalog	2021	0.0341		0	metabolic, endocrine	both	genetically supported target	FALSE
SLC6A3-D009290	0.873	5	SLC6A3-D009290	SLC6A3	D009290	Narcolepsy	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2021	458724	D012893	Sleep Wake Disorders	OTG		Sleep duration	https://genetics.opentargets.org/study/GCST007561	2019			0.47906644129502	0.81	1	SLC6A3-D009290-D012893	Launched	0.81	1	GWAS	GWAS Catalog	2019	0.696		3	neurology, psychiatry	both	genetically supported target	TRUE
SLC6A3-D012148	0.866	3	SLC6A3-D012148	SLC6A3	D012148	Restless Legs Syndrome	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		458724	D012893	Sleep Wake Disorders	OTG		Sleep duration	https://genetics.opentargets.org/study/GCST007561	2019			0.47906644129502	0.81	1	SLC6A3-D012148-D012893	Phase II	0.81	1	GWAS	GWAS Catalog	2019	0.696		2	neurology, psychiatry	both	genetically supported target	FALSE
SLC6A3-D012893	1	3	SLC6A3-D012893	SLC6A3	D012893	Sleep Wake Disorders	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		458724	D012893	Sleep Wake Disorders	OTG		Sleep duration	https://genetics.opentargets.org/study/GCST007561	2019			0.47906644129502	0.81	1	SLC6A3-D012893-D012893	Phase II	0.81	1	GWAS	GWAS Catalog	2019	0.696		2	neurology, signs/symptoms, psychiatry	both	genetically supported target	FALSE
SLC6A3-D020920	0.929	3	SLC6A3-D020920	SLC6A3	D020920	Dyssomnias	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		458724	D012893	Sleep Wake Disorders	OTG		Sleep duration	https://genetics.opentargets.org/study/GCST007561	2019			0.47906644129502	0.81	1	SLC6A3-D020920-D012893	Phase II	0.81	1	GWAS	GWAS Catalog	2019	0.696		2	neurology, psychiatry	both	genetically supported target	FALSE
SLC6A4-D009765	1	4	SLC6A4-D009765	SLC6A4	D009765	Obesity	Phase III		Phase III	4		4	TRUE	TRUE	TRUE	FALSE	FALSE		458741	D009765	Obesity	OTG		Body mass index	https://genetics.opentargets.org/study/GCST007039	2018			0.397469175859831	0.74	1	SLC6A4-D009765-D009765	Phase III	0.74	1	GWAS	GWAS Catalog	2018			3	metabolic, signs/symptoms	both	genetically supported target	FALSE
SLC6A4-D011218	0.805	2	SLC6A4-D011218	SLC6A4	D011218	Prader-Willi Syndrome		Phase I	Phase I		3	2	TRUE				FALSE		458741	D009765	Obesity	OTG		Body mass index	https://genetics.opentargets.org/study/GCST007039	2018			0.397469175859831	0.74	1	SLC6A4-D011218-D009765	Phase I	0.74	1	GWAS	GWAS Catalog	2018			0	neurology, congenital, metabolic	both	genetically supported target	FALSE
SLC7A11-D001008	1	4	SLC7A11-D001008	SLC7A11	D001008	Anxiety Disorders		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		459098	D001008	Anxiety Disorders	OTG		Neurociticism	https://genetics.opentargets.org/study/GCST006940	2018			0.575146389069616	1	1	SLC7A11-D001008-D001008	Phase III	1	1	GWAS	GWAS Catalog	2018	0.012919334685137		2	psychiatry	gwas	genetically supported target	FALSE
SLC7A11-D003863	1	2	SLC7A11-D003863	SLC7A11	D003863	Depression	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		459102	D003863	Depression	OTG		Depressive symptoms	https://genetics.opentargets.org/study/GCST007340	2019			0.416981377783566	1	1	SLC7A11-D003863-D003863	Phase I	1	1	GWAS	GWAS Catalog	2019	0.0059141736		1	psychiatry	gwas	genetically supported target	FALSE
SLC7A11-D009771	0.879	4	SLC7A11-D009771	SLC7A11	D009771	Obsessive-Compulsive Disorder		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		459098	D001008	Anxiety Disorders	OTG		Neurociticism	https://genetics.opentargets.org/study/GCST006940	2018			0.575146389069616	1	1	SLC7A11-D009771-D001008	Phase III	1	1	GWAS	GWAS Catalog	2018	0.012919334685137		2	psychiatry	gwas	genetically supported target	FALSE
SLC9A3-D007676	0.93	3	SLC9A3-D007676	SLC9A3	D007676	Kidney Failure, Chronic	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		459652	D051437	Renal Insufficiency	OTG		Creatinine levels	https://genetics.opentargets.org/study/GCST90025946	2021			0.251397737615395	0.78	1	SLC9A3-D007676-D051437	Phase II	0.78	1	GWAS	GWAS Catalog	2021	0.0175589		2	other	both	genetically supported target	FALSE
SMAD7-D003093	0.89	3	SMAD7-D003093	SMAD7	D003093	Colitis, Ulcerative	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		462343	D015212	Inflammatory Bowel Diseases	OTG		Inflammatory bowel disease	https://genetics.opentargets.org/study/GCST001725	2012			0.372821846553966	0.77	1	SMAD7-D003093-D015212	Phase II	0.77	1	GWAS	GWAS Catalog	2012		1.057	2	digestive	both	genetically supported target	FALSE
SMAD7-D003424	0.907	3	SMAD7-D003424	SMAD7	D003424	Crohn Disease	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		462343	D015212	Inflammatory Bowel Diseases	OTG		Inflammatory bowel disease	https://genetics.opentargets.org/study/GCST001725	2012			0.372821846553966	0.77	1	SMAD7-D003424-D015212	Phase II	0.77	1	GWAS	GWAS Catalog	2012		1.057	2	digestive	both	genetically supported target	FALSE
SOAT1-D000152	1	3	SOAT1-D000152	SOAT1	D000152	Acne Vulgaris	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		467999	D000152	Acne Vulgaris	OTG		acne vulgaris	https://genetics.opentargets.org/study/GCST90092000	2022			0.248437292193111	0.77	1	SOAT1-D000152-D000152	Phase II	0.77	1	GWAS	GWAS Catalog	2022		1.08	2	dermatology	both	genetically supported target	FALSE
SOAT1-D012628	0.898	3	SOAT1-D012628	SOAT1	D012628	Dermatitis, Seborrheic	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		467999	D000152	Acne Vulgaris	OTG		acne vulgaris	https://genetics.opentargets.org/study/GCST90092000	2022			0.248437292193111	0.77	1	SOAT1-D012628-D000152	Phase II	0.77	1	GWAS	GWAS Catalog	2022		1.08	2	dermatology	both	genetically supported target	FALSE
SOST-D001851	0.811	3	SOST-D001851	SOST	D001851	Bone Diseases, Metabolic	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		469051	D018488	Bone Demineralization, Pathologic	OTG		Bone mineral density (hip)	https://genetics.opentargets.org/study/GCST000297	2008			0.652954959645926	0.5	1	SOST-D001851-D018488	Phase II	0.5	1	GWAS	GWAS Catalog	2008	0.08		2	musculoskeletal, metabolic	both	genetically supported target	FALSE
SOST-D010024	0.809	2	SOST-D010024	SOST	D010024	Osteoporosis		Phase I	Phase I		3	2	TRUE				TRUE		469051	D018488	Bone Demineralization, Pathologic	OTG		Bone mineral density (hip)	https://genetics.opentargets.org/study/GCST000297	2008			0.652954959645926	0.5	1	SOST-D010024-D018488	Phase I	0.5	1	GWAS	GWAS Catalog	2008	0.08		0	musculoskeletal, metabolic	both	genetically supported target	FALSE
STAT3-D003093	0.875	3	STAT3-D003093	STAT3	D003093	Colitis, Ulcerative	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		481188	D003424	Crohn Disease	OTG		Crohn's disease	https://genetics.opentargets.org/study/GCST000207	2008			0.403026760197454	0.54	1	STAT3-D003093-D003424	Phase II	0.54	1	GWAS	GWAS Catalog	2008		1.1800000000000002	2	digestive	both	genetically supported target	FALSE
STAT3-D011565	1	3	STAT3-D011565	STAT3	D011565	Psoriasis	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		481212	D011565	Psoriasis	OTG		Psoriasis	https://genetics.opentargets.org/study/GCST004346	2017			0.344105717650137	0.56	1	STAT3-D011565-D011565	Phase II	0.56	1	GWAS	GWAS Catalog	2017	0.1024		2	dermatology	both	genetically supported target	FALSE
SYK-D016553	0.855	5	SYK-D016553	SYK	D016553	Purpura, Thrombocytopenic, Idiopathic	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE		487139	D013921	Thrombocytopenia	OTG		Red blood cell count	https://genetics.opentargets.org/study/GCST007069	2018			0.223542397091287	0.53	1	SYK-D016553-D013921	Launched	0.53	1	GWAS	GWAS Catalog	2018			3	hematology, immune, signs/symptoms	both	genetically supported target	TRUE
TACR3-D004700	1	2	TACR3-D004700	TACR3	D004700	Endocrine System Diseases	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		489036	D004700	Endocrine System Diseases	OTG		Bioavailable testosterone levels	https://genetics.opentargets.org/study/GCST90012103	2020			0.263661899897855	0.98	1	TACR3-D004700-D004700	Phase I	0.98	1	GWAS	GWAS Catalog	2020	0.0474364		1	endocrine	gwas	genetically supported target	FALSE
TGFB1-D010003	1	5	TGFB1-D010003	TGFB1	D010003	Osteoarthritis	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		500769	D010003	Osteoarthritis	OTG		Osteoarthritis	https://genetics.opentargets.org/study/GCST90038686	2021			0.0294117647058824	0.66	1	TGFB1-D010003-D010003	Launched	0.66	1	GWAS	GWAS Catalog	2021		1.01277136611018	3	musculoskeletal	both	genetically supported target	TRUE
TGFB2-D005901	0.925	2	TGFB2-D005901	TGFB2	D005901	Glaucoma	Phase I		Phase I	2		2	TRUE	FALSE			TRUE		500926	D009798	Ocular Hypertension	OTG		Intraocular pressure	https://genetics.opentargets.org/study/GCST005580	2018			0.26001300390117	0.88	1	TGFB2-D005901-D009798	Phase I	0.88	1	GWAS	GWAS Catalog	2018	0.1037		1	ophthalmology	both	genetically supported target	FALSE
THRB-D006937	0.861	3	THRB-D006937	THRB	D006937	Hypercholesterolemia		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		503193	D015228	Hypertriglyceridemia	OTG		Triglycerides	https://genetics.opentargets.org/study/GCST007133	2018			0.678715381614875	0.96	1	THRB-D006937-D015228	Phase II	0.96	1	GWAS	GWAS Catalog	2018	0.018		1	metabolic	both	genetically supported target	FALSE
THRB-D006938	0.825	3	THRB-D006938	THRB	D006938	Hyperlipoproteinemia Type II		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		503193	D015228	Hypertriglyceridemia	OTG		Triglycerides	https://genetics.opentargets.org/study/GCST007133	2018			0.678715381614875	0.96	1	THRB-D006938-D015228	Phase II	0.96	1	GWAS	GWAS Catalog	2018	0.018		1	congenital, metabolic	both	genetically supported target	FALSE
TNFRSF13B-D009101	1	3	TNFRSF13B-D009101	TNFRSF13B	D009101	Multiple Myeloma	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		517898	D009101	Multiple Myeloma	OTG		Multiple myeloma	https://genetics.opentargets.org/study/GCST002140	2013			0.105215123859192	0.86	1	TNFRSF13B-D009101-D009101	Phase II	0.86	1	GWAS	GWAS Catalog	2013		1.255	2	oncology	both	genetically supported target	FALSE
TNFRSF1A-D007249	1	2	TNFRSF1A-D007249	TNFRSF1A	D007249	Inflammation	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		518126	D007249	Inflammation	OTG		C-reactive protein levels	https://genetics.opentargets.org/study/GCST009777	2020			0.422701224277156	0.53	1	TNFRSF1A-D007249-D007249	Phase I	0.53	1	GWAS	GWAS Catalog	2020	0.0198902		1	signs/symptoms	gwas	genetically supported target	FALSE
TNFRSF1A-D008103	0.851	2	TNFRSF1A-D008103	TNFRSF1A	D008103	Liver Cirrhosis	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		518131	D008105	Liver Cirrhosis, Biliary	OTG		Primary biliary cirrhosis	https://genetics.opentargets.org/study/GCST005581	2012			0.422701224277156	0.54	1	TNFRSF1A-D008103-D008105	Phase I	0.54	1	GWAS	GWAS Catalog	2012		1.272	1	digestive, signs/symptoms	gwas	genetically supported target	FALSE
TNFRSF1A-D009103	1	2	TNFRSF1A-D009103	TNFRSF1A	D009103	Multiple Sclerosis	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		518144	D009103	Multiple Sclerosis	OTG		Multiple sclerosis	https://genetics.opentargets.org/study/GCST000424	2009			0.422701224277156	0.55	1	TNFRSF1A-D009103-D009103	Phase I	0.55	1	GWAS	GWAS Catalog	2009		1.2	1	neurology, immune	both	genetically supported target	FALSE
TNFRSF1A-D013167	1	2	TNFRSF1A-D013167	TNFRSF1A	D013167	Spondylitis, Ankylosing	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		518152	D013167	Spondylitis, Ankylosing	OTG		Ankylosing spondylitis	https://genetics.opentargets.org/study/GCST005529	2013			0.424541791238788	0.57	1	TNFRSF1A-D013167-D013167	Phase I	0.57	1	GWAS	GWAS Catalog	2013		1.1300000000000006	1	musculoskeletal	both	genetically supported target	FALSE
TNFRSF1A-D015535	0.956	2	TNFRSF1A-D015535	TNFRSF1A	D015535	Arthritis, Psoriatic	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		518152	D013167	Spondylitis, Ankylosing	OTG		Ankylosing spondylitis	https://genetics.opentargets.org/study/GCST005529	2013			0.424541791238788	0.57	1	TNFRSF1A-D015535-D013167	Phase I	0.57	1	GWAS	GWAS Catalog	2013		1.1300000000000006	1	musculoskeletal, dermatology	both	genetically supported target	FALSE
TNFRSF1A-D018805	0.809	2	TNFRSF1A-D018805	TNFRSF1A	D018805	Sepsis	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		518126	D007249	Inflammation	OTG		C-reactive protein levels	https://genetics.opentargets.org/study/GCST009777	2020			0.422701224277156	0.53	1	TNFRSF1A-D018805-D007249	Phase I	0.53	1	GWAS	GWAS Catalog	2020	0.0198902		1	infection, signs/symptoms	gwas	genetically supported target	FALSE
TNFSF15-D001249	1	3	TNFSF15-D001249	TNFSF15	D001249	Asthma	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		518806	D001249	Asthma	OTG		Asthma (childhood onset)	https://genetics.opentargets.org/study/GCST012429	2021			0.276565341647181	0.8	1	TNFSF15-D001249-D001249	Phase II	0.8	1	GWAS	GWAS Catalog	2021			2	respiratory, immune	both	genetically supported target	FALSE
TNFSF15-D003093	0.89	3	TNFSF15-D003093	TNFSF15	D003093	Colitis, Ulcerative		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		518843	D015212	Inflammatory Bowel Diseases	OTG		Inflammatory bowel disease	https://genetics.opentargets.org/study/GCST000225	2008			0.671627242006758	0.84	1	TNFSF15-D003093-D015212	Phase II	0.84	1	GWAS	GWAS Catalog	2008			1	digestive	both	genetically supported target	FALSE
TNFSF15-D003424	1	3	TNFSF15-D003424	TNFSF15	D003424	Crohn Disease		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		518819	D003424	Crohn Disease	OTG		Crohn's disease	https://genetics.opentargets.org/study/GCST000207	2008			0.677283341982356	0.85	1	TNFSF15-D003424-D003424	Phase II	0.85	1	GWAS	GWAS Catalog	2008		1.22	1	digestive	both	genetically supported target	FALSE
TNFSF4-D001249	1	3	TNFSF4-D001249	TNFSF4	D001249	Asthma	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		518918	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST003987	2016			0.300715214564369	0.78	1	TNFSF4-D001249-D001249	Phase II	0.78	1	GWAS	GWAS Catalog	2016			2	respiratory, immune	both	genetically supported target	FALSE
TNFSF4-D003876	0.851	3	TNFSF4-D003876	TNFSF4	D003876	Dermatitis, Atopic		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		518933	D004485	Eczema	OTG		Eczema	https://genetics.opentargets.org/study/GCST007075	2018			0.324243604726659	0.85	1	TNFSF4-D003876-D004485	Phase II	0.85	1	GWAS	GWAS Catalog	2018			1	congenital, dermatology, immune	gwas	genetically supported target	FALSE
TNFSF4-D065631	0.817	3	TNFSF4-D065631	TNFSF4	D065631	Rhinitis, Allergic	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		518918	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST003987	2016			0.300715214564369	0.78	1	TNFSF4-D065631-D001249	Phase II	0.78	1	GWAS	GWAS Catalog	2016			2	respiratory, immune	both	genetically supported target	FALSE
TRPM8-D008881	1	2	TRPM8-D008881	TRPM8	D008881	Migraine Disorders	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		529566	D008881	Migraine Disorders	OTG		Migraine	https://genetics.opentargets.org/study/GCST001105	2011			0.192077922077922	0.76	1	TRPM8-D008881-D008881	Phase I	0.76	1	GWAS	GWAS Catalog	2011		1.1800000000000002	1	neurology	both	genetically supported target	FALSE
TSLP-D001249	1	5	TSLP-D001249	TSLP	D001249	Asthma	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE		530977	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST001182	2011			0.726936551187232	0.87	1	TSLP-D001249-D001249	Launched	0.87	1	GWAS	GWAS Catalog	2011			3	respiratory, immune	both	genetically supported target	TRUE
TSLP-D003876	0.851	3	TSLP-D003876	TSLP	D003876	Dermatitis, Atopic		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		531024	D004485	Eczema	OTG		Eczema	https://genetics.opentargets.org/study/GCST007075	2018			0.0271725032425422	0.73	1	TSLP-D003876-D004485	Phase II	0.73	1	GWAS	GWAS Catalog	2018			1	congenital, dermatology, immune	gwas	genetically supported target	FALSE
TSLP-D009298	1	4	TSLP-D009298	TSLP	D009298	Nasal Polyps		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		TRUE		531078	D009298	Nasal Polyps	OTG		Nasal polyps	https://genetics.opentargets.org/study/GCST007443	2019			0.726936551187232	0.87	1	TSLP-D009298-D009298	Phase III	0.87	1	GWAS	GWAS Catalog	2019		1.3513513	2	respiratory, signs/symptoms	gwas	genetically supported target	FALSE
TSLP-D012852	1	4	TSLP-D012852	TSLP	D012852	Sinusitis		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		TRUE		531092	D012852	Sinusitis	OTG		Chronic sinusitis	https://genetics.opentargets.org/study/GCST90018823	2021			0.726936551187232	0.87	1	TSLP-D012852-D012852	Phase III	0.87	1	GWAS	GWAS Catalog	2021	0.0827		2	infection, respiratory	gwas	genetically supported target	FALSE
TSLP-D029424	0.807	3	TSLP-D029424	TSLP	D029424	Pulmonary Disease, Chronic Obstructive		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		530977	D001249	Asthma	OTG		Asthma	https://genetics.opentargets.org/study/GCST001182	2011			0.726936551187232	0.87	1	TSLP-D029424-D001249	Phase II	0.87	1	GWAS	GWAS Catalog	2011			1	respiratory	both	genetically supported target	FALSE
TYK2-D001172	1	3	TYK2-D001172	TYK2	D001172	Arthritis, Rheumatoid		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		535975	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis [EA]	https://genetics.opentargets.org/study/GCST002318_2	2013			0.0426014784074698	0.5	1	TYK2-D001172-D001172	Phase II	0.5	1	GWAS	GWAS Catalog	2013			1	musculoskeletal, dermatology, immune	gwas	genetically supported target	FALSE
TYK2-D001327	1	2	TYK2-D001327	TYK2	D001327	Autoimmune Diseases		Phase I	Phase I		3	2	TRUE				FALSE		535986	D001327	Autoimmune Diseases	OTG		Autoimmune traits	https://genetics.opentargets.org/study/GCST007071	2018			0.0426014784074698	0.55	1	TYK2-D001327-D001327	Phase I	0.55	1	GWAS	GWAS Catalog	2018			0	immune	both	genetically supported target	FALSE
TYK2-D011565	1	5	TYK2-D011565	TYK2	D011565	Psoriasis	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		536070	D011565	Psoriasis	OTG		Psoriasis	https://genetics.opentargets.org/study/GCST004346	2017			0.0426014784074698	0.5	1	TYK2-D011565-D011565	Launched	0.5	1	GWAS	GWAS Catalog	2017			3	dermatology	both	genetically supported target	TRUE
TYK2-D012859	0.81	3	TYK2-D012859	TYK2	D012859	Sjogren's Syndrome		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		535975	D001172	Arthritis, Rheumatoid	OTG		Rheumatoid arthritis [EA]	https://genetics.opentargets.org/study/GCST002318_2	2013			0.0426014784074698	0.5	1	TYK2-D012859-D001172	Phase II	0.5	1	GWAS	GWAS Catalog	2013			1	musculoskeletal, ophthalmology, dermatology, immune	both	genetically supported target	FALSE
TYK2-D015535	0.899	4	TYK2-D015535	TYK2	D015535	Arthritis, Psoriatic		Phase III	Phase III		5	4	TRUE	TRUE	TRUE		FALSE		536070	D011565	Psoriasis	OTG		Psoriasis	https://genetics.opentargets.org/study/GCST004346	2017			0.0426014784074698	0.5	1	TYK2-D015535-D011565	Phase III	0.5	1	GWAS	GWAS Catalog	2017			2	musculoskeletal, dermatology	both	genetically supported target	FALSE
TYR-D008545	1	3	TYR-D008545	TYR	D008545	Melanoma		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		536300	D008545	Melanoma	OTG		Melanoma	https://genetics.opentargets.org/study/GCST000437	2009			0.260609216349909	0.85	1	TYR-D008545-D008545	Phase II	0.85	1	GWAS	GWAS Catalog	2009		1.29	1	oncology	both	genetically supported target	FALSE
TYRP1-D008545	1	2	TYRP1-D008545	TYRP1	D008545	Melanoma	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		536413	D008545	Melanoma	OTG		Cutaneous malignant melanoma	https://genetics.opentargets.org/study/GCST010304	2020			0.651956323930846	0.66	1	TYRP1-D008545-D008545	Phase I	0.66	1	GWAS	GWAS Catalog	2020		1.0727311	1	oncology	both	genetically supported target	FALSE
VDR-D006973	1	2	VDR-D006973	VDR	D006973	Hypertension	Phase I		Phase I	2		2	TRUE	FALSE			FALSE		546574	D006973	Hypertension	OTG		Hypertension	https://genetics.opentargets.org/study/GCST90038604	2021			0.035001296344309	0.58	1	VDR-D006973-D006973	Phase I	0.58	1	GWAS	GWAS Catalog	2021		1.0191901078602	1	cardiovascular	both	genetically supported target	FALSE
VEGFA-D003924	1	2	VEGFA-D003924	VEGFA	D003924	Diabetes Mellitus, Type 2		Phase I	Phase I		3	2	TRUE				FALSE		546763	D003924	Diabetes Mellitus, Type 2	OTG		Type 2 diabetes	https://genetics.opentargets.org/study/GCST006867	2018			0.708950376721226	0.59	1	VEGFA-D003924-D003924	Phase I	0.59	1	GWAS	GWAS Catalog	2018		1.0561180829416046	0	metabolic, endocrine	both	genetically supported target	FALSE
VEGFA-D008269	0.816	5	VEGFA-D008269	VEGFA	D008269	Macular Edema	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE		546895	D008268	Macular Degeneration	OTG		Age-related macular degeneration	https://genetics.opentargets.org/study/GCST001100	2011			0.483123458392834	0.54	1	VEGFA-D008269-D008268	Launched	0.54	1	GWAS	GWAS Catalog	2011		1.1500000000000006	3	ophthalmology	both	genetically supported target	TRUE
VEGFA-D009216	0.936	5	VEGFA-D009216	VEGFA	D009216	Myopia	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	FALSE	2022	546937	D012030	Refractive Errors	OTG		Refractive error	https://genetics.opentargets.org/study/GCST010002	2020			0.483123458392834	0.55	1	VEGFA-D009216-D012030	Launched	0.55	1	GWAS	GWAS Catalog	2020			3	ophthalmology	both	genetically supported target	TRUE
VEGFA-D011471	1	3	VEGFA-D011471	VEGFA	D011471	Prostatic Neoplasms		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		546936	D011471	Prostatic Neoplasms	OTG		Prostate cancer	https://genetics.opentargets.org/study/GCST011049	2021			0.501558643979738	0.7	1	VEGFA-D011471-D011471	Phase II	0.7	1	GWAS	GWAS Catalog	2021		1.039	1	oncology	both	genetically supported target	FALSE
VEGFA-D012174	0.813	3	VEGFA-D012174	VEGFA	D012174	Retinitis Pigmentosa		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		546895	D008268	Macular Degeneration	OTG		Age-related macular degeneration	https://genetics.opentargets.org/study/GCST001100	2011			0.483123458392834	0.54	1	VEGFA-D012174-D008268	Phase II	0.54	1	GWAS	GWAS Catalog	2011		1.1500000000000006	1	ophthalmology, congenital	both	genetically supported target	FALSE
VEGFA-D014565	0.828	3	VEGFA-D014565	VEGFA	D014565	Urogenital Neoplasms		Phase II	Phase II		4	3	TRUE	TRUE			FALSE		546936	D011471	Prostatic Neoplasms	OTG		Prostate cancer	https://genetics.opentargets.org/study/GCST011049	2021			0.501558643979738	0.7	1	VEGFA-D014565-D011471	Phase II	0.7	1	GWAS	GWAS Catalog	2021		1.039	1	oncology	both	genetically supported target	FALSE
VEGFA-D050197	0.828	3	VEGFA-D050197	VEGFA	D050197	Atherosclerosis	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		FALSE		546754	D003324	Coronary Artery Disease	OTG		Coronary artery disease	https://genetics.opentargets.org/study/GCST005194	2017			0.568418314255983	0.74	1	VEGFA-D050197-D003324	Phase II	0.74	1	GWAS	GWAS Catalog	2017		1.03935465862725	2	cardiovascular	both	genetically supported target	FALSE
VWF-D006467	1	5	VWF-D006467	VWF	D006467	Hemophilia A	Launched	Launched	Launched	5	6	5	TRUE	TRUE	TRUE	TRUE	TRUE		550800	D006467	Hemophilia A	OTG		Factor VIII levels	https://genetics.opentargets.org/study/GCST000626	2010			0.36495970886405	0.71	1	VWF-D006467-D006467	Launched	0.71	1	GWAS	GWAS Catalog	2010			3	hematology, congenital	both	genetically supported target	TRUE
VWF-D013927	0.858	2	VWF-D013927	VWF	D013927	Thrombosis		Phase I	Phase I		3	2	TRUE				TRUE		550812	D020246	Venous Thrombosis	OTG		Deep venous thrombosis	https://genetics.opentargets.org/study/GCST90038615	2021			0.364293152824785	0.7	1	VWF-D013927-D020246	Phase I	0.7	1	GWAS	GWAS Catalog	2021		1.0016128692768	0	cardiovascular	both	genetically supported target	FALSE
VWF-D020246	1	3	VWF-D020246	VWF	D020246	Venous Thrombosis	Phase II		Phase II	3		3	TRUE	TRUE	FALSE		TRUE		550812	D020246	Venous Thrombosis	OTG		Deep venous thrombosis	https://genetics.opentargets.org/study/GCST90038615	2021			0.364293152824785	0.7	1	VWF-D020246-D020246	Phase II	0.7	1	GWAS	GWAS Catalog	2021		1.0016128692768	2	cardiovascular	both	genetically supported target	FALSE
WT1-D010051	0.839	3	WT1-D010051	WT1	D010051	Ovarian Neoplasms		Phase II	Phase II		4	3	TRUE	TRUE			TRUE		555754	D016889	Endometrial Neoplasms	OTG		Endometrial cancer	https://genetics.opentargets.org/study/GCST006464	2018			0.358490566037736	0.85	1	WT1-D010051-D016889	Phase II	0.85	1	GWAS	GWAS Catalog	2018		1.09330749409612	1	oncology	gwas	genetically supported target	FALSE
